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Development of the neural retina is a complex process requiring step-wise 
induction of specified retinal progenitor cells (RPCs) from the neural ectoderm and their 
coordinated proliferative expansion and differentiation into the mature neurons and glia 
of the adult retina. The homeobox gene Vsx2 is expressed in RPCs and required for 
proper execution of this retinal program. In the absence of Vsx2 function, maintenance of 
retinal identity, RPC proliferation, and retinal neurogenesis are disrupted, with serious 
consequences on overall ocular development and visual function. Despite the obvious 
importance of Vsx2, an understanding of the molecular mechanisms by which Vsx2 
regulates these processes is lacking and few direct targets have been identified. To further 
define the role of Vsx2, we sought to determine the relationship between Vsx2 and the 
extrinsic signaling pathways regulating RPC properties. Through the analysis of genetic 
chimeras and candidate signaling pathways, we evaluated the contribution of Vsx2 to the 
regulation of extrinsic signaling pathways involved in the cellular processes of retinal 
development. We find that Vsx2 mediates the response of RPCs to the signals driving 
retinal specification and maintenance, largely through cell autonomous repression of the 
RPE determinant Mitf. We also find that Vsx2-deficient RPCs exhibit a robust cell 
autonomous delay in the initiation of retinal neurogenesis, revealing an essential role for 
Vsx2 in the temporal regulation of neurogenic competence. In contrast, we find that 
regulation of RPC proliferation by Vsx2 involves significant cell nonautonomous 
iv 
 
contributions, suggesting an important role for Vsx2 in regulating the availability of 
retinal proliferation signals. Analysis of the retinal mitogen Sonic Hedgehog (Shh) and its 
signaling pathway in Vsx2-deficient retinas further supported this role, demonstrating 
that Vsx2 is required to ensure sufficient availability of Shh. We also describe a potential 
role for Vsx2 in the regulation of RPC responsiveness to Hedgehog (Hh) pathway 
stimulation. Taken together, the data presented in this dissertation demonstrate the 
requirement for Vsx2 in promoting both the reception and availability of the extrinsic 
signals necessary for the regulation of RPC properties, thereby ensuring the proper 
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Functional anatomy of the retina 
 The retina is the sensory neural tissue of the eye responsible for mediating the 
initial steps in vision. In the vertebrate eye, the retina lines the inner surface of the 
posterior aspect of the eyeball (Figure 1.1A). The retina is a laminated tissue composed 
of six major classes of retinal neurons, which include retinal ganglion cells, amacrine 
cells, horizontal cells, bipolar cells, and cone and rod photoreceptors (Figure 1.1B). 
These neurons are organized into three cellular layers separated by two neuropil layers 
where synaptic contacts are made between cell types. An important glial class in the 
retina is a type of radial glia known as Müller glia, whose processes span the three cell 
layers and provide important support functions for adjacent neurons. Microglia and 
astrocytes are also dispersed throughout the retina, migrating in from extraretinal sources. 
Basally, the retina bounds the vitreous body, an aqueous chamber filling the main cavity 
of the eyeball. Apically, the retina abuts the retinal pigmented epithelium (RPE), a 
pigmented epithelial monolayer providing important support functions for the retina. 
 The neural retina is a sensory tissue specialized for the detection, transduction, 
and transmission of visual information. Light entering the eye through the pupil is 
focused by the lens onto the retina (Figure 1.1A). Photons enter the retina from the vitreal 
side and pass through its transparent inner layers to the light-detecting cells in the outer 
nuclear layer (Figure 1.1B). Photoreceptors located in the outer nuclear layer are 
photosensitive by virtue of visual pigments in their outer segments that undergo a 
conformational change in response to the absorption of light photons. Photoreceptors 
transduce these light signals into electrical signals, which they then transmit to ganglion 
cells in the ganglion cell layer via electrical and chemical synapses with the horizontal, 
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bipolar, and amacrine interneurons of the inner nuclear layer. The functional circuits 
created by specific combinations of connections with these interneurons also provide 
initial processing of the visual image during this transmission. The resultant visual 
information is transmitted by ganglion cells, the projection neurons of the retina, via their 
axons, which exit the eye at the optic disc and travel through the optic nerve to visual 
processing centers of the brain. The structure and organization of the retina and its 
component parts are essential for their proper function. Thus, disruptions in the 
development of this tissue have severe consequences on visual function.  
 
Vertebrate retinal development 
 Development of the neural retina is a complex process requiring precise 
regulation of many cellular processes and gene functions. This process can be divided 
into two main developmental periods. In the first, the retinal fate is established through a 
step-wise induction process and associated with dramatic morphological changes. During 
the subsequent period of retinal histogenesis, this tissue undergoes extensive growth and 
maturation.  
 
Step-wise induction of retinal fate 
Eye field specification.  Induction of the retinal fate initiates early in vertebrate 
embryonic development, prior to overt morphological evidence of eye formation, with 
specification of the eye field. Early embryological studies in amphibian and chick 
embryos identified the existence of an eye anlagen, or eye field, in the anterior 
neuroepithelium of neurula stage embryos, which exhibits eye forming potential (Figure 
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1.2A) [reviewed in (Adelmann, 1936a, b)]. Studies in Xenopus identified a group of 
transcription factors whose overlapping expression patterns define the eye field (Zuber et 
al., 2003). Collectively, these genes are known as the vertebrate eye field transcription 
factors (EFTFs) and include ET, Rx1, Pax6, Six3, Lhx2, tll, and Optx2. These genes form 
a self-regulating transcriptional network that specifies the eye field (Zuber et al., 2003). 
Coordinated overexpression of these EFTFs together is sufficient to induce ectopic eyes 
even in nonneural tissues of the Xenopus embryo (Zuber et al., 2003) and to direct 
pluripotent cells from Xenopus animal caps to generate ectopic eye-like structures when 
transplanted into nonneural regions, as well as morphologically and functionally normal 
eyes when transplanted in place of the host eye field (Viczian et al., 2009). Specification 
of the eye field by EFTFs is highly conserved. A similar model of coordinated gene 
expression driving eye field specification has been proposed in Drosophila, involving 
homologs of the vertebrate EFTFs (Kumar, 2009). Many of these EFTFs are also critical 
for eye formation in the mouse. Rx, Pax6, Six3, and Lhx2 mouse mutants exhibit 
anophthalmia (absence of eyes) (Hill et al., 1991; Hogan et al., 1986; Lagutin et al., 2003; 
Mathers et al., 1997; Porter et al., 1997; Tucker et al., 2001). Detailed analyses of eye 
formation in these mice reveal that Pax6 and Lhx2 null mouse mutants progress past eye 
field specification and arrest in subsequent stages of retinal development (Baumer et al., 
2003; Hill et al., 1991; Porter et al., 1997; Yun et al., 2009). Failure of Rx and Six3 null 
mouse mutants to also progress into subsequent stages of retinal development suggests 
that Rx and Six3 may be the key mediators of eye field specification. In support of such a 
role for Rx, Rx null cells are excluded from the eye field in genetic chimeras, suggesting 
that they lack eye field identity (Medina-Martinez et al., 2009). Despite early expression 
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in the eye field, Optx2/Six6 and Tll are also not required for early specification of the eye 
field, as eye formation occurs in Six6 and Tll null mouse mutants (Li et al., 2002; Yu et 
al., 2000).  
Many extrinsic signals have been implicated in the induction of the eye field. 
Most are known neuralizing signals, involved in directing anterior neural fate. 
Misexpression of the secreted BMP inhibitors noggin and chordin (in the presence of 
Otx2) induce expression of EFTFs in pluripotent cells of Xenopus animal caps (Zuber et 
al., 2003). Furthermore, Noggin also directs these cells to a retinal fate and eye formation 
(Lan et al., 2009; Viczian et al., 2009). Multiple members of Wnt/Fz signaling have also 
been implicated. Signaling through the Wnt receptor Frizzled 3 (Fz3) is both necessary 
and sufficient to promote expression of EFTFs and eye formation in Xenopus (Rasmussen 
et al., 2001). Similarly, Wnt11/Fz5 signaling through the noncanonical pathway also 
promotes expression of EFTFs and eye formation. In contrast, Wnt8b/Fz5 signaling 
through the canonical Wnt/β-catenin pathway antagonizes eye field induction and 
promotes caudal diencephalon fate (Cavodeassi et al., 2005). Notch is an important eye-
inducing signal in Drosophila (Kurata et al., 2000). In vertebrates, constitutively active 
Notch induces expression of EFTFs in animal cap assays and promotes duplication of eye 
structures in Xenopus (Onuma et al., 2002). Insulin-like growth factors (IGFs) also 
promote ectopic eye formation in neural tissues (Eivers et al., 2004; Pera et al., 2003; 
Pera et al., 2001; Richard-Parpaillon et al., 2002). In many cases it is not clear whether 
these signals contribute to the induction of an eye field or simply promote anterior neural 
fates. Thus, the precise role of these signals in the specification of the eye field is 
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currently poorly defined. Moreover, how these signals integrate together to effectively 
promote eye field specification will require future attention.  
Following specification, the single central eye field is subsequently resolved into 
bilateral eye primordial (Figure 1.2B). Lineage tracing experiments in Xenopus revealed 
that bifurcation occurs due to suppression of eye field potential in the medial domain, 
rather than by lateral migration of eye field cells (Li et al., 1997). This suppression is 
signaled from the underlying prechordal plate (Li et al., 1997). Removal of the prechordal 
plate prevents bifurcation of the eye field and promotes cyclopia (Adelmann, 1936b; Li et 
al., 1997). Current evidence suggests that the prechordal plate-derived bifurcation signal 
is sonic hedgehog (Shh) (Chiang et al., 1996; Furimsky and Wallace, 2006; Geng et al., 
2008; Rorick et al., 2007), consistent with findings of cyclopia in Shh and hedgehog (Hh) 
pathway mutants (Chiang et al., 1996; Ekker et al., 1995; Macdonald et al., 1995; Zhang 
et al., 2001). 
Patterning of the optic neuroepithelium.  Further induction of the retinal fate 
within the EFTF-defined neuroepithelium of these bilateral eye fields results from 
patterning. This patterning involves interactions with neighboring tissues and complex 
morphological changes of the neuroepithelium. From the bilateral eye fields, evagination 
of the EFTF-defined neuroepithelium forms the bilateral optic vesicles (Figure 1.2C). In 
mammals, this is immediately preceded by evagination of the presumptive forebrain, 
forming the optic pit. Contact of the evaginating optic vesicle with the overlying surface 
ectoderm induces formation of the lens placode in the adjacent surface ectoderm (Figure 
1.2D). Subsequent invagination of the lens placode and distal optic vesicle generates the 
lens vesicle and bilayered optic cup (Figure 1.2E). The inner neuroepithelial layer of the 
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optic cup further develops into the neural retina, while the outer neuroepithelial layer 
forms the RPE. Cells located in the peripheral optic cup, at the border between the retina 
and RPE, eventually give rise to parts of the iris and ciliary body. The optic stalk derives 
from the ventral proximal aspect of the optic vesicle. The morphogenetic process of 
invagination that forms the optic cup continues ventrally into the proximal aspect of the 
optic vesicle, forming the choroid fissure along the length of the optic stalk. Blood 
vessels and projecting axons traverse through this fissure, which eventually gives rise to 
the optic nerve.  
Establishment of the retinal domain within the EFTF-defined optic 
neuroepithelium results from patterning of the optic vesicle. By the late optic vesicle 
stage, regional patterning establishes restricted expression of several transcription factors, 
which mark the presumptive domains of the retina, RPE, and optic stalk (Figure 1.2 D). 
Expression of the paired-like homeobox gene Vsx2 is induced in the distal optic vesicle 
and marks the presumptive retina (Liu et al., 1994). Expression of Mitf, a basic helix-
loop-helix gene, in the dorsal proximal region of the optic vesicle marks the presumptive 
RPE. In mouse, Mitf is initially broadly expressed throughout the optic vesicle, but 
expression becomes restricted by the late optic vesicle stage (Bora et al., 1998; 
Nakayama et al., 1998; Nguyen and Arnheiter, 2000). Downregulation of Mitf in the 
distal domain coincides with Vsx2 upregulation (Horsford et al., 2005), consistent with 
reports that Mitf transcription is directly repressed by Vsx2 (Bharti et al., 2008). 
Moreover, Mitf expression persists throughout the presumptive retina in Vsx2 null mouse 
mutants (Horsford et al., 2005; Rowan et al., 2004). Whether Mitf exerts reciprocal 
transcriptional repression of Vsx2 to further define the boundary between the retina and 
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RPE is still unclear, but appears unlikely as misexpression of Mitf in the presumptive 
retinal domain failed to alter retinal identity (Horsford et al., 2005). In chick, the 
existence of an initially broad Mitf expression domain remains controversial (Fuhrmann 
et al., 2000; Muller et al., 2007). In the ventral proximal region of the optic vesicle, the 
presumptive optic stalk domain is marked by expression of the ventral determinant and 
paired homeobox gene, Pax2, and absence of Vsx2 (Baumer et al., 2003; Nornes et al., 
1990; Schwarz et al., 2000). These region-specific factors not only mark their respective 
domains but also facilitate maintenance of their respective regional identities (Horsford et 
al., 2005; Rowan et al., 2004; Schwarz et al., 2000).  
Axial patterning of the optic neuroepithelium also begins during optic vesicle 
stages. The most prominent and well characterized is dorsal-ventral patterning. Like 
Pax2, the homeobox genes Vax1 and Vax2 also exhibit restricted expression to the 
ventral optic vesicle (Mui et al., 2005; Ohsaki et al., 1999; Take-uchi et al., 2003). In 
contrast, Pax6, another paired homeobox gene and EFTF, and Tbx5, a T-box gene, 
exhibit dorsal-specific expression in the optic vesicle  (Baumer et al., 2003; Behesti et al., 
2006; Schwarz et al., 2000; Sowden et al., 2001; Walther and Gruss, 1991). Initially, 
Pax6 and Pax2 are co-expressed throughout the early optic vesicle, but later exhibit 
complementary expression along the dorsal-ventral axis (Baumer et al., 2003). Pax6 and 
Pax2 transcriptionally repress each other and their respective expression domains expand 
in the absence of the other (Schwarz et al., 2000). Vax1 and Vax2 also transcriptionally 
repress Pax6 (Mui et al., 2005). Thus, the boundary between the retina and optic stalk is 
established by reciprocal transcriptional repression of Pax2 and Pax6, facilitated in part 
by Vax1 and Vax2. Nasal-temporal patterning also occurs within the optic vesicle, but is 
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not as well characterized. Some factors exhibit patterning along both axes. For example, 
the ventral determinant Vax1 also exhibits differential naso-temporal expression, with 
expression restricted nasally (Mui et al., 2005).  
Regional patterning of the optic vesicle occurs primarily along the dorsal-ventral 
axis, and therefore, it is perhaps not surprising that these patterning events are linked. For 
example, the ventral determinants Pax2, Vax1, and Vax2 are all required for proper 
development of the optic stalk (Mui et al., 2005; Schwarz et al., 2000; Take-uchi et al., 
2003). Furthermore, disruption of dorsal-ventral patterning by inverting the polarity of 
the optic vesicle during the critical period in which this patterning is established blocks 
retina and RPE formation. Inversion before or after this critical period resulted in normal 
or inverted expression, respectively, of both dorsal and ventral gene expression, which in 
turn permitted subsequent determination of the retinal and RPE domains (Uemonsa et al., 
2002). Together, these findings demonstrate that regional fate determination within the 
optic vesicle is tightly coupled to dorsal-ventral patterning.  
Regional and axial patterning of the optic vesicle is driven by inductive signals 
from neighboring tissues and the optic vesicle itself. Despite much effort, induction of the 
retinal fate within the optic neuroepithelium remains incompletely defined. Removal of 
the overlying surface ectoderm blocks induction of Vsx2 expression and subsequent 
retina formation (Hyer et al., 1998; Nguyen and Arnheiter, 2000), suggesting that signals 
from the surface ectoderm direct specification of the presumptive retinal domain within 
the optic vesicle. These surface ectoderm-derived signals have been proposed to be 
members of the FGF family due to the unique ability of members of this signaling class 
to direct the presumptive RPE towards a retinal fate (Nguyen and Arnheiter, 2000; 
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Pittack et al., 1997; Vogel-Hopker et al., 2000; Zhao et al., 2001; Zhao and Overbeek, 
1999). FGF1 and FGF2 are expressed in the surface ectoderm overlying the distal optic 
vesicle (Nguyen and Arnheiter, 2000; Pittack et al., 1997), and experimental 
manipulations supplying these signals are sufficient to restore Vsx2 expression and retina 
formation in the absence of surface ectoderm (Hyer et al., 1998; Nguyen and Arnheiter, 
2000). Additionally, FGF2 neutralizing antibodies block retina formation (Pittack et al., 
1997). However, Fgf1/2 double knockout mice lack obvious eye defects, suggesting that 
FGF1 and FGF2 are not the retina-inducing signals in the surface ectoderm. In addition to 
FGF1 and FGF2, several other FGF family members are also sufficient to direct the 
presumptive RPE towards a retinal fate. Thus, it is possible that other FGF family 
members present in the surface ectoderm normally mediate this function or are able to 
compensate for the loss of FGF1 and FGF2.  
Ras-dependent MAPK signaling within the optic neuroepithelium is both 
necessary and sufficient for retina formation. The protein tyrosine phosphatase Shp2 is 
essential for full activation of MAPK signaling in response to growth factor stimulation 
of receptor tyrosine kinases (Dance et al., 2008). Conditional inactivation of Shp2 in the 
optic vesicle resulted in cell autonomous loss of Vsx2 expression and disrupted retinal 
development in the inactivated area. Furthermore, activated Ras, a downstream 
component of the pathway, restored Vsx2 expression and retinal development in Shp2 
mutants (Cai et al., 2010). Activated Ras is also sufficient to direct the presumptive RPE 
towards a retinal fate (Zhao et al., 2001).  
FGF receptors are receptor tyrosine kinases capable of signaling through the Ras-
dependent MAPK pathway (Szebenyi and Fallon, 1999) and the ability of at least FGF2 
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to direct the presumptive RPE towards a retinal fate requires Shp2 (Cai et al., 2010). 
Thus, an attractive model for retinal induction is one in which FGF signals from the 
overlying surface ectoderm activate Ras-dependent MAPK signaling in the distal domain 
of the optic vesicle. Other receptor tyrosine kinases also activate the MAPK pathway. 
Thus, the surface ectoderm-derived signal for retinal specification may actually be a non-
FGF ligand that activates Ras-dependent MAPK signaling. Consistent with this, 
exogenous EGF is also sufficient to restore Vsx2 induction and retina formation in the 
absence of surface ectoderm (Nguyen and Arnheiter, 2000). Interestingly, EGF is not 
sufficient to direct the presumptive RPE towards a retina fate (Nguyen and Arnheiter, 
2000), possibly due to absence of the appropriate receptors within this domain. However, 
a model in which non-FGF signals induce the retinal fate fails to account for the ability of 
FGF2 neutralizing antibodies to block retina formation. An intriguing addition to these 
models, and one that helps account for the activity of FGF2 neutralizing antibodies, is the 
possibility that surface ectoderm signals (FGF or others) establish an FGF-expressing 
domain within the optic vesicle itself that in turn induces Vsx2 and retinal fate through 
autocrine signaling (Chow and Lang, 2001; Horsford et al., 2005; Nguyen and Arnheiter, 
2000). In support of this model, expression of FGF15 initiates within the presumptive 
retina around the same time as Vsx2 (McWhirter et al., 1997; Nguyen and Arnheiter, 
2000) and this expression is also lost when Ras-MAPK signaling is disrupted in Shp2 
conditional mutants (Cai et al., 2010). However, ocular defects have not been reported in 
Fgf15 knockout mice (Vincentz et al., 2005), suggesting that FGF15 may not be an 
essential factor for induction of the retinal domain. FGF8 and FGF9 also exhibit 
expression within the optic vesicle. FGF9 is expressed in the distal optic vesicle and both 
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targeted and transient misexpression within the proximal optic vesicle directs the 
presumptive RPE toward a retinal fate (Zhao et al., 2001; Zhao and Overbeek, 1999). 
However, evaluation of ocular development in Fgf9 knockout mice reveals only minor 
expansion of the RPE into the peripheral retina, suggesting that FGF9 is also not required 
for initial specification of the retinal fate; rather, FGF9 is important for defining the 
boundary between the retina and adjacent RPE (Zhao et al., 2001). In chick, FGF8 
expression in the distal optic vesicle initiates soon after contact with the surface ectoderm 
(Vogel-Hopker et al., 2000). However, ocular defects have not been reported in mice 
carrying targeted Fgf8 hypomorphic or null alleles (Frank et al., 2002; Meyers et al., 
1998). Although these loss-of-function studies fail to implicate a specific FGF signal in 
the induction of the retinal fate, it is possible that other FGFs compensate for their loss. 
Thus, identification of the retinal-inducing signal and its tissue source requires further 
research.  
 Additional inductive signals from adjacent tissues direct specification of the RPE 
and optic stalk and mediate dorsal-ventral patterning within the optic neuroepithelium.  
Extraocular tissues from the dorsal head region are both necessary and sufficient to 
specify the RPE fate in the chick optic vesicle (Kagiyama et al., 2005). Additional studies 
demonstrated that extraocular mesenchyme, but not surface ectoderm, is required for 
RPE specification (Fuhrmann et al., 2000). The ability of activin to restore RPE 
development in the absence of extraocular tissues suggests that activin or other activin-
like signals from the extraocular mesenchyme specify the RPE fate (Fuhrmann et al., 
2000). Shh emanating from the midline of the ventral forebrain ventralizes the optic 
vesicle by inducing the ventral determinants Pax2, Vax1, and Vax2 to promote 
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subsequent development of the optic stalk (Chiang et al., 1996; Ekker et al., 1995; 
Furimsky and Wallace, 2006; Macdonald et al., 1995; Take-uchi et al., 2003). BMP4 
signals from the optic vesicle itself are both necessary and sufficient to induce dorsal 
fates (Behesti et al., 2006; Murali et al., 2005). Canonical Wnt signaling through β-
catenin is both necessary and sufficient to direct specification of peripheral fates (iris and 
ciliary body) from the optic neuroepithelium (Cho and Cepko, 2006). This patterning 
may initiate as early as the optic vesicle stage via Wnt2b signals from the dorsal surface 
ectoderm (Cho and Cepko, 2006). While these signals do not directly induce the retinal 
fate, disruptions of these signals or their downstream regional and axial determinants 
often indirectly affect retinal specification.  
Regional and axial patterning of the optic neuroepithelium requires both inductive 
signals and an underlying competence to respond to these signals. The LIM homeobox 
gene and EFTF, Lhx2, is an essential link between these inductive signals and their 
regional and axial determinants. In Lhx2 null mice, eye field specification occurs, but 
development arrests at the optic vesicle stage and the optic cup and lens never form, 
resulting in anophthalmia (Porter et al., 1997). Both regional and axial patterning of the 
optic vesicle fails in the absence of Lhx2, as expression of regional and dorsal-ventral 
determinants either fails to initiate or is not maintained (Yun et al., 2009). Lhx2 mediates 
these patterning events through both cell autonomous and cell nonautonomous regulation, 







Once the presumptive retinal domain is specified, further development is required 
for the formation of a mature and functional retina. Although the retinal fate is initially 
specified in these retinal progenitor cells (RPCs), this identity requires active 
maintenance. Furthermore, the small population of RPCs specified in the optic vesicle 
undergoes robust proliferative expansion to generate the necessary cell numbers for 
population of the adult retina. From these proliferating RPCs, retinal neurogenesis 
produces the six classes of retinal neurons and one of the three types of glia present in the 
mature retina. Collectively, these developmental processes define the period of retinal 
histogenesis. 
Maintenance of retinal identity.  Experimental manipulations in the mouse 
indicate that initial specification of retinal identity in optic neuroepithelial cells of the 
distal optic vesicle is not sufficient for subsequent retinal development. Removal of the 
overlying surface ectoderm after initial induction of Vsx2 and FGF15 in the presumptive 
retinal domain abrogated neural retina formation (Nguyen and Arnheiter, 2000). Initial 
expression of Vsx2 was lost in the distal optic vesicle resulting in maintained Mitf 
expression and subsequent pigmentation, suggesting differentiation into RPE. The ability 
of FGFs and EGF to prevent these changes in the absence of surface ectoderm suggests 
that many of the same signals or signaling pathways implicated in the specification of 
retinal identity are also involved in its maintenance. The intrinsic factor Vsx2 is also 
required for maintenance of retinal identity, particularly for the prevention of aberrant 
gene expression programs and promoting RPC properties (Horsford et al., 2005; Rowan 
et al., 2004).  
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The requirement for active maintenance of retinal identity may be transient. 
Impairment of MAPK signaling (activated by FGFs and other tyrosine kinase receptors) 
through conditional inactivation of Shp2 in the retina revealed that only early inhibition 
of the pathway during the optic vesicle stage disrupted retinal development. Effective 
blockade of MAPK signaling at later optic cup stages failed to disrupt retinal 
development, suggesting that retinal identity may no longer require active maintenance at 
later stages (Cai et al., 2010). Alternatively, another pathway or intrinsic factor may 
fulfill such a role at later ages. Conditional inactivation of Vsx2, for example, at later 
stages has not been performed.  
RPC proliferation.  Extensive proliferative expansion of the RPC population is the 
principal mechanism of retinal growth. Total cell number increases dramatically during 
retinal histogenesis. Quantification of this increase in the rat retina revealed that over a 
period of approximately 17 days, beginning at embryonic day 14 (E14), total retinal cell 
number increased 400-fold, from 62000 to nearly 25 million (Alexiades and Cepko, 
1996). RPC proliferation largely accounts for the increase in retinal cell number. 
Astrocytes, microglia and vascular-associated cells migrate into the retina via the hyaloid 
artery and choroid fissure of the optic stalk during this period and partially contribute to 
the increase in retinal cell number. However, the influx of astrocytes in the rat retina 
involves a relatively small number of cells and begins after the peak rate of increase in 
total cell number (Watanabe and Raff, 1988). Microglial migration occurs early, during 
the period of rapid cell number increase, but analysis of retinal microglia reveals a 
relatively small contribution to total retinal cell number in the rat (Ashwell et al., 1989). 
The striking increase in cell number in the developing retina is also region specific. The 
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RPE develops from a similarly sized region of the optic vesicle immediately adjacent to 
the presumptive retinal domain and maintains close proximity with the developing neural 
retina; however, cell number differs greatly between these tissues throughout 
development.  
 Regulation of proliferation ultimately must influence progression through the cell 
cycle (Figure 1.3A). The decision to reenter the cell cycle occurs during the G1 phase at 
the restriction point and is tightly regulated [reviewed in (Giacinti and Giordano, 2006; 
Levine and Green, 2004; Lundberg and Weinberg, 1999)]. Failure to progress past this 
critical G1 checkpoint forces cells into G0 and cell cycle exit. Progression through G1 
past the restriction point and into S phase is driven by the activation of the G1 cyclin-
dependent kinases (CDKs) Cdk4/6 and Cdk2 and inhibition of cyclin-dependent kinase 
inhibitors (CDKIs), such as KIP and INK family members (Figure 1.3B). These 
regulatory activities are mediated by the G1 cyclins (D- and E-cyclins). The resulting 
inactivation of retinoblastoma proteins (RB) through step-wise CDK-mediated 
phosphorylation releases RB-mediated inhibition of the E2F transcription factors. E2Fs 
activate transcription of target genes necessary for progression into S-phase. E2F targets 
include E-cyclins, establishing a positive feedback loop that ensures progression into S 
phase. Expression analyses and manipulation of many of these G1 components suggests 
that this regulatory pathway is active in RPC proliferation (Levine and Green, 2004).  
Mitogens are essential extrinsic regulators of proliferation. Mitogens are required 
in G1 prior to the restriction point for progression through the cell cycle (Figure 1.3A). 
Beyond the restriction point, further exposure to mitogens is no longer necessary as the 
cell is intrinsically committed to progress through the remaining phases of the cell cycle 
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and divide. Mitogen signaling in G1 induces rapid upregulation of D-cyclins to initiate 
the regulatory cascade driving the G1-to-S phase transition (Figure 1.3B). Consistent 
with this role, inhibition of mitogen signaling in the absence of RB proteins fails to block 
G1 progression dependent on those mitogens [reviewed in (Giacinti and Giordano, 2006; 
Levine and Green, 2004; Lundberg and Weinberg, 1999)]. In the retina, many 
extracellular signals are mitogenic for RPCs, including Shh (Jensen and Wallace, 1997; 
Sakagami et al., 2009; Wang et al., 2005), TGFα (Anchan et al., 1991; Lillien and Cepko, 
1992), TGFβ3 (Anchan and Reh, 1995), FGF2 and FGF1 (Lillien and Cepko, 1992), EGF 
(Anchan et al., 1991; Lillien and Cepko, 1992), VEGF (Hashimoto et al., 2006), NT-
3/Trk C signaling (Das et al., 2000), and Wnts (Kubo et al., 2003, 2005; Sanchez-
Sanchez et al., 2010; Van Raay et al., 2005). 
 Cyclin D1 (Ccnd1) is a critical intrinsic regulator of RPC proliferation in the 
developing retina. As mentioned, D-cyclins are an integral part of the cell cycle 
machinery, driving the regulatory cascade that promotes S phase entry (Figure 1.3B). 
Ccnd1 null mice exhibit hypocellular retinas as a result of impaired RPC proliferation 
(Das et al., 2009; Fantl et al., 1995; Ma et al., 1998; Sicinski et al., 1995). Kinetics 
analysis revealed a lengthened cell cycle in Ccnd1 null retinas that was largely 
independent of changes in S phase time, suggesting that Ccnd1 is required to ensure the 
proper rate of progression of RPCs through the cell cycle (Das et al., 2009). Cyclin D3 
(Ccnd3) is also expressed in the retina and prematurely upregulated in the absence of 
Ccnd1 (Das et al., 2009; Das et al., 2012). However, genetic deletion of Ccnd3 in Ccnd1 
null retinas had little effect on the cell cycle progression of RPCs, indicating that the 
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upregulation of Ccnd3 in RPCs was unable to compensate for the loss of Ccnd1 in the 
regulation of RPC proliferation, at least at P0 (Das et al., 2012).  
 In addition to Ccnd1 and components of the cell cycle machinery, many other 
intrinsic factors have also been implicated in the regulation of RPC proliferation. The 
propensity of RPCs to proliferate appears to be tightly linked with their specification. 
Most of the EFTFs are reported to promote RPC proliferation, including Rx, Pax6, Six6, 
Six3, and Tll. Furthermore, many of these have been shown to regulate components of 
the cell cycle machinery [reviewed in (Agathocleous and Harris, 2009; Levine and Green, 
2004)]. Sox2 is also expressed throughout retinal development and its restricted 
expression in the neural retina is essential for RPC proliferation. Conditional inactivation 
of Sox2 in RPCs dramatically reduced the number of cycling RPCs (Taranova et al., 
2006). Additionally, the retina-specific marker Vsx2 is also critical for proper regulation 
of RPC proliferation. Vsx2-deficient mice exhibit aberrant retinal expression of cell cycle 
components, severely reduced RPC proliferation, and hypocellular retinas (Burmeister et 
al., 1996; Green et al., 2003; Levine and Green, 2004).  
Regulation of RPC proliferation is dynamic. Expression of the intrinsic regulators 
and extrinsic mitogens changes both temporally and spatially during the proliferative 
period. For example, the EFTF Six6 promotes RPC proliferation in mouse, at least in part 
through its interaction with Dach2 to transcriptionally repress p27/Kip1, and Six6 null 
mice exhibit severely hypolplastic retinas (Li et al., 2002). However, Six6 expression is 
progressively downregulated in embryonic RPCs during optic cup stages, suggesting that 
it may not participate in the regulation of postnatal RPC proliferation (Li et al., 2002). A 
second example is the retinal mitogen Shh, which is first expressed by ventral midline 
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cells and then later by retinal ganglions cells soon after their differentiation. Expression 
of Gli1, a target gene whose expression is solely dependent upon active Hh signaling, 
reveals dynamic activation of this signaling pathway in RPCs in response to these 
changes in the source of Shh.  Expression of Gli1 in the optic vesicle reveals active 
signaling in response to midline Shh; however, this signaling is transient and Gli1 is 
dramatically downregulated in the early optic cup (Furimsky and Wallace, 2006). As 
ganglion cell differentiation proceeds in a central-to-peripheral wave across the optic cup, 
upregulation of Gli1 in adjacent RPCs closely follows, also expanding in a central-to-
peripheral manner, but lagging behind the leading edge of ganglion cell differentiation 
(Wang et al., 2005). Thus, RPCs experience both temporal and spatial changes in their 
exposure to the potentially mitogenic effects of Shh. Retinal neurons also produce anti-
mitogenic signals. TGFβ1 and TGFβ2 inhibit RPC proliferation in vitro and are 
expressed in the postnatal retina together with their receptors (Close et al., 2005). 
Furthermore, inhibition of TGFβ signaling blocks the anti-mitogenic effect of retinal 
neurons in in vitro cultures and increases and extends postnatal RPC proliferation in vivo  
(Close et al., 2005). These findings suggest that as retinal neurons accumulate in the 
postnatal retina, the increased activation of TGFβ signaling, likely in response to 
accumulating expression of retinal neuron-derived TGFβ2 or TGFβ1, drives the postnatal 
decline in RPC proliferation. 
In addition to developmental changes in the expression of mitogen signals 
themselves, the responsiveness of RPCs to these mitogens also changes over time. For 
example, TGFα, FGF2, and FGF1 are mitogenic for RPCs; however, between E15 and P0 
(~7 days) the responsiveness of RPCs to both FGF2 and FGF1 decreased, while 
20 
 
responsiveness to TGFα increased (Lillien and Cepko, 1992). The increased 
responsiveness of RPCs to TGFα correlated with a dramatic increase in the expression of 
EGF receptors (which mediate TGFα signaling) over the same time period. Increasing 
EGF receptor number using retroviral infection at the early time points increased RPC 
responsiveness to endogenous signals, suggesting that changes in EGF receptor 
expression likely underlie the observed changes in RPC responsiveness to TGFα and may 
be relevant to regulation of RPC proliferation in vivo (Lillien and Wancio, 1998).  
Retinal neurogenesis.  Retinal neurogenesis produces the six classes of retinal 
neurons (ganglion cells, amacrine cells, bipolar cells, horizontal cells, and rod and cone 
photoreceptors) and one glial cell type (Müller glia) from a common pool of multipotent 
RPCs (Turner et al., 1990). Generation of the seven classes of retinal cell types occurs 
according to an evolutionarily conserved sequence such that each cell type is produced 
during a limited, but overlapping period (Figure 1.4A). Ganglion cells are born first, 
followed by cones, horizontal cells, amacrine cells, rods, bipolar cells, and, lastly, Müller 
glia (Young, 1985). Retinal neurogenesis is tightly regulated and proceeds in a specific 
spatio-temporal pattern. Neurogenesis initiates at different times in different parts of the 
retina. In the mouse, initiation occurs in the central retina, dorsal to the optic stalk, and 
progresses in a peripherally-spreading wave (Figure 1.4B) (Hufnagel et al., 2010). Thus, 
development in the peripheral retina lags behind that of the central retina. In other 
vertebrates, location of initiation and direction of spread may differ slightly, but all show 
a wave of neurogenic progression that generally proceeds in a central-to-peripheral 
fashion (Kay et al., 2005; McCabe et al., 1999). Following specification and migration 
21 
 
into the appropriate retinal layer, these retinal neurons and glia undergo further 
maturation, send out processes and establish synaptic connections. 
Retinal cell fate determination is largely mediated by members of the homeobox, 
bHLH, and forkhead transcription factor families [reviewed in (Ohsawa and Kageyama, 
2008)]. Many of these genes are required for retinal cell type differentiation, and in their 
absence, the relevant cell type is not produced. However, many of these genes appear to 
only bias RPCs toward a particular cell fate, as not all cells expressing these genes will 
go on to differentiate into that cell type, which has been described for ath5 and ganglion 
cell determination (Mu and Klein, 2004; Yang et al., 2003). Furthermore, many of these 
genes are inefficient at promoting the relevant cell types on their own. Instead, specific 
combinations of these factors are required. An intriguing hypothesis that will require 
further evaluation is that homeobox genes specify the nuclear layer, while bHLH genes 
specify the particular cell type within that layer (Ohsawa and Kageyama, 2008). 
Additional levels of regulation are required, however, because factors specifying different 
cell types are often coexpressed within the same cell. Thus, in addition to transcriptional 
regulation of these factors, posttranslational regulation through phosphorylation and 
SUMOylation or posttranscriptional regulation through the regulation of mRNA stability 
or translation are also important for cell fate determination [reviewed in (Andreazzoli, 
2009)].  
Extrinsic signals also participate in the regulation of cell fate decisions. In chick 
and mouse, Shh, Gdf11, and VEGF inhibit the ganglion cell fate, while TGFβ inhibits 
amacrine cell differentiation. These signals are secreted by the cell types they inhibit, 
providing a negative feedback loop to locally control cell type generation (Hashimoto et 
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al., 2006; Kim et al., 2005; Ma et al., 2007; Wallace, 2008; Wang et al., 2005). Shh has 
also been implicated in promoting Müller glia and possibly bipolar cell fate, independent 
of its effects on proliferation (Wallace, 2008). Notch signaling also appears to regulate 
cell fate decisions, with specific ligand and receptor combinations promoting ganglion 
cell or cone fates (Jadhav et al., 2006a; Jadhav et al., 2006b; Riesenberg et al., 2009; 
Rocha et al., 2009; Yaron et al., 2006). 
Retinal neurogenesis produces the seven retinal cell types from a common pool of 
multipotent RPCs. However, the observation of single clones comprised entirely of rod 
photoreceptors, even from early progenitors, provides some evidence for a subpopulation 
of lineage-biased progenitors (Turner et al., 1990). Conditional ablation of Pax6 restricts 
RPCs to the amacrine cell fate, suggesting that Pax6 controls much of the multipotency 
of RPCs (Marquardt et al., 2001). Consistent with a role in mediating RPC multipotency, 
Pax6 transcriptionally activates several bHLH factors involved in biasing RPCs towards 
particular retinal cell fates, with the notable exception of NeuroD, which promotes the 
amacrine cell fate (Marquardt et al., 2001). Although RPCs are multipotent, their 
potential for generating the different retinal cell types changes over time. The prevailing 
model for this temporal change in developmental potential argues that as development 
proceeds, RPCs progress unidirectionally through competence states that restrict the 
subsets of retinal cell types RPCs can generate during a given period. Regulation of these 
competence states appears largely intrinsic. Early progenitors only generate early cell 
types, while late progenitors only generate late cell types, even in heterochronic 
environments [reviewed in (Cepko et al., 1996; Livesey and Cepko, 2001)]. In mouse, 
ikaros was recently identified as a critical intrinsic factor conferring competence for the 
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generation of early born cell types. The effects of ikaros loss of function and 
misexpression on cell type generation suggest the presence of at least three different 
temporal competence states through which RPCs pass (Elliott et al., 2008). However, the 
precise number of temporal competence states in mouse is not known, nor are the 
remaining intrinsic factors defining these competence states and controlling their 
temporal progression. Although extrinsic signals have little contribution to the definition 
of these temporal competence states, signaling may act to refine their temporal 
progression. The observation that RPCs are intrinsically competent to generate ganglion 
cells for a period following the normal termination of ganglion cell genesis has led to the 
suggestion that feedback inhibition blocks cell type generation until intrinsic changes in 
competence are established (Kim et al., 2005; Wallace, 2011).  
 The initiation of neurogenesis is regulated both temporally and spatially by 
intrinsic and extrinsic factors. Delta-Notch signaling is a central regulator of neurogenesis 
in the CNS. In the retina, inhibition of Notch signaling in loss of function mutants for 
Notch pathway components promotes precocious neurogenesis, while constitutive 
activation of Notch signaling delays neurogenesis (Bao and Cepko, 1997; Riesenberg et 
al., 2009; Tomita et al., 1996; Yaron et al., 2006). In retinas of Hes1 null mutants, 
precocious neurogenesis began days before normal initiation in wild type retinas, while 
still retaining, in large part, the normal temporal progression of cell type determinants 
(Lee et al., 2005). These findings suggest that Hes1, possibly in its role as a 
transcriptional effector of Notch signaling, mediates the temporal onset of retinal 
neurogenesis. Sox2 is required to confer neurogenic competence. Conditional ablation of 
Sox2 not only blocks RPC proliferation but also cell autonomously prevents 
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differentiation of RPCs. The role for Sox2 in promoting neurogenic competence in RPCs 
is mediated in large part through Sox2-dependent regulation of Notch1 expression 
(Taranova et al., 2006).  
The initiation of neurogenesis in the central retina may be induced by FGF signals 
from the optic stalk or central retina. In zebrafish, signals from the distal optic stalk tissue 
are both necessary and sufficient for the induction of the initial patch of ath5 expression 
and ganglion cell differentiation in the ventro-nasal retina (Masai et al., 2000). FGF8 was 
sufficient to restore the initiation of ganglion cell differentiation in the absence of 
specified optic stalk tissue. Furthermore, the ventro-nasal expression of ath5 is prevented 
in fgf3/fgf8 double mutants or through pharmacological inhibition of FGFs (Martinez-
Morales et al., 2005). In the chick, FGF3 and FGF8 are expressed in overlapping patterns 
in the central retina and FGF8 is additionally expressed in the optic stalk (Martinez-
Morales et al., 2005). The ability of FGF8 to induce secondary ectopic sites of ganglion 
cell differentiation and pharmacological inhibition to block normal differentiation 
(Martinez-Morales et al., 2005) suggests that the role of a central FGF signaling center in 
the induction of the initial patch of ganglion cell differentiation may be conserved. 
Regulation of the subsequent progression of neurogenesis from the initial central 
patch is controversial. The sequential induction model proposes that signals, likely Hh, 
from nascent neurons induce neighboring RPCs to differentiate, thereby propagating a 
wave of ganglion cell differentiation across the retina (Neumann and Nuesslein-Volhard, 
2000). However, expression of the ganglion cell determinant ath5 progresses across the 
retina in the absence of differentiated ganglion cells in zebrafish lakritz mutants (Kay et 
al., 2005). The peripherally-spreading wave of ganglion cell differentiation also still 
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occurs in explants of peripheral chick RPCs even when isolated from differentiating 
central cells well before the wave front reaches the central most extent of the explant 
(McCabe et al., 1999). Additionally, naïve zebrafish RPCs eventually expressed ath5 and 
differentiated into ganglion cells and photoreceptors even when transplanted into 
nonretinal tissues (Kay et al., 2005). These findings argue against the sequential 
induction model and suggest that the progression of neurogenesis depends largely on 
intrinsic regulation, based on a preprogrammed intrinsic timer. Furthermore, this timer 
appears to be sensitive to positional identity. Transplanted zebrafish RPCs express ath5 at 
times consistent with ath5 expression in their original retinal position, independent of the 
location into which they are transplanted (Kay et al., 2005). Studies in zebrafish suggest 
that this timer may be preprogrammed by midline-derived Shh signals (Kay et al., 2005). 
Neurog2/Ngn2 is an important intrinsic component regulating the spatial progression of 
neurogenesis. In mouse, a peripherally-spreading wave of Neurog2 expression precedes 
that of ath5. In the absence of Neurog2, initial progression of the neurogenic wave front 
stalls, but is rescued at later time points. Induction of the initial patch of ath5 and 
ganglion cell differentiation is unaffected in Neurog2 null retinas, revealing that initiation 
and subsequent progression of the neurogenic wave are genetically separable events 
(Hufnagel et al., 2010).  
Although intrinsic regulation is critical for progression of the neurogenic wave 
front, extrinsic signals are sufficient to alter progression. In zebrafish, Shh promotes 
progression of the wave front (Neumann and Nuesslein-Volhard, 2000). Inhibition of 
FGF signaling in chick slowed or blocked progression of the neurogenic wave front, as 
indicated by the extent of ganglion cell differentiation, while exogenous FGF1, but not 
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FGF8, promoted progression (McCabe et al., 1999). However, FGF, Shh, and Neurog2 
all regulate ath5 and, therefore, ganglion cell differentiation, making it difficult to 
separate the role of these factors in ganglion cell differentiation from a potential role in 
the spatial progression of neurogenesis within the progenitor population.  
Perspectives.  During development, the specification and maintenance of retinal 
identity, proliferation of RPCs, and retinal neurogenesis are tightly regulated cellular 
processes involving many intrinsic and extrinsic factors. Much progress has been made in 
the identification of genes and signaling pathways involved in the regulation and 
execution of these various cellular processes, revealing the importance of both intrinsic 
and extrinsic factors to their regulation. However, an understanding of how these 
extracellular signals and intrinsic factors are combined into efficient regulatory networks 
is largely lacking.  
Further complicating the study of these regulatory networks is the fact that these 
developmental processes are not entirely separable, nor is their regulation. Regulatory 
mechanisms driving retinal specification and maintenance, proliferation and neurogenesis 
all exert their influences on the same cell population, the RPCs. Consequently, 
perturbations in the regulation of one process often elicit secondary changes in another 
process and vice versa. Furthermore, factors and signaling pathways often participate in 
the regulation of multiple processes and even in multiple aspects of a given cellular 
process. Thus, it will be important in the future to understand the regulation of each of 
these developmental processes in the context of retinal histogenesis as a whole and to 
define the mechanisms through which these competing processes are coordinated within 
RPCs to ensure the orderly and efficient execution of the retinal program.   
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Vsx2 in retinal development 
Vsx2 is a paired-like CVC homeobox gene 
The visual system homeobox gene Vsx2 was originally named Chx10 to reflect its 
similarity to Ceh-10, a C. elegans homeodomain protein (Liu et al., 1994). Vsx2 contains 
several conserved regions with other homeobox proteins (Figure 1.5). Vsx2 belongs to 
the paired-like class of homeodomain-containing transcription factors based on similarity 
of the homeodomain with that of the Drosophila paired gene, absence of a paired 
domain, and a glutamine at position 50 within the homeodomain (Galliot et al., 1999; Liu 
et al., 1994). Like many paired class proteins, Vsx2 also contains an OAR domain, 
named after Otp, Aristaless, and Rax, the homeodomain proteins in which this domain 
was first identified (Ferda Percin et al., 2000; Galliot et al., 1999). Vsx2 contains an 
octapeptide sequence (FGIQEILG) located N-terminal to the homeodomain, as observed 
in several classes of homeodomain proteins; but, like many other paired-like class 
proteins, Vsx2 contains a phenylalanine in the first position (Ferda Percin et al., 2000; 
Galliot et al., 1999; Liu et al., 1994). Vsx2 also contains a CVC domain, named for the 
three homeodomain proteins from which it was identified, Chx10, Vsx1, and Ceh-10. The 
CVC domain is located immediately C-terminal to the homeodomain and ultimately 
defines this family of paired-like homeodomain proteins (Ferda Percin et al., 2000; 
Galliot et al., 1999; Svendsen and McGhee, 1995). Vsx2 and its orthologs (Alx, Chx10, 
and Ceh-10) are highly conserved from humans to nematodes (Barabino et al., 1997; 
Belecky-Adams et al., 1997; Chen and Cepko, 2000; Ferda Percin et al., 2000; Levine et 
al., 1997a; Liu et al., 1994; Passini et al., 1997; Passini et al., 1998; Strickler et al., 2002; 
Svendsen and McGhee, 1995). Conservation is particularly strong within the 
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homeodomain and CVC domains, which are identical in human, mouse, goldfish, and 
cavefish Vsx2 sequences. Together, these two domains mediate the transcriptional 
activity of Vsx2. Vsx2 functions as a strong general repressor, but also exhibits context-
dependent weak activator activity (Dorval et al., 2005). Several point mutations in the 
Vsx2 homeodomain ablate DNA binding affinity and indicate that the arginine at position 
200 and asparagine at position 198 are critical for this function (Dorval et al., 2005; Ferda 
Percin et al., 2000; Zou and Levine, 2012). Consistent with disruption of DNA binding, 
these mutations also abolish repressor activity. Although the homeodomain on its own is 
sufficient to mediate DNA binding (Dorval et al., 2005), mutations in or deletion of the 
CVC domain weaken DNA binding (Dorval et al., 2005; Zou and Levine, 2012), 
suggesting that one function of the CVC domain is to enhance the DNA binding affinity 
of the homeodomain. The CVC domain also appears to mediate the repressor activity of 
Vsx2, as deletion of the CVC domain abolished transcriptional repression, despite only 
slightly weakened DNA binding (Dorval et al., 2005). The importance of this repressor 
activity in vivo is revealed by the fact that several missense mutations identified in the 
CVC domain of human patients produce phenotypes that are strikingly similar to those 
produced by mutations predicted to generate a functional null (Bar-Yosef et al., 2004; 
Iseri et al., 2010; Reis et al., 2011).  
 
Ocular expression of Vsx2 
Vsx2 is the earliest and most specific marker of the presumptive retina and, 
therefore, of specified RPCs. As previously described, Vsx2 expression initiates within 
the presumptive neural retina during the late optic vesicle stage in response to inductive 
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signals from the overlying surface ectoderm that activate Ras-dependent MAPK signaling 
in the distal optic vesicle and establish the presumptive retinal domain. As development 
proceeds, ocular expression of Vsx2 is primarily restricted to RPCs of the neural retina, 
with weak expression also reported in the adjacent presumptive ciliary body epithelium. 
Expression in RPCs is maintained throughout retinal development, but terminated in all 
postmitotic retinal cells, except bipolar cells and a subset of Müller glia. Thus, as retinal 
neurogenesis proceeds, Vsx2 expression is restricted to the outer region of the inner 
nuclear layer where these cell types are located (Barabino et al., 1997; Belecky-Adams et 
al., 1997; Chen and Cepko, 2000; Ferda Percin et al., 2000; Levine et al., 1997a; Liu et 
al., 1994; Passini et al., 1997; Passini et al., 1998; Rowan and Cepko, 2004; Strickler et 
al., 2002). A possible exception is the zebrafish ortholog Alx, whose expression has not 
been reported in postmitotic neurons (Barabino et al., 1997). However, this expression 
analysis may not have extended to the period of bipolar cell genesis. Expression analysis 
in zebrafish using a goldfish Vsx2 probe did reveal expression in the outer aspect of the 
inner nuclear layer (Passini et al., 1997), suggesting that Alx may indeed be expressed in 
bipolar cells in zebrafish. Vsx2 expression also persists in the developing and mature 
germinal zone (or ciliary marginal zone) of retinas from several species of teleosts, 
including zebrafish, goldfish and several cavefish (Barabino et al., 1997; Levine et al., 
1997a; Passini et al., 1997; Passini et al., 1998; Strickler et al., 2002). This peripheral 
region in the adult retina is present in many teleosts and contains mitotically active retinal 
progenitors that permit continued generation of mature retinal cells throughout life. Thus, 
expression of Vsx2 is consistently associated with retinal-specific progenitor cells across 
vertebrate species.  
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Mutations in Vsx2 disrupt retinal development 
Human patients with mutations in Vsx2 present clinically with autosomal 
recessive nonsyndromic congenital microphthalmia (small eye), with or without 
associated ocular anomalies (Bar-Yosef et al., 2004; Burkitt Wright et al., 2010; Faiyaz-
Ul-Haque et al., 2007; Ferda Percin et al., 2000; Iseri et al., 2010; Reis et al., 2011). The 
associated ocular anomalies vary, but include colobomas, iris anomalies, cataracts, and 
retinal detachments. Although at least one patient exhibited some light perception, all 
patients lacked functional vision. The identified mutations in these patients (Figure 1.5) 
are predicted to impair Vsx2 function through disruption of the homeodomain and/or 
CVC domain, or through production of an abnormal or truncated protein. Two mouse 
lines carrying spontaneous recessive mutations in the Vsx2 gene, ocular retardation (or) 
and ocular retardation J (orJ), also exhibit microphthalmia, cataractous lenses, 
coloboma, and disrupted retinal lamination, as well as failure to form the optic nerve 
(Bone-Larson et al., 2000; Burmeister et al., 1996; Robb et al., 1978; Truslove, 1962). 
Identification of the mutation in orJ mice revealed a single point mutation creating a 
premature stop codon within the homeodomain (Figure 1.5). Absence of detectable Vsx2 
protein in these mice suggests that this allele is a functional null (Burmeister et al., 1996). 
Knockdown of the zebrafish homolog, Alx, with antisense oligonucleotides also 
promotes reduced eye size and disrupted eye development (Barabino et al., 1997). 
Studies in the defined Vsx2-null mouse mutant, orJ, reveal that these defects in ocular 
development arise from multiple disruptions in the execution of the retinal program 
(Figure 1.6), consistent with retinal-specific expression of Vsx2 during ocular 
development. Specifically, orJ retinas exhibit compromised retinal identity, severely 
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reduced RPC proliferation, delayed neurogenesis, and absence of bipolar cells (Bone-
Larson et al., 2000; Burmeister et al., 1996; Green et al., 2003; Horsford et al., 2005; 
Rowan et al., 2004).  
Several lines of evidence suggest that retinal specification occurs in the absence 
of Vsx2 function. First, expression of Vsx2 transcript is unaffected in orJ retinas 
(Rutherford et al., 2004; Sigulinsky et al., 2008), indicating that inductive signals have 
established regional patterning within the optic vesicle. Furthermore, orJ retinal cells 
express several additional neural retina-specific markers and generate mature retinal cell 
types (Bone-Larson et al., 2000; Burmeister et al., 1996; Green et al., 2003; Horsford et 
al., 2005; Rowan et al., 2004; Rutherford et al., 2004), revealing that execution of the 
retinal program persists in orJ retinas, albeit disrupted. Methods used to restore retinal 
formation in the absence of surface ectoderm and to direct the presumptive RPE towards 
a retinal fate, including exposure to FGFs and activation of MAPK signaling, are often 
associated with upregulation of Vsx2 (Cai et al., 2010; Nguyen and Arnheiter, 2000; 
Zhao et al., 2001). However, misexpression of Vsx2 on its own in the presumptive RPE 
appears insufficient to direct these cells towards a retinal fate, although one study 
demonstrated that Vsx2 was sufficient to downregulate several RPE genes (Horsford et 
al., 2005; Rowan et al., 2004). These findings reveal that Vsx2 is neither necessary nor 
sufficient to specify the retinal fate and that FGFs and MAPK signaling activate 
additional mechanisms for specification of the retinal fate.  Instead, Vsx2 is required in 
the maintenance of retinal identity, namely, to prevent aberrant gene expression programs 
(Figure 1.6). Several genes with RPE-restricted expression, including the RPE 
determinant Mitf, exhibit ectopic or expanded expression throughout all or part of the orJ 
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retina (Horsford et al., 2005; Rowan et al., 2004). Expression of these genes likely 
contributes to the hyperpigmentation observed in the periphery of orJ retinas as ocular 
development progresses (Figure 1.6) (Green et al., 2003; Horsford et al., 2005; Rowan et 
al., 2004; Truslove, 1962). Exacerbating this aberrant gene expression program promotes 
further activation of the pigmentation program and increased disruption of the retinal 
program. Forced overexpression of Mitf in orJ retinas enhanced the pigmentation 
phenotype and further impaired neurogenesis (Horsford et al., 2005).  Similar phenotypes 
were observed in the retinas of homozygous Vsx2
R227W
 knock-in mice and correlated with 
markedly elevated expression of the RPE determinants Mitf and Otx (Zou and Levine, 
2012). Conversely, genetic reduction of Mitf improved retinal development in all Vsx2 
mutant backgrounds (Horsford et al., 2005; Konyukhov and Sazhina, 1966; Zou and 
Levine, 2012). These findings reveal that the aberrant RPE-like gene expression program 
and in particular, maintained expression of Mitf, contributes significantly to Vsx2 mutant 
phenotypes. These findings also suggest that a major function of Vsx2 is to prevent 
activation of such aberrant gene expression programs. Acquisition and maintenance of 
retinal identity involve both extrinsic and intrinsic regulators. While studies have 
implicated Vsx2 downstream of the extrinsic signals and upstream of many intrinsic 
factors involved in the acquisition and maintenance of retinal identity (Horsford et al., 
2005; Nguyen and Arnheiter, 2000; Rowan et al., 2004), it is not clear from these studies 
whether Vsx2 also influences the extrinsic signals required for maintenance of retinal 
identity. 
Ocular tissues of orJ mice develop normally through the initial formation of the 
optic cup. However, as development proceeds, orJ eyes are increasingly smaller than 
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those of wild type littermates and develop thin, hypocellular retinas. Decreased retinal 
volume and cell number are detected as early as E11.5 (Bone-Larson et al., 2000; 
Burmeister et al., 1996). By P0, orJ retinas exhibit a striking 19-fold reduction in cell 
number (Green et al., 2003). The severe hypocellularity of the orJ retina results primarily 
from defective RPC proliferation (Figure 1.6) (Bone-Larson et al., 2000; Burmeister et 
al., 1996; Dhomen et al., 2006; Green et al., 2003; Konyukhov and Sazhina, 1971). The 
slowed rate of cell cycle progression in the orJ retina appears, in large part, due to 
aberrant accumulation of the cell cycle inhibitor p27/KIP1. Genetic deletion of p27/KIP1 
in the orJ retina largely restores retinal cell number without influencing neurogenesis or 
apoptosis. Regulation of p27/KIP1 by Vsx2 is indirect and involves post-transcriptional 
mechanisms largely mediated by Ccnd1 (Green et al., 2003). Additionally, genetic 
removal of the RPE determinant, Mitf, in orJ retinas also improves retinal size and RPC 
proliferation (Horsford et al., 2005; Konyukhov and Sazhina, 1966). In melanocytes and 
melanoma cell lines, MITF directly promotes p27/KIP1, as well as a related CIP/KIP 
family member, p21/CIP (Carreira et al., 2005; Lekmine et al., 2007). Recently, Mitf was 
also implicated in transcriptional activation of p27/KIP1 in the chick optic vesicle 
(Tsukiji et al., 2009), suggesting that Vsx2-mediated regulation of p27/KIP1 may also be 
partially Mitf dependent. Mitogens are also key extrinsic regulators of cell cycle 
progression. Mitogen signals are required in early G1 to promote G1 progression through 
upregulation of D-cyclins [reviewed in (Levine and Green, 2004)]. In the orJ retina, 
expression of Ccnd1, a G1 phase D-cyclin, is reduced (Green et al., 2003), but it is not 
known whether this results from direct transcriptional regulation by Vsx2 or indirectly 
through Vsx2-mediated regulation of mitogen signals or their signaling pathways.  
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  Vsx2 regulates multiple aspects of retinal neurogenesis. Vsx2 is required for 
proper temporal regulation of the initiation of neurogenesis. While the general principles 
of neurogenesis appear maintained in the orJ retina, including the central to peripheral 
wave of neuron production and temporal birth order, initiation is delayed (Figure 1.6) 
(Bone-Larson et al., 2000; Robb et al., 1978; Rutherford et al., 2004). However, it is not 
clear whether this delay reflects an inability to respond to the neurogenic signal(s) or 
absence of the necessary signal(s). Vsx2 also participates in the regulation of cell fate. 
Lineage analysis in zebrafish reveals that Vsx2 RPCs are multipotent, eventually giving 
rise to all retinal cell types over the course of retinal neurogenesis (Vitorino et al., 2009). 
However, in contrast to Pax6 (Marquardt et al., 2001), Vsx2 transcriptionally represses 
several factors which normally bias RPCs towards specific cell fates, including ath5 and 
Vsx1, while Vsx2 itself promotes a subclass of bipolar cell fates (Clark et al., 2008; 
Vitorino et al., 2009). Thus, selective downregulation of Vsx2 in RPCs during 
development results in derepression of bias factors and subsequent restriction of lineage 
potential (Vitorino et al., 2009). Bipolar cells are uniquely absent in retinas of orJ mice 
(Figure 1.6) (Bone-Larson et al., 2000; Burmeister et al., 1996) and their generation is not 
rescued in orJ, p27/KIP1 double mutants (Green et al., 2003), suggesting their absence is 
due to a specific requirement for Vsx2 in their specification or maturation, rather than a 
secondary effect of insufficient proliferative expansion for this late-born cell type. This is 
further supported by a number of studies showing that Vsx2 promotes the bipolar fate, 
typically at the expense of rod photoreceptors (Belecky-Adams et al., 1997; Dorval et al., 
2006; Hatakeyama et al., 2001; Livne-Bar et al., 2006; Rowan and Cepko, 2004; 
Rutherford et al., 2004; Toy et al., 2002; Vitorino et al., 2009). Additionally, Müller glia, 
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another late-born retinal cell type, are generated in the orJ retina (Burmeister et al., 
1996), which also argues against the possibility that the abnormally small progenitor pool 
is depleted prior to bipolar cell generation. Excluding bipolar cells, all retinal cell types 
are generated in the orJ retina, but their organization into the retina’s stereotyped laminar 
architecture fails (Bone-Larson et al., 2000). This disruption in retinal lamination appears 
to be a secondary effect of defective RPC proliferation, as it is largely rescued by 
significant restoration of cell number in orJ, p27/KIP1 double mutants (Green et al., 
2003). 
Active research examining the affected cellular processes in orJ retinas has 
revealed altered expression of many intrinsic factors, which undoubtedly contributes to 
the defective regulation of RPC properties and, consequently, the phenotypes observed in 
orJ retinas. However, a critical unanswered question is to what extent are the orJ 
phenotypes dependent on changes in the extrinsic regulation of RPC behavior? 
Furthermore, to what extent do these changes in extracellular signaling account for the 
aberrant regulation of intrinsic factors? There are multiple ways to address these 
questions. One way is to take a candidate approach and examine the impact of Vsx2 
deficiency on a pathway with known roles in regulating processes also affected in orJ 
retinas. Using this approach, retinal Shh signaling was examined to determine whether 
changes in this signaling pathway contributed to the defects in RPC proliferation in the 
orJ retina. Expression of Ccnd1, an established target of mitogen signaling that promotes 
cell cycle progression, is reduced in the orJ retina, suggesting that reduced mitogen input 
may contribute to slowed RPC proliferation. Shh is an important retinal mitogen and 
preliminary data indicated that this signaling pathway was sensitive to loss of Vsx2 
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function in the retina. A second approach is to determine the contribution of altered 
extracellular signals to the disruption of cellular processes by evaluating the ability of a 
wild type environment to rescue the orJ phenotypes. An established and powerful tool for 
addressing such questions is the genetic chimera.  
 
Shh signaling in the regulation of RPC proliferation 
Shh and the Hh signaling pathway 
 Sonic hedgehog (Shh) is a member of the Hedgehog (Hh) family of secreted 
signaling molecules. In mouse, this family also includes Desert Hedgehog (Dhh) and 
Indian Hedgehog (Ihh) [reviewed in (Ingham and McMahon, 2001)]. Shh is produced as 
a precursor protein that undergoes several processing steps [reviewed in (Mann and 
Beachy, 2004; Ryan and Chiang, 2012)]. The catalytically active carboxy-terminal 
domain of the precursor protein mediates linked autoprocessing events. Autoproteolytic 
cleavage generates the biologically active amino-terminal fragment (SHH-N). During 
cleavage, a cholesteryl moiety is covalently added to the carboxy-terminus of the 
resulting SHH-N polypeptide. The carboxy terminal fragment (SHH-C) is then 
ubiquitinated and degraded by the proteosome. Subsequent palmitoylation of SHH-N 
results in covalent addition of palmitate to the amino-terminal cysteine. These lipid 
modifications are important for modulating the multimerization and spatial distribution of 
SHH-N (cholesteryl moiety) and for increasing its potency (palmitate) [reviewed in 
(Mann and Beachy, 2004; Nybakken and Perrimon, 2002; Ryan and Chiang, 2012)]. 
Release of processed SHH-N (referred to hereafter as SHH) from the producing cell is 
facilitated by Dispatched (Disp) (Ma et al., 2002). SHH exhibits both short- and long-
37 
 
range signaling activity (Ingham and McMahon, 2001), and a number of molecules have 
been implicated in facilitating the movement of SHH and regulating its range of activity 
[reviewed in (Cohen, 2003; Ingham and McMahon, 2001; Nybakken and Perrimon, 2002; 
Varjosalo and Taipale, 2008)].  
Much of Shh function is mediated by transcriptional regulation of Hh target genes 
through activity of the Hh signaling pathway. However, some functions of Shh, 
particularly those of migration and axon guidance, are elicited independent of this 
transcriptional activity (Riobo and Manning, 2007; Yam et al., 2009). Despite significant 
conservation from Drosophila to vertebrates, marked differences exist in the mechanisms 
of Hh signal transduction [reviewed in (Huangfu and Anderson, 2006; Varjosalo and 
Taipale, 2008)]. Here, only the vertebrate pathway will be described. [For further review 
see (Huangfu and Anderson, 2006; Ingham and McMahon, 2001; Jiang, 2006; Nybakken 
and Perrimon, 2002; Riobo and Manning, 2007; Rohatgi and Scott, 2007; Ryan and 
Chiang, 2012; Varjosalo and Taipale, 2008; Wallace, 2008)]. 
The Hh pathway is a series of repressive interactions that ultimately regulates the 
balance of activator and repressor forms of transcriptional effectors (Figure 1.7). The Hh 
receptor is Patched homolog 1 (Ptch1), a 12-transmembrane domain protein. However, 
three additional Hh-binding proteins, CDO, BOC, and Gas1, function as essential 
coreceptors in vertebrates. These proteins form constitutive complexes with Ptch1 and are 
required for induction of Shh-dependent signaling (Allen et al., 2011; Izzi et al., 2011). 
Patched homolog 2 (Ptch2) and Hh interacting protein (Hhip) also bind Hh ligands, but 
lack downstream signaling (Carpenter et al., 1998; Chuang et al., 2003; Chuang and 
McMahon, 1999; Rahnama et al., 2004). Thus, Ptch2 and Hhip function as negative 
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regulators, limiting the level and possibly the range of Hh signaling. In the absence of Hh 
ligand, Ptch1 inhibits Smoothened (Smo), a 7-transmembrane protein related to G-
protein-coupled receptors, responsible for transduction of the Hh signal. The mechanism 
by which Ptch1 inhibits Smo is still unclear, but direct binding is not favored. Binding 
and expression studies typically fail to support a physical interaction between the two 
proteins and Ptch1-mediated inhibition of Smo is nonstoichiometric, which would not be 
expected in a direct binding model. A number of small molecules have been discovered 
to act as Smo agonists and antagonists, and Ptch1 shares structural similarity with the 
bacterial Resistance, Nodulation, Division (RND) family of small molecule pumps, 
suggesting that Ptch1 may inhibit Smo activity through the regulation of local 
concentrations of small molecules. However, a relevant endogenous small molecule has 
yet to be identified (Rohatgi and Scott, 2007; Ryan and Chiang, 2012). Hh binding 
represses Ptch1 function, which relieves the Ptch1-mediated inhibition of Smo and allows 
Smo activation. Activation of Smo involves a conformational change induced by 
phosphorylation of the carboxy-terminal tail by GRK2 and CK1α. Smo activity 
ultimately regulates the processing and localization of the Gli proteins. The Gli proteins 
are a family of zinc finger transcription factors that function as the principal effectors of 
the Hh pathway and activate or repress target gene expression depending on the presence 
or absence of Hh ligand, respectively. 
In the absence of Hh ligand, and therefore absence of Smo activity, full-length Gli 
proteins (Gli-FL) are proteolytically processed, resulting in a truncated transcriptional 
repressor form (Gli-R) or complete degradation.  Suppressor of Fused (SuFu) binds Gli-
FL and sequesters it in the cytosol, preventing nuclear localization and activation. 
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Phosphorylation of carboxy-terminal residues by PKA primes Gli-FL for further 
phosphorylation by GSK3β, and CK1α. Hyperphosphorylated Gli-FL is recognized by 
the βTrCP E3 ubiquitin ligase, resulting in ubiquitination and degradation by the 
proteasome. Limited degradation of only carboxy-terminal peptides results in the 
truncated amino-terminal form that serves as a transcriptional repressor (Jiang, 2006; 
Riobo and Manning, 2007; Ryan and Chiang, 2012). SuFu binding promotes the 
processing of Gli-FL (Humke et al., 2010), possibly by recruiting GSK3β (Kise et al., 
2009) and βTrCP (Tempe et al., 2006) to Gli-FL and mediating their interaction.  
In the presence of Hh, activated Smo inhibits Gli processing and promotes Gli 
localization to the nucleus and activation. The mechanisms linking Smo to Gli regulation 
are still poorly understood, but may center on the inhibition of SuFu and PKA. Activated 
Smo promotes the disassembly of SuFu-Gli complexes (Humke et al., 2010; Tukachinsky 
et al., 2010), which likely serves to limit proteolytic processing and release of Gli-FL for 
nuclear localization and activation. PKA is a potent negative regulator of Hh signaling, 
promoting the proteolytic processing of Gli while preventing (in a dominant fashion) Hh- 
and Smo-induced disassembly of SuFu-Gli complexes and subsequent nuclear 
translocation and formation of Gli-A complexes (Humke et al., 2010; Riobo and 
Manning, 2007; Tempe et al., 2006; Tukachinsky et al., 2010). Activated Smo, possibly 
signaling through G-proteins, represses PKA activity using two potential mechanisms. In 
the first, PKA inhibition is mediated by activation of the PKA inhibitors PI3K and Akt. 
In the second, PKA activity is reduced by inhibiting adenylyl cyclase, a potent activator 
of PKA activity (Riobo and Manning, 2007). Following dissociation from SuFu, Gli-FL 
translocates to the nucleus, a process that involves microtubules. Conversion of Gli-FL to 
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its activator form (Gli-A) appears to require further processing within the nucleus. The 
nature of and mechanisms driving such processing are still unclear, but may involve 
phosphorylation, deacetylation, or other yet unidentified processes. Complicating the 
study of Gli-A formation is Gli degradation promoted by SPOP-Cul3 E3 ligase, which 
also occurs in the nucleus. Thus, changes in Gli-FL within the nucleus could be 
associated with activation, degradation, or both (Humke et al., 2010; Jiang, 2006; Ruiz i 
Altaba, 1999; Ryan and Chiang, 2012).  
The Gli family consists of three members, Gli1-3, that exhibit differential 
proteolytic processing. Gli3 is efficiently processed into the truncated repressor form and 
is the primary transcriptional repressor in the absence of Hh ligand. Gli3 also functions as 
a transcriptional activator in the presence of Hh. Gli2 functions principally as a 
transcriptional activator. In the absence of Hh, Gli2 is mostly degraded; however, a small, 
but significant fraction is proteolytically processed into a repressor form, consistent with 
in vivo findings that Gli2 also exhibits context-specific repressor activity. Gli1 appears to 
exist solely as a transcriptional activator; proteolytic processing completely degrades Gli-
FL with no evidence of a repressor form. Gli1 is a potent transcriptional activator whose 
expression is completely dependent upon active Hh signaling; however, its function in 
mouse appears dispensable in the presence of Gli2 and Gli3 (Ingham and McMahon, 
2001; Riobo and Manning, 2007; Ryan and Chiang, 2012; Wallace, 2008). These three 
Gli proteins also differ in the binding affinities of their zinc finger domains for the 
various Gli DNA binding sites (Nakashima et al., 2002). Thus, transcriptional activation 
and repression of Hh target genes is determined by both the relative abundance of 
activator versus repressor forms and relative binding affinity for Gli consensus sites.  
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 Growing evidence supports a role for primary cilia in vertebrate Hh signaling. 
Primary cilia are solitary, nonmotile, and present on most vertebrate cells, except during 
cell division. Most Hh pathway components are enriched in primary cilia and exhibit 
dynamic, Hh-dependent trafficking. Furthermore, mutations in genes required for 
ciliogenesis disrupt localization of Hh pathway components and Hh signal transduction. 
In particular, genes involved in intraflagellar transport (IFT), the bidirectional trafficking 
mechanism required for the construction and maintenance of cilia and basal body 
formation, are key regulators of Hh signaling (Goetz and Anderson, 2010; Huangfu and 
Anderson, 2006; Rohatgi and Scott, 2007; Ryan and Chiang, 2012). 
 
Shh-mediated regulation of RPC proliferation 
 Shh participates in multiple steps of eye and retinal development, including the 
stimulation of RPC proliferation [reviewed in (Amato et al., 2004; Wallace, 2008)]. In 
the mouse, RPCs express the necessary signaling components of the Hh pathway and 
exhibit Hh-dependent target gene expression during retinal development (Dakubo et al., 
2003; Jensen and Wallace, 1997; Mu et al., 2004; Nakashima et al., 2002; Wang et al., 
2005) and reviewed in (Amato et al., 2004; Wallace, 2008). During the proliferative 
period, the principal source of Shh ligand in the retina is differentiated ganglion cells. 
Retinal ganglion cells produce Shh soon after differentiation (Wang et al., 2005). 
Consistent with this, Shh is a direct transcriptional target of Pou4f2, a required 
differentiation factor for ganglion cells (Mu et al., 2004). Moreover, Shh expression is 
severely reduced in Pou4f2 null retinas (Mu et al., 2004) or upon ganglion cell death (Mu 
et al., 2005; Wang et al., 2002). Hh-induced target gene expression in RPCs of the 
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neuroblast layer closely follows the central to peripheral wave of ganglion cell 
differentiation and Shh production (Wang et al., 2005). Depletion of retinal ganglion cells 
(Mu et al., 2004; Wang et al., 2002) or conditional ablation of retinal Shh results in loss 
of Hh target gene expression in adjacent RPCs. Shh expression is also detected in the 
inner nuclear layer, possibly in amacrine cells or melanopsin-expressing ganglion cells 
(Jensen and Wallace, 1997; Wallace, 2008).  
 Extraretinal sources of Shh include the RPE and ventral midline. Ihh is expressed 
in the RPE during this period, but is not sufficient to induce Hh target gene expression in 
RPCs in the absence of ganglion cell-derived Shh (Dakubo et al., 2003). Midline-derived 
Shh may contribute early during optic vesicle stages, as optic vesicle outgrowth was 
reduced in Gli1,Gli2 double mutants (Furimsky and Wallace, 2006). However, 
proliferation in the optic cup at these stages was not analyzed and any role for midline-
derived Shh in RPC proliferation would be transient as Hh-dependent target gene 
expression is downregulated in the optic cup prior to the initiation of retinal neurogenesis 
(Furimsky and Wallace, 2006). 
Shh and active Hh signaling are both necessary and sufficient for RPC 
proliferation. In rodents, recombinant, pre-processed SHH-N stimulates RPC 
proliferation and increases total cell number in vitro (Jensen and Wallace, 1997; Levine 
et al., 1997b). Furthermore, constitutive activation of the Hh pathway in vivo, through 
Ptch1 heterozygosity or retroviral infection of a Ptch1-insensitive activated Smo allele 
(Smo-M2), promoted increased RPC proliferation in mouse (Black et al., 2003; Moshiri 
and Reh, 2004; Yu et al., 2006). Blocking endogenous Shh and Hh signaling, through 
treatment with neutralizing anti-SHH antibodies (Wallace and Raff, 1999), conditional 
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ablation of retinal Shh (Wang et al., 2005), or conditional ablation of Smo in RPCs 
(Sakagami et al., 2009), reduced RPC proliferation. Consistent with defective RPC 
proliferation, mice with conditional ablation of Shh or Smo also exhibit a reduced 
progenitor pool, decreased clone size, and/or microphthalmia (Sakagami et al., 2009; 
Wang et al., 2005; Wang et al., 2002). Toxin-induced death of ganglion cells also 
reduced RPC proliferation, suggesting that ganglion-cell derived Shh is the principal 
source of mitogenic Shh in the retina during the proliferative period (Mu et al., 2005).  
Shh and activation of Hh signaling promotes RPC proliferation by influencing 
cell cycle progression. Loss of Hh signaling through conditional ablation of Smo in the 
mouse resulted in altered distribution of RPCs in cell cycle phases, namely an increased 
G1 population and decreased S and G2/M populations. Further analysis revealed that Hh 
signaling is critical for promoting the G1/S phase transition (Sakagami et al., 2009). 
These changes in the cell cycle correlate with Hh-dependent changes in expression of cell 
cycle components. Retinal ganglion cell-derived Shh is required for cyclin D1 
expression, but not Myc expression (Mu et al., 2005; Wang et al., 2005). Constitutively 
active Smo induced increased cyclin D1 expression (Yu et al., 2006), while conditional 
ablation reduced expression of a number of cyclins and E2F1 required for G1 and G2 
progression in the cell cycle, and an increased number of cells expressing the cell cycle 
inhibitor p27/KIP1 (Sakagami et al., 2009). These findings in the mouse are consistent 
with studies in Xenopus and zebrafish, which demonstrated that manipulation of Hh 
signaling altered the expression of cell cycle components and promoted corresponding 




Genetic mouse chimeras and dissection  
of complex gene function 
 The chimeras of ancient mythology were fantastical imaginary creatures that 
combined physical elements of multiple animals. Today, chimeras more commonly refer 
to individuals whose cells derived from more than one zygote, and typically differ in 
genotype. These modern genetic chimeras are powerful research tools for developmental 
biologists, providing fine scale resolution of studies addressing cell lineage, patterns of 
tissue growth and associated cellular behaviors, and gene function. 
 
Generation of genetic mouse chimeras  
 Genetic mouse chimeras were first introduced in the 1960s. Multiple methods are 
now available for their generation, differing in the relative contribution of the host cell 
populations to the embryonic tissues and/or the source of the genotypically distinct cell 
populations (Figure 1.8) (Nagy and Rossant, 2001; Rossant and Spence, 1998; Tam and 
Rossant, 2003). Diploid embryos at the eight-cell stage exhibit the greatest 
developmental potential and their aggregation generates chimeras with the potential for 
mosaic contribution to all tissues of the embryo. A variation on this method, using a 
tetraploid embryo, biases the contribution of the diploid embryo towards the epiblast-
derived embryo proper, while the tetraploid embryo predominantly contributes to the 
extraembryonic primitive endoderm and trophectoderm. Such lineage restriction 
facilitates functional testing of gene requirements in extraembryonic versus embryonic 
tissues. With the advent of targeted gene mutation in pluripotent embryonic stem (ES) 
cells, the use of chimeras was no longer restricted to studying spontaneous mutants. ES 
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cells exhibit more limited lineage potential than diploid eight-cell embryos or inner cell 
mass (ICM) cells and contribute solely to the embryo proper lineages of the epiblast. 
Chimeras can be generated either through aggregation of ES cells with diploid or 
tetraploid embryos or through injection of ES cells into blastocyst embryos. The use of 
ES cells therefore overcomes several limitations associated with creating chimeras from 
homozygous lethal mutants. Resulting chimeric blastocysts from all methods are 
surgically returned to the uterus of a pseudopregnant female for subsequent embryonic 
development.  
 Regardless of the method used for the generation of genetic mouse chimeras, a 
means of distinguishing the two distinct cell populations is crucial for interpreting the 
resulting cellular behaviors and phenotypes. Such markers must exhibit ubiquitous, cell 
autonomous expression that can be detected in mosaic tissues and ideally is inert to the 
expressing cells (Nagy and Rossant, 2001; Rossant and Spence, 1998; Tam and Rossant, 
2003). A lack of markers providing the necessary spatial resolution limited the early use 
of genetic chimeras. Electrophorectic variants of the housekeeping gene GPI, and strain- 
or mutant-specific DNA polymorphisms, provided the necessary expression profile, but 
lacked spatial resolution in situ. In the eye, many early chimera studies took advantage of 
pigment markers to distinguish between the cells deriving from pigmented versus albino 
embryos. However, the spatial resolution of pigmentation is restricted to the pigmented 
RPE in the eye and only at later stages of ocular development once pigmentation 
becomes apparent. Species- and strain-specific DNA satellite markers provided spatial 
resolution in all embryonic tissues, but were technically difficult. The development of 
ubiquitously expressed, easily detectable transgenic markers has greatly enhanced the use 
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of genetic mouse chimeras. The most common of these is the E. coli-derived β-
galactosidase gene. The use of jellyfish-derived green fluorescent protein (GFP) and its 
spectral variants are quickly growing in popularity, especially since they enable 
evaluation of cell distribution in living organisms.  
 
Use of genetic mouse chimeras in the study of development  
and gene function 
 Genetic chimeras have multiple uses in the study of developmental biology. 
Patterns of tissue growth and the underlying cellular behaviors are important for 
understanding tissue histogenesis and organogenesis. Genetic chimeras provide a unique 
means to addressing these issues in vivo. In the eye, analyses in chimeras have 
contributed to the discovery that growth in the RPE becomes progressively restricted to 
the distal edge and centripetal migration of limbal stem cell progeny continually renews 
dying cells in the corneal epithelium [reviewed in (Collinson et al., 2004)]. In the retina, 
analysis of the patterns of chimerism revealed the growth of radial clones and contributed 
to the realization of the multipotency of RPCs [reviewed in (Collinson et al., 2004)]. 
Chimera analyses were also instrumental in the identification of tangential dispersion as 
an active process directing the orderly spacing of retinal subtypes. In particular, chimeras 
were used to characterize the distance of tangential dispersion for retinal cell types 
(Reese et al., 1999) and reviewed in (Reese and Galli-Resta, 2002). 
 Genetic chimeras provide a powerful and unbiased approach to phenotypic 
analysis. They are particularly useful in defining the roles of genes with complex 
functions and phenotypes by enabling analyses of lineage potential, autonomy, and cell 
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behavior in the absence of gene function. Reduced contribution or exclusion of mutant 
cells from a particular lineage, in the absence of cell death and changes in proliferation, 
reveals a role for the gene of interest in the specification or differentiation of that lineage 
(Rossant and Spence, 1998; Tam and Rossant, 2003). In Rx null mice, the retina, RPE 
and optic stalk fail to form due to developmental arrest prior to optic vesicle formation 
(Mathers et al., 1997). The use of Rx chimeras revealed that this phenotype is the result 
of failed specification, rather than deficient proliferation, as Rx null cells are excluded 
from the eye field optic neuroepithelium and its subsequent lineages (Medina-Martinez et 
al., 2009). In complex phenotypes, chimera analyses of lineage potential can be used to 
evaluate multiple lineages in the same animal to determine the primary site of action of a 
gene. For example, chimeras demonstrated that the retina degeneration genes rd (Pde6b) 
and Rds act within the neural retina to promote photoreceptor degeneration, while rdy 
acts in the RPE to promote photoreceptor degeneration in the adjacent neural retina 
(LaVail and Mullen, 1976; Mullen and LaVail, 1976; Sanyal et al., 1986). Pax6 null 
mutants fail to form eyes due to developmental arrest at the optic vesicle stage and lack 
lenses (Baumer et al., 2003; Hill et al., 1991). However, Pax6 is expressed in many 
tissues associated with eye development, including the eye field, throughout the optic 
vesicle, the retina and RPE of the optic cup, facial epithelium, lens placode, and lens 
(Walther and Gruss, 1991). Thus, defining the individual roles of Pax6 in ocular 
development using null mutants proved difficult. Analysis of genetic chimeras revealed 
that the absence of lenses in Pax6 null embryos resulted from a requirement of Pax6 in 
the surface ectoderm for lens formation, rather than failure of the Pax6 null optic vesicle 
to stimulate lens induction (Collinson et al., 2000; Collinson et al., 2003; Li et al., 2007; 
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Quinn et al., 1996). These analyses also revealed that retinal formation can proceed even 
in the absence of a lens when Pax6 was present in the optic vesicle (inferred from the 
predominance of wild type cells in the retina and RPE), suggesting that developmental 
arrest in the optic vesicle results from a requirement for Pax6 gene function in the optic 
vesicle rather than a failure of Pax6 null embryos to generate the lens (Li et al., 2007). In 
chimeras, Pax6 null cells were also excluded from the corneal epithelium and displayed 
reduced contribution to the corneal stroma and endothelium, revealing a previously 
unappreciated role for Pax6 in cornea development (Collinson et al., 2003; Li et al., 
2007). Use of tissue specific conditional knockouts has both confirmed and extended the 
analysis of Pax6 function in ocular development [reviewed in (Ashery-Padan and Gruss, 
2001; Collinson et al., 2004)].      
Genetic chimeras also provide the gold standard test for autonomy of gene 
function (Figure 1.9A). A gene functions cell autonomously if the original mutant 
phenotype manifests exclusively in genotypically mutant cells, irrespective of 
mutant:wild type proportions (Figure 1.9A). More commonly, exclusion of mutant cells 
from a particular tissue or lineage reveals cell autonomous gene function (Rossant and 
Spence, 1998; Tam and Rossant, 2003). As previously described, the exclusion of Rx null 
cells from the eye field optic neuroepithelium and its resulting lineages in chimeras 
reveals a cell autonomous role for Rx in the specification of the optic neuroepithelium 
(Medina-Martinez et al., 2009). Pax6 null cells are largely excluded from the developing 
neural retina in Pax6 chimeras, and those that do contribute to the retina die perinatally, 
leaving only Pax6-deficient microglia, pericytes, astrocytes and vascular endothelial 
cells, which derive from extra-retinal sources and migrate into the developing retina (Li 
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et al., 2007). Cell nonautonomous gene function is revealed by the ability of surrounding 
wild type cells to rescue the mutant phenotype in genotypically mutant cells (Figure 
1.9A). Cell nonautonomous gene function is also revealed by the converse; the ability of 
mutant cells to induce a mutant phenotype on genotypically wild type cells, and typically 
occurs when mutant cell contribution is high (Rossant and Spence, 1998; Tam and 
Rossant, 2003). Misexpression of a mutant rhodopsin gene in transgenic mice causes 
retinal degeneration. Generation of chimeras with these mice revealed that the mutant 
gene transgene induced degeneration in a cell nonautonomous fashion, as both wild type 
and mutant patches exhibited equal levels of degeneration. However, the degree of 
degeneration depended on the contribution of wild type cells; a greater contribution of 
wild type cells promoted reduced levels of degeneration (Huang et al., 1993). It is 
important to note that a gene may exhibit cell autonomous and cell nonautonomous 
functions, depending on the readout. For example, a transcription factor responsible for 
expression of a cell surface or secreted signaling molecule would exhibit a cell 
autonomous function if the readout was the expression of the signaling molecule, but cell 
nonautonomous if the readout was a change in cellular behavior, provided the signal 
acted in a paracrine fashion. Chimera analysis provides not only an unbiased approach for 
evaluating the contribution of cell nonautonomous mechanisms to mutant phenotypes, 
but also a powerful tool for placing gene function in the context of known signaling 
pathways regulating specific processes. Determining the autonomy of gene function in a 
cellular behavior enables researchers to determine whether the gene functions to regulate 
cell surface or secreted signaling molecules or acts on intrinsic factors involved in the 
regulation of cell behavior (Figure 1.9B). Further analysis of intrinsic factors in chimeras 
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can then be used to further refine the role of genes involved in the regulation of intrinsic 
factors.  
 Chimeras also facilitate detection of defects in cell behavior, which often become 
more apparent in the competitive environment of chimeras. Such behaviors include cell 
adhesion and migration. Cell adhesion differences are thought to underlie the segregation 
of Pax6 null and wild type cells in Pax6 chimeras and apparent physical exclusion of 
mutant cells from the presumptive retina into ectopic vesicles (Collinson et al., 2000; 
Collinson et al., 2003; Li et al., 2007; Quinn et al., 1996). Differences in cell surface 
properties drove segregation of wild type and Lhx2 null cells in aggregation assays and 
likely promoted the clustering of Lhx2 null and wild type cells into discrete patches in the 
telencephalon of Lhx2 chimeras (Mangale et al., 2008). In Rx chimeras, Rx null cells 
contributed to the proximal optic stalk region, but segregated from wild type cells 
creating alternating columns of wild type and Rx null cells. These columns exhibited 
different thicknesses, suggesting that unlike adjacent wild type cells, Rx null cells fail to 
participate in convergent extension (Medina-Martinez et al., 2009). 
Genetic mosaics provide an additional approach to answering these same 
questions (Rossant and Spence, 1998). Together, genetic chimeras and mosaics provide a 
diverse array of research tools for the study of multiple aspects of development. Each 
provides its own unique contribution to developmental studies and complements the 
other. Together and on their own, these techniques provide a powerful means of 
dissecting complex gene function and embryogenesis.  
Aggregation chimeras were reported previously for the or allele of Vsx2 
(Kindiakov and Koniukhov, 1986; Osipov and Vakhrusheva, 1982, 1984). or is allelic to 
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orJ utilized in the present studies. In these chimeras, both retinal structure and eye size 
were improved compared to homozygous or mice, although microphthalmia was still 
noted in or chimeras. Reduction in eye size generally correlated with the contribution of 
or cells, as indicated by analysis of chimerism in the adjacent RPE. Additionally, eye size 
and retinal structure both improved with age. The inability to distinguish or and wild type 
cells in the chimeric retina in these studies precluded interpretation of these results. Thus, 
it is not clear whether improved retinal development resulted from rescued or cell 
behavior or compensation by wild type cells. To distinguish between these possibilities 
and evaluate Vsx2 function using a defined Vsx2 null allele, we sought to re-evaluate 
chimeras in the present study.  
 
Summary and goals 
Retinal development is a complex process involving stepwise induction from 
neural ectoderm and subsequent coordination of competing processes to ensure proper 
growth and differentiation during retinal histogenesis. The homeobox gene Vsx2 is an 
essential regulator of multiple aspects of retinal histogenesis. Maintenance of retinal 
identity, RPC proliferation and retinal neurogenesis still occur to some extent in the orJ 
retina, but the absence of Vsx2 function severely disrupts their execution. This not only 
impedes retinal development, but also has serious consequences on overall ocular 
development and visual function. Despite the obvious importance of Vsx2 in these 
cellular processes and retinal histogenesis, the molecular mechanisms underlying the 
regulation of these processes by Vsx2 is lacking and few direct targets have been 
identified. Given the importance of both extracellular cues and intrinsic factors in these 
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processes and the central role for Vsx2 in the regulation of RPC properties, it is possible 
that Vsx2 may regulate both extrinsic and intrinsic factors. Thus, the major focus of this 
work was to determine the degree to which Vsx2 regulates the extracellular signals 
involved in the various cellular processes of retinal histogenesis. Both candidate and 
unbiased approaches were undertaken to address this question. In the former, the known 
retinal mitogen Shh and its signaling pathway were evaluated in orJ retinas to determine 
whether altered Shh production or Hh signaling contributed to the defective proliferation 
observed in the orJ retina (Chapters 2 and 3). An unbiased approach was also undertaken 
to evaluate the contribution of altered extracellular signals to the disruption of cellular 
processes during retinal histogenesis in the absence of Vsx2. This was accomplished by 
determining the autonomy of Vsx2 functions using genetic mouse chimeras (Chapter 4).   
These studies will facilitate the dissection of Vsx2 function and help place Vsx2 
in the context of known signaling pathways that regulate the processes driving retinal 
histogenesis. They will also address fundamental questions regarding the mechanisms 
regulating RPC properties and provide insight into the coordination and integration of 
extracellular cues and intrinsic factors in the regulation of these properties. Advancing 
our understanding of normal retinal development and the necessary factors regulating 
RPC properties will facilitate development of techniques to control stem cells for 
therapeutic purposes in the treatment of retinal disorders and degenerative diseases. Many 
of the developmental principles driving retinal histogenesis, including multipotent 
progenitors, progenitor proliferation, and ordered differentiation, also underlie the 
development of other central nervous system structures, including the cortex and 
cerebellum (Donovan and Dyer, 2005). Thus, advances in the understanding of regulation 
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of RPC properties, integration of extrinsic signals and intrinsic factors, and coordination 
of progenitor properties will also contribute to a general understanding of the principles 





















Figure 1.1.  Basic anatomy of the eye and retina. (A) Schematized cross section of the 
vertebrate eye illustrating the location of the neural retina and associated ocular tissues. 
Yellow arrow shows the path of light through the eye. (B) Schematic diagram illustrating 
the cytoarchitecture of the adult vertebrate retina. Apical is oriented to the top and basal 
to the bottom. Gray arrows indicate the direction of the light path and neural information 
flow. Abbreviations:  A, amacrine cell; B, bipolar cell; C, cone photoreceptor; CB, ciliary 
body; Ch, choroid; Co, cornea; G, ganglion cell; GCL, ganglion cell layer; H, horizontal 
cell; I, iris; ILM, inner limiting membrane; INL, inner nuclear layer; IPL, inner plexiform 
layer; IS, photoreceptor inner segments; L, lens; M, Müller glia; NF, nerve fiber layer; 
NR, neural retina; OLM, outer limiting membrane; ON, optic nerve; ONH, optic nerve 
head; ONL, outer nuclear layer; OPL, outer plexiform layer; OS, photoreceptor outer 























Figure 1.2. Overview of vertebrate retinal development. (A) The eye field (orange) is 
specified as single territory in the anterior neuroepithelium during the early neurula stage. 
(B) This single eye field is then resolved into the bilateral eye primordial. (C) 
Evagination of the neuroepithelium within each eye primordium generates the optic 
vesicles. (D) Patterning of the optic vesicle divides the optic neuroepithelium into the 
presumptive domains of the neural retina, retinal pigmented epithelium (RPE), and optic 
stalk. Early contact of the optic vesicle with the overlying surface ectoderm induces 
formation of the lens placode. (E) Invagination of the lens placode and distal optic vesicle 
generates the lens vesicle and bilayered optic cup, establishing the overall structure of the 
eye and positioning of ocular tissues. The optic neuroepithelium positioned at the border 
between the retina and RPE eventually contributes to components of the ciliary body and 
iris (C/I).  In A and B, anterior is up and posterior is down; while dorsal is up and ventral 
is down in C-E. Abbreviations:  dOS, dorsal optic stalk; EF, eye field; LP, lens placode; 
LV, lens vesicle; M, mesenchyme; ONE, optic neuroepithelium; OV, optic vesicle; NR, 
neural retina; pNR, presumptive neural retina; pOS, presumptive optic stalk; pRPE, 




























Figure 1.3. The cell cycle and regulation of G1 progression. (A) Cells progress through 
four distinct phases of the cell cycle. Mitogen signals are required in early G1 to promote 
G1 progression past the restriction point for entry into S phase. (B) The regulatory 
cascade driving the G1-to-S phase transition involves a positive feedback loop and 
initiation by mitogen signals. Abbreviations:  CDKI, cyclin-dependent kinase inhibitor; 










































Figure 1.4. Temporal and spatial progression of retinal neurogenesis. (A) The seven 
major classes of retinal cell types are generated during limited but overlapping periods 
and according to an evolutionarily conserved birth order. In the mouse, retinal 
neurogenesis begins with ganglion cell generation around embryonic day 11 (E11) and is 
completed around postnatal day 12 (P12). (B) Retinal neurogenesis proceeds in a specific 
spatio-temporal pattern across the neural retina. In the mouse, neurogenesis initiates in a 
small central patch, dorsal to the optic stalk. Over time, neurogenesis progresses in a 
peripherally-spreading wave. Dorsal is up and posterior is left. Abbreviations:  L, lens; 











































Figure 1.5. Structure of the Vsx2 gene and protein. The genomic structure of the Vsx2 
gene and its relation to the domain structure of the Vsx2 protein is illustrated. The Vsx2 
gene contains five known exons, represented as numbered boxes. Coding regions of each 
exon in the Vsx2 gene are shown in gray, noncoding regions in white. Protein regions 
encoded by each exon are indicated by dotted lines. Conserved protein domains are 
indicated as follows:  the octapeptide sequence is depicted in blue, the homeodomain in 
green, the CVC domain in red, and the OAR domain in yellow. Locations of mutations 
identified in humans are indicated by blue arrows, while the orJ mutation in mouse is 





















Figure 1.6. Model of disrupted retinal development in the orJ retina. Patterning of the 
optic vesicle directs optic neuroepithelial cells towards one of three ocular identities, 
resulting in the specification of progenitors of the neural retina, RPE, and optic stalk. 
Each of these progenitor populations undergoes proliferative expansion and 
differentiation into their mature cell types. In the absence of Vsx2 function in the orJ 
retina, these processes are disrupted. Failure to downregulate the RPE determinant Mitf 
in specified RPCs indicates compromised maintenance of retinal identity (1a). Aberrant 
expression of Mitf and other genes typically associated with the RPE gene expression 
program promote activation of a pigmentation program, often leading to 
hyperpigmentation of retinal cells at later developmental ages (1b). Relative to RPE and 
optic stalk progenitors, RPCs exhibit robust proliferative expansion that is severely 
reduced in the absence of Vsx2 function (2). Multiple aspects of retinal neurogenesis are 
also disrupted. Although the temporal birth order of retinal cell types is maintained, 
initiation of this process is delayed approximately 2 days in the orJ retina (3). Lastly, orJ 
RPCs fail to generate bipolar cells, likely due to a specific requirement for Vsx2 in their 
specification or maturation (4). Abbreviations:  AC, amacrine cell; BC, bipolar cell; 
Cone, cone photoreceptor; GC, ganglion cell; HC, horizontal cell; MG, Müller glia cell; 
ONC, optic neuroepithelial cell; OS, optic stalk; OSP, optic stalk progenitor; Prolif, 
proliferation; RPC, retinal progenitor cell; RPE, retinal pigmented epithelium; RPEP, 







































Figure 1.7. Detailed overview of the vertebrate Hh signaling pathway. Transduction of 
Hh signals in receptive cells alters transcriptional regulation of Hh target genes in the 
nucleus. Refer to the text for a detailed description of ligand reception and signal 
transduction mechanisms. Abbreviations:  Gli-A, activator form of Gli proteins; Gli-R, 
Gli repressor form of Gli proteins; Gli-FL, full-length Gli proteins; (p), phosphorylation; 






















Figure 1.8. Methods of chimera generation and resultant lineage contribution of cell 
populations. Genotypically distinct cell populations for use in the generation of chimeric 
blastocysts can be obtained from a variety of sources. Generation of chimeric blastocysts 
is accomplished either through aggregation of the cell populations or through injection of 
ES or TS cells into blastocyst stage embryos. Contribution of the distinct cell populations 
to the chimeric blastocyst and subsequent embryonic tissues varies and depends upon the 
developmental potential of the source of each cell population. The three lineages in 
blastocyst stage embryos have distinct fates. The trophectoderm contributes exclusively 
to the trophoblast layer of the placenta. The primitive endoderm contributes to the yolk 
sac endoderm. The epiblast contributes to both the embryo proper and extraembryonic 
cells. Embryo:embryo combinations are shown in green, ES cell:embryo combinations in 
magenta, and TS cell:embryo combinations in blue. Solid colors indicate nonmosaic 
contribution while patterns indicate mosaic contribution. Segregation of cell populations 
in tetraploid:embryo combinations are not as complete as in tetraploid:ES cell 
combinations. Abbreviations:  ep, epiblast; ES, embryonic stem cells; ICM, inner cell 
mass; P, placenta; pE, primitive endoderm; tr, trophectoderm; TS, trophoblast stem cells; 





















Figure 1.9.  Relationship between autonomy and gene function. (A) Schematic 
illustrating phenotypic outcomes for autonomous and nonautonomous gene function 
using genetic chimeras. Cell autonomous gene function is revealed when the mutant cell 
retains its mutant phenotype, irrespective of wild type cell contribution to the tissue, 
indicating that the mutant cell is refractory to extrinsic signals provided by adjacent wild 
type cells. Cell nonautonomous gene function is revealed when the mutant phenotype is 
rescued in genotypically mutant cells by extrinsic signals provided by wild type cells. (B) 
Possible autonomous and nonautonomous modes of Vsx2 gene function in the regulation 
of cellular processes, based on the biochemical function of Vsx2 as a transcription factor 
and restricted expression of Vsx2 to the cell population exhibiting the mutant phenotypes. 
The following possible types of Vsx2-mediated regulation would manifest as cell 
autonomous functions in chimeras:  Vsx2 regulates intrinsic components of the 
regulatory signaling pathway (1) and/or downstream intrinsic factors involved in the 
execution of the cellular process (2), but Vsx2 itself is not an intrinsic component; Vsx2 
mediates the effects of the signaling pathway on the cellular process (3). The following 
possible types of Vsx2-mediated regulation would manifest as cell nonautonomous 
functions in chimeras:  Vsx2 regulates availability of the ligand indirectly by affecting 
development of non-RPC cell types responsible for ligand production (4) or directly 
through transcriptional regulation of the ligand in RPCs (5); Vsx2 regulates extrinsic 
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ALTERED EXTRACELLULAR ENVIRONMENT IN THE 
VSX2 NULL RETINA CHANGES THE DYNAMICS OF 





Proliferative expansion of retinal progenitor cells (RPCs) is required for the 
proper growth and development of the neural retina, ensuring sufficient generation of 
both the appropriate number and types of differentiated retinal cells. The homeobox gene 
Vsx2 is expressed in RPCs and an essential regulator of their proliferation. Mutations in 
Vsx2 cause microphthalmia (small eye) in both humans and mice (Bar-Yosef et al., 2004; 
Bone-Larson et al., 2000; Burkitt Wright et al., 2010; Burmeister et al., 1996; Faiyaz-Ul-
Haque et al., 2007; Ferda Percin et al., 2000; Iseri et al., 2010; Reis et al., 2011; Robb et 
al., 1978). This condition arises primarily from a profound defect in RPC proliferation 
that produces a severely hypocellular retina (Bone-Larson et al., 2000; Burmeister et al., 
1996; Dhomen et al., 2006; Ferda Percin et al., 2000; Green et al., 2003; Konyukhov and 
Sazhina, 1971). 
The slowed rate of cell cycle progression observed in RPCs in the absence of 
Vsx2 function correlated with aberrant expression of G1 phase cell cycle components, 
including accumulation of the cell cycle inhibitor p27/KIP1 and downregulation of the 
cell cycle promoter cyclin D1 (Ccnd1) (Green et al., 2003; Sigulinsky et al., 2008). 
Genetic deletion of p27/KIP1 in Vsx2-deficient retinas largely restored retinal cell 
number without influencing neurogenesis or apoptosis (Green et al., 2003). Furthermore, 
Ccnd1 is an important mediator in the prevention of p27/KIP1 accumulation by Vsx2 in 
RPCs (Green et al., 2003), suggesting that promoting high levels of Ccnd1 expression is a 
major function of Vsx2 in its regulation of RPC proliferation. Mitogens are also essential 
regulators of cell cycle progression, upregulating D-cyclins to promote G1 progression 
[reviewed in (Giacinti and Giordano, 2006; Lundberg and Weinberg, 1999)]. Thus, it was 
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not clear whether decreased expression of Ccnd1 resulted from direct transcriptional 
regulation by Vsx2 or indirectly through Vsx2-mediated regulation of mitogen signals or 
their signaling pathways. 
Sonic hedgehog (Shh) acts as a mitogen in a number of developing tissues. Shh is 
a secreted glycoprotein that activates the Hedgehog (Hh) pathway. Shh binds to and 
inhibits the Hh receptor, Patched homolog 1 (Ptch1), relieving Ptch1-mediated inhibition 
of Smoothened (Smo). Activated Smo both inhibits proteolytic processing of the Gli 
family of transcriptional effectors into truncated repressors and promotes their activation 
and nuclear localization to elicit transcriptional activation and derepression of Hh target 
genes [reviewed in (Ryan and Chiang, 2012)]. In the retina, Shh is expressed by retinal 
ganglion cells soon after their differentiation. RPCs express Hh pathway components and 
upregulate Hh target gene expression in response to this ganglion cell-derived Shh 
production (Wallace, 2008). Shh is a well-established retinal mitogen and required for 
sufficient RPC proliferation [for review, see (Wallace, 2008)]. Treatment with exogenous 
Shh or increased signaling activity of the Hedgehog (Hh) pathway through manipulation 
of Hh pathway components stimulates RPC proliferation and increases retinal cell 
number (Jensen and Wallace, 1997; Levine et al., 1997; Moshiri and Reh, 2004; Yu et al., 
2006). Conversely, attenuation of endogenous Hh signaling through neutralization of 
endogenous Shh or genetic ablation of Shh or Hh pathway components decreases RPC 
proliferation, often leading to a reduced progenitor pool, reduced clone size, or 
microphthalmia (Sakagami et al., 2009; Wallace and Raff, 1999; Wang et al., 2005). Shh 
and activation of the Hh pathway stimulates RPC proliferation by promoting G1 
progression (Sakagami et al., 2009). Similar to loss of Vsx2 function, disruption of Hh 
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signaling results in aberrant expression of cell cycle components, including an increase in 
the number of p27/KIP1-expressing cells and downregulation of Ccnd1 (Sakagami et al., 
2009). 
Thus, we examined the potential role for Shh signaling in mediating Vsx2-
dependent regulation of RPC proliferation. Previously, we reported reduced Hh signaling 
in the retinas of ocular retardation J (orJ) mice, which carry a recessive null allele of 
Vsx2 (Sigulinsky et al., 2008). Embryonically, altered activation of Hh signaling in the 
orJ retina correlated with delayed generation of retinal ganglion cells, the relevant source 
of endogenous retinal Shh. Neonatally, reduced Hh signaling activity persisted in the orJ 
retina and was associated with reduced levels of Shh mRNA and protein. Furthermore, 
addition of exogenous Shh stimulated upregulation of Hh target genes and increased RPC 
proliferation at both ages. These findings suggested that reduced availability of Shh 
ligand is a major cause of reduced Hh signaling activity in vivo and likely contributes to 
the defective proliferation of orJ RPCs.   
In the present work, we report that upon dissociation, orJ cells exhibit greatly 
diminished responsiveness to treatment with a recombinant, active form of Shh protein 
(SHH-N). Reduced responsiveness of orJ RPCs to Hh pathway stimulation is not 
mutually exclusive with our previous finding of reduced ligand availability in the orJ 
retina. Thus, we sought to investigate the nature of the change underlying this impaired 
responsiveness, as this change may be relevant in vivo and would contribute to our 
understanding of Vsx2-mediated regulation of Shh signaling and RPC proliferation. Here, 
we detail the diminished responsiveness of orJ RPCs to SHH-N in dissociated cell 





 orJ mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). 
Wild type (+) and orJ alleles were determined by PCR and restriction digest, as 
previously described (Burmeister et al., 1996) from adult ear clips or neonatal tail 
samples. Black Swiss mice were purchased from Taconic Farms, Inc. (Hudson, NY, 
USA). The orJ allele was introduced into the Black Swiss background by mating orJ 
(129/Sv) mice with Black Swiss mice and selecting for the orJ allele. Except where noted 
in the text, experiments were performed using mice maintained on the 129/Sv 
background. Previous analyses and our own unpublished observations suggest that eye 
development (Rowan et al., 2004) and expression of Hh target genes (this study, data not 
shown) is indistinguishable between heterozygous orJ (+/orJ) and wild type (+/+) mice. 
Thus, mice with these genotypes were considered equivalent and referred to as wild type 
in the text. Homozygous orJ (orJ/orJ) mice are referred to as orJ. The day of birth was 
considered postnatal day 0 (P0). Animal use and care was conducted in accordance with 
IACUC guidelines. 
 
Dissociated cell culture 
 P0 retinal tissue was dissected from surrounding ocular tissues in Hank’s buffered 
saline solution and the lens and inner vasculature removed. Retinal tissue was incubated 





triturated into single-cell suspension, and resuspended in Dulbecco’s Modified Eagle 
Medium: Nutrient Mixture F-12 (DMEM/F12; Invitrogen), containing 0.6% glucose, 
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0.1125% NaHCO3 (Invitrogen), 5 mM HEPES (Invitrogen), 1% FBS (Invitrogen), 1.5 
µM thymidine (Invitrogen), GlutaMAX (0.5X, Invitrogen), 25 µg/ml insulin (Sigma, St. 
Louis, MO, USA); 100 µg/ml transferrin (Sigma), 60 µM putrescine (Sigma), 30 nM 
selenium (Sigma), 20 nM progesterone (Sigma), and Penicillin/Streptomycin (1X, 
Invitrogen). Cell suspensions were plated at a density of 100,000 cells/well using 24-well 
cell culture plates and maintained in 1 ml of the supplemented culture medium. For 
proliferation assays, dissociated retinal cells were plated onto sterilized and UV-treated 
cover slips precoated with poly-D-lysine (40 µg/ml; Sigma) and Matrigel (0.01X). For 
assays examining gene expression, dissociated retinal cells were plated directly onto the 
bottoms of precoated (40 µg/ml poly-D-lysine and 0.01X Matrigel) wells. Plates were 
briefly spun and cells allowed to settle for 1 hour at 37 °C and 5% CO2 to promote 
adherence to the plate or coverslips prior to addition of growth factors or 
pharmacological agents. Cultures were incubated at 37 °C and 5% CO2 with gentle 
nutating for the remaining culture period. Due to the severe hypocellularity of the orJ 
retina, retinas from multiple animals were pooled per sample. Distinct poolings were each 
counted as a separate n. Wild type retinas were not pooled, each animal providing a 
separate n. 
 
Retinal explant culture 
 Retinal explant cultures were performed as previously described (Sigulinsky et 
al., 2008). Briefly, P0 retinal tissue with the lens and vitreal chamber intact was dissected 
from surrounding ocular tissues in HBSS and cultured in 1 ml of the supplemented 
culture medium. Growth factors or pharmacological agents were diluted directly in the 
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culture medium immediately prior to culturing. Cultures were incubated at 37 °C and 5% 
CO2 with gentle nutating. 
 
Growth factor and pharmacological challenge 
To test responsiveness to Hh ligand stimulation, dissociated retinal cells or retinal 
explants were cultured in the presence or absence of 108 ng/ml SHH-N (Levine et al., 
1997).  Purified baculovirus-derived SHH-N was a kind gift from H. Roelink. To test 
responsiveness to Smo activation, the Smo agonist purmorphamine (EMD Chemicals, 
Philadelphia, PA, USA) was added to cultures of dissociated retinal cells and retinal 
explants. Unless otherwise noted, purmorphamine was used at a final concentration of 1 
µM (0.4% DMSO). DMSO (0.4%, v/v) served as a vehicle control. To inhibit PKA 
activity, the isoquinolinesulfonamide H89 (10 µM; Sigma) was added to cultures of 
dissociated retinal cells. For retinal explants, one explant from each mouse was cultured 
in the presence of factors or pharmacological agents, while the contralateral explant 
served as a control, cultured in the absence of factors and pharmacological agents or in 
the presence of a vehicle control.  
For proliferation assays, dividing cells in S phase were labeled by incorporation 
of the thymidine analog bromodeoxyuridine (BrdU; Sigma). Dissociated retinal cells 
were cultured for 24 or 48 hours with BrdU present during the final 2 or 4 hours, 
respectively, at a final concentration of 10 µg/ml. For gene expression measurements, 
dissociated retinal cells and retinal explants were cultured for 8 hours, except where 
noted in the text. For retinal explants, the lens and inner vasculature were removed from 
the retinal tissue immediately following the culture period, prior to RNA isolation. This 
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was performed on ice to limit changes in gene expression. In the postdissociation 
recovery experiments, dissociated orJ retinal cells were cultured for 24 hours in the 
presence of nonmitogenic concentrations of FGF-2 (0.1 ng/ml; C. Zou, personal 
communication; R&D Systems, Minneapolis, MN, UAS) to promote cell survival. FGF-2 
was added to the culture medium one hour after plating (0 hour). After 24 hours, 
purmorphamine (1 µM) or DMSO alone (0.4%) was added to the culture medium by 
replacing half the existing culture medium with fresh media containing two times the 
final concentrations of FGF-2 and purmorphamine or DMSO.  
 
Semiquantitative RT-PCR (sqRT-PCR) and analysis 
 Gene expression was measured by sqRT-PCR and analyzed as previously 
described (Sigulinsky et al., 2008). Student’s unpaired t-test or Welch’s two sample t-test 
was performed to determine statistical significance, as appropriate (based on results of 
the F-test of Variances), using Jmp 7.0 (SAS Institute, Inc., Cary, NC, USA). 
 
Immunocytochemistry and marker analysis 
 At the end of the culture period, dissociated retinal cells plated on cover slips 
were fixed in 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS, pH 7.5) 
for 30 minutes. Coverslips with adherent cells were either stained immediately or washed 
with PBS and stored at 4 °C in PBS containing 0.01% sodium azide (NaN3) until 
staining. Staining was performed with adherent cells on cover slips in 24-well culture 
plates. Adherent cells were washed in PBS and pretreated with blocking buffer (2% 
normal goat serum, 0.15% TritonX-100, and 0.01% NaN3 in PBS) for 30 minutes. Cells 
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were then incubated overnight at 4 °C with the following primary antibodies diluted in 
blocking buffer: mouse anti-BrdU (1:100; clone B44, Cat# 347580, BD Biosciences, San 
Jose, CA, USA); mouse anti-γ-tubulin (1:1000; clone GTU-88, Cat# T6557, Sigma); 
mouse anti-acetylated α-tubulin (1:10,000; clone 6-11B-1, Cat# T6793, Sigma); and 
rabbit anti-Arl13b (1:4500; gift of Tamara Caspary). Primary antibodies were followed 
by PBS washes and incubation for 1 hour at room temperature with appropriate species-
specific secondary antibodies conjugated to AlexaFluor488 or 568 (Invitrogen-Molecular 
Probes, Eugene, OR, USA) diluted 1:1000 in blocking buffer. Hydrochloric acid 
treatment (2N HCl, 30 minutes at room temperature) was performed prior to incubation 
with the BrdU antibody. Nuclei were counterstained with 4,6-diamidino-2-phenylindole 
(DAPI; Fluka, Switzerland). After washing in PBS, the coverslips were mounted onto 
glass slides in Fluoromount-G (SouthernBiotech, Birmingham, AL, USA).  
Visualization and image capture for proliferation and cell death assays was 
performed using an Eclipse E600 epi-fluorescence microscope (Nikon Instruments Inc., 
Melville, NY, USA) equipped with a Spot-RT slider CCD camera (Diagnostic 
Instruments Inc., Sterling Heights, MI, USA). Visualization and image capture for 
evaluation of primary cilia was performed using an Olympus FluoView FV1000 confocal 
laser scanning microscope and FV10-ASW software (Olympus America Inc., Center 
Valley, PA, USA). Images were processed using Adobe Photoshop CS5 Extended 
(Adobe Systems Inc., San Jose, CA, USA). FluoView confocal files were first converted 
using the Bio-Formats Importer Plugin (LOCI, University of Wisconsin-Madison, 
Madison, WI, USA) and ImageJ (NIH). 
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Proliferation of dissociated retinal cells was assayed by quantification of BrdU 
incorporation. The percentage of BrdU-labeled cells was calculated by determining the 
number of BrdU-positive cells in the total cell population (DAPI-positive) per cover slip. 
A minimum of 1000 cells were counted by random field analysis on each cover slip. 
Counts were performed blinded to treatment condition and genotype. To determine the 
statistical significance of the effects of SHH-N on proliferation, Student’s unpaired t-test 
or Welch’s two sample t-test was performed as appropriate (based on results of the F-test 
of Variances). Statistical significance for the dose response curves of purmorphamine 
treatment on proliferation was determined by ANOVA, followed by Tukey-Kramer HSD 
post hoc multiple comparison tests. All statistical analyses performed using Jmp 7.0 (SAS 
Institute, Inc., Cary, NC, USA). 
 
Results 
 Culturing of acutely-dissociated mammalian retinal cells is a well-established 
experimental paradigm, resulting in the generation of clones of similar size and 
composition to those generated in vivo (Cayouette et al., 2003). Such cultures are 
routinely used in the study of mitogen responsiveness and other developmental behaviors 
of mammalian retinal cells. Previously, we demonstrated that SHH-N addition to P0 orJ 
retinal explants was sufficient to enhance RPC proliferation and the expression of Hh 
pathway target genes (Sigulinsky et al., 2008). Expecting similar responses in dissociated 
P0 orJ retinal cells, we were surprised to observe that SHH-N addition failed to elicit a 
proliferative response (Figure 3.1). Furthermore, expression of the Hh target genes 
Ccnd1, Gli1, Hhip, Ptch1 and Ptch2 were only minimally enhanced, if at all, in response 
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to SHH-N (Figure 3.2A), indicating impaired responsiveness of orJ cells to SHH-N 
stimulation. These findings are in stark contrast to the robust proliferative and 
transcriptional responses observed in orJ retinal explants within similar or shorter culture 
periods (Sigulinsky et al., 2008). Dissociated P0 wild type cells responded robustly to 
SHH-N treatment both at the level of proliferation (Figure 3.1) and Hh target gene 
expression (Figure 3.2A) under identical culture conditions, suggesting that the 
dissociation procedure and culture conditions are compatible with SHH-N 
responsiveness. To address whether differential effects of SHH-N addition on the RPC 
population underlie the difference in responsiveness, we examined expression of Vsx2 
and Smo. The mutation in the orJ allele creates a premature stop codon in the Vsx2 gene 
and the resulting truncated protein is not detected, but Vsx2 mRNA is still strongly 
expressed and provides a reliable marker of RPCs. Smo is required for transduction of Hh 
signals, but is not a transcriptional target of Hh signaling nor is it affected by loss of Vsx2 
function (Sigulinsky et al., 2008), providing a reliable marker of Hh-responsive RPCs. 
Expression levels of Vsx2 and Smo were unchanged in response to SHH-N addition and 
not significantly different between wild type and orJ dissociated retinal cells (Figure 
3.2B), suggesting that the difference in SHH-N responsiveness between wild type and orJ 
cells was not likely due to SHH-N-dependent changes in the RPC population or Smo 
expression. 
 To better understand the dynamics of Hh responsiveness in dissociated cell 
culture, we examined the temporal profile of Hh target gene expression in dissociated 
wild type cells (Figure 3.3). RNA was collected from freshly dissected retina (tissue), 
from dissociated retinal cells at the time of plating (-1 hour), at the time of SHH-N 
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addition (0 hour), and 4, 8, and 12 hours after SHH-N addition. Expression levels were 
normalized to the expression levels in dissected wild type retinal tissue, which was set at 
100% and served as the reference expression level. In general, Hh target gene expression 
declined in the period between tissue isolation and SHH-N addition, but expression levels 
stabilized in the cultures exposed to SHH-N. In contrast, target gene expression in the 
cultures without SHH-N (control) continued to decline. These observations suggest SHH-
N treatment did not enhance the magnitude of Hh signaling in wild type cells, but 
prevented its further decline. 
 We then compared the gene expression profiles between dissociated wild type and 
orJ cells. Because of the severe hypocellularity of the orJ retina and, therefore, the 
limited availability of orJ cells (Green et al., 2003), we restricted our analyses to a single 
time point, 8 hours after SHH-N addition. By this time, gene expression levels had 
stabilized in both the control and SHH-N treated wild type cultures (Figure 3.3). 
Comparison of the wild type and orJ control cultures 8 hours after SHH-N addition 
(Figure 3.4) revealed that they reached an equivalent, low level of Hh target gene 
expression, consistent with minimal Hh signaling. However, the levels of Hh target gene 
expression differed considerably between wild type and orJ cultures treated with SHH-N, 
with levels in orJ cultures much reduced. The expression levels of Gli1 and Ptch2 were 
modestly elevated in the SHH-N treated orJ cultures compared to the orJ control, 
suggesting a limited, but detectable responsiveness to SHH-N, which is more easily seen 
by calculating their relative fold change in expression (Figure 3.2A). Comparison of Vsx2 
expression 8 hours after SHH-N addition revealed reduced levels in control wild type 
cultures and both control and SHH-N treated orJ cultures, while Smo expression declined 
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similarly in all conditions and genotypes (Figure 3.5). Reduced levels of Vsx2 and Smo 
are suggestive of a decline in the progenitor population in these cultures. However, the 
lack of consistent differences between control and SHH-N treated cultures and the 
presence of a significant progenitor population at the end of culture suggests that the 
change or lack of change in Hh target gene expression between control and SHH-N 
treated cultures likely reflects the responsiveness of wild type and orJ retinal cells to 
SHH-N addition.  
 The diminished response of dissociated orJ retinal cells to SHH-N, relative to 
dissociated wild type cells, is consistent with a change in the Hh pathway that impairs the 
responsiveness of orJ retinal cells to Hh pathway stimulation. As mentioned above, this 
is in stark contrast to explant cultures where orJ cells respond robustly to SHH-N 
treatment, even surpassing the levels of Hh target gene expression observed in the orJ 
retina in vivo (Sigulinsky et al., 2008). It was therefore unclear what hindered the ability 
of dissociated orJ RPCs to respond to SHH-N. To determine whether disruption occurred 
at the level of Hh ligand reception or within the intracellular portion of the pathway, we 
sought to stimulate Hh signaling with purmorphamine, a Hh pathway agonist that binds 
to and activates Smo in a ligand- and receptor-independent manner (Sinha and Chen, 
2006; Wu et al., 2004). Overall, purmorphamine elicited responses similar to SHH-N. In 
explant cultures of wild type P0 retina, the expression levels of Hh target genes were 
maintained relative to the in vivo expression level in response to purmorphamine 
addition, and in P0 orJ explants, purmorphamine stimulated increased expression of Hh 
target genes, surpassing the in vivo expression levels of the orJ retina (Figure 3.6). In 
dissociated cell cultures, purmorphamine enhanced proliferation in a dose-dependent 
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fashion over control levels in P0 wild type cells, but P0 orJ cells failed to exhibit a 
proliferative response (Figure 3.7). The response of dissociated P0 wild type cells to 
purmorphamine addition limited the decline or maintained expression of Hh target genes, 
while P0 orJ cells failed to respond or exhibited only a modest transcriptional response to 
purmorphamine treatment compared to control cultures (Figure 3.8). 
The diminished response of dissociated orJ cells to purmorphamine suggested 
that a disruption in the Hh pathway exists at the level of, or downstream of, Smo. 
Because growing evidence suggests that Smo activity is restricted to the primary cilium 
in mammalian cells (Goetz and Anderson, 2010; Huangfu and Anderson, 2006; Rohatgi 
and Scott, 2007; Ryan and Chiang, 2012), we asked whether dissociation caused a deficit 
of primary cilia in orJ cells. To assess this, we stained dissociated cells with antibodies 
against γ-tubulin and either acetylated α-tubulin or Arl13b one hour after plating (0 hour). 
γ-tubulin marks the basal body, the site of nucleation and base of the primary cilium (Han 
et al., 2009). Acetylated α-tubulin is enriched in the ciliary axoneme and commonly used 
as a marker of the primary cilium in both neural and nonneural cell types (Han et al., 
2009; Milenkovic et al., 2009; Rohatgi et al., 2007). However, in dissociated retinal cells, 
acetylated α-tubulin often stained the entire cell and its processes (data not shown), 
resulting in limited usefulness for the identification of a cilia deficit in dissociated orJ 
cells. Arl13b is a small GTPase belonging to the Arf/Arl family that is required for 
ciliogenesis and specifically enriched in the ciliary axoneme, colocalizing with acetylated 
α-tubulin and adjacent to γ-tubulin in the primary cilium of diverse cell types (Caspary et 
al., 2007; Hori et al., 2008). Using these markers, we still observed staining patterns that 
were consistent with the presence of primary cilium on both wild type and orJ cells 
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following dissociation (Figure 3.9). These results suggest that the primary cilium was not 
uniquely sensitive to the dissociation paradigm in the orJ cells. However, presence of the 
primary cilium in orJ cells does not rule out a problem with Smo regulation or activity.  
It also remains possible that disruption of Hh signaling occurs further downstream 
of Smo. cAMP-dependent protein kinase A (PKA) is a potent inhibitor of Hh signaling, 
promoting proteolytic processing of the Gli proteins into transcriptional repressors and 
blocking (in a dominant fashion) Hh- and Smo-induced disassembly of SuFu-Gli 
complexes and subsequent nuclear translocation and formation of Gli-A complexes 
(Humke et al., 2010; Riobo and Manning, 2007; Tempe et al., 2006; Tukachinsky et al., 
2010). Consistent with a dominant role for PKA-mediated inhibition of Hh signaling, 
increasing PKA activity blocks SHH-N-induced patterning of somites and proliferation of 
RPCs and purmorphamine-induced osteogenesis in multipotent mesenchymal progenitors 
(Fan et al., 1995; Jensen and Wallace, 1997; Wu et al., 2004). Additionally, a dominant 
negative form of PKA mimics the effects of ectopic Shh on patterning of the neural tube 
(Epstein et al., 1996), indicating that PKA-mediated inhibition is important for 
modulating Hh signaling activity in vivo. We therefore asked whether Hh signaling in 
dissociated orJ retinal cells could be enhanced by inhibiting PKA activity. To test this, 
we treated dissociated P0 orJ cells with purmorphamine in combination with H89, an 
isoquinolinesulfonamide that is highly selective for PKA and blocks its kinase activity by 
competing with ATP for the ATP binding pocket (Engh et al., 1996). In the presence of 
H89, Hh signaling was enhanced as revealed by approximately 2.5 fold increases in Gli1 
and Hhip expression compared to orJ cells treated with purmorphamine alone. 
Furthermore, these enhanced expression levels were roughly equivalent to that observed 
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in vivo in the orJ retina (Figure 3.10A-C). This observation suggests that Gli protein 
activation and nuclear translocation events are largely intact in orJ cells. Preliminary data 
indicate that H89 elicits only a minimal transcriptional response on its own, well below 
the level of target gene induction stimulated by the combination of H89 and 
purmorphamine (Figure 3.10D). Although still a preliminary finding, this suggests that 
the observed transcriptional response largely depends on Hh pathway stimulation through 
purmorphamine or SHH-N, and not H89 alone. Confirmation of these results would 
suggest that dissociated orJ cells respond, at least to some degree, to Hh pathway 
activation, even below Smo. Although such a finding implicates disruption of the Hh 
pathway at the level of PKA regulation or upstream of PKA input, it does not exclude a 
problem with Smo regulation or impairment of the pathway between Smo and PKA, as 
reduced pathway activation coupled with reduced PKA inhibition could also explain the 
current observations if resting levels of PKA activity are sufficient to largely counteract a 
low level of pathway activation. Distinguishing between these possibilities will require 
additional experimentation.  
 Because the dissociation paradigm is not expected to exert differential effects on 
wild type and orJ cells, we reasoned that perhaps the difference in responsiveness 
occurred as a result of delayed restoration of a limiting factor that was diminished upon 
dissociation, possibly due to a general lower rate of biosynthesis in orJ cells. To test this 
possibility, we allowed orJ cells to recover for 24 hours following dissociation before 
stimulating the Hh pathway with purmorphamine. During this postdissociation recovery 
period, orJ cells were cultured only in the presence of nonmitogenic concentrations of 
FGF-2 to promote survival. Purmorphamine was then added at 24 hours to stimulate the 
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Hh pathway. Although purmorphamine treated cultures exhibited a 10 fold increase in 
Gli1 expression relative to controls, comparison of expression levels at the end of culture 
to in vivo tissue levels revealed that Hh target gene expression had continued to decline, 
despite the addition of purmorphamine (Figure 3.11; compare to Figure 3.8). Thus, the 
recovery period failed to restore the competence of orJ cells to respond to Hh pathway 
activation.  
 To begin to evaluate the potential contribution of cell death to our findings, we 
measured the extent of apoptosis in dissociated cultures using an early apoptosis marker, 
caspase-3. Preliminary findings reveal an elevated frequency of apoptosis in orJ cultures 
relative to wild cultures at 24 hours irrespective of Hh pathway stimulation, as indicated 
by an increased proportion of caspase-3-positive cells in all treatment groups (Figure 
3.12A). However, only minimal levels (<1%) of apoptosis were observed in dissociated 
orJ cultures at 8 hours (Figure 3.12B). 
 
Interpretation and future directions 
Here, we show that dissociation results in severely diminished responsiveness of 
orJ retinal cells to Hh pathway stimulation. Dissociated orJ retinal cells failed to exhibit 
a proliferative response to treatment with recombinant Shh ligand or Smo agonist, which 
correlated with weak or absent maintenance of Hh target gene expression. This is in 
contrast to wild type retinal cells, which retain responsiveness to Hh stimulation after 
dissociation, exhibiting transcription of Hh target genes and proliferation of RPCs in 
response to recombinant Shh ligand and Smo agonist.  
123 
 
The robust responsiveness of orJ cells to Hh pathway stimulation in retinal 
explant cultures [(Sigulinsky et al., 2008) and this study] reveals that the core signal 
transduction cascade is largely intact in the absence of Vsx2 function. This finding raises 
concern regarding whether the loss of responsiveness in dissociated orJ cells reflects a 
specific role for Vsx2 in the regulation of Hh pathway activity versus a secondary or 
nonspecific effect of the dissociation procedure on orJ retinal cells. Restoration of Hh 
responsiveness by transfection of full-length Vsx2 would suggest that absence of Vsx2 is 
responsible for the altered responsiveness and rule out possible effects of the dissociation 
procedure that are not Vsx2-specific. However, this finding does not address whether 
Vsx2 function is directly required for regulation of Hh pathway activity, as roles in 
processes that influence the RPC population or metabolic activity would indirectly affect 
Hh responsiveness. Because a postdissociation recovery period of 24 hours failed to 
restore the competence of orJ retinal cells to respond to Hh pathway stimulation, it is 
unlikely that a role in promoting metabolic activity fully explains the diminished 
responsiveness in dissociated orJ retinal cells.  
Reduction of the Hh-responsive cell population (RPCs) during the culture period 
could mimic loss of Hh responsiveness. Two obvious mechanisms that could cause 
reductions in the RPC population are precocious differentiation into neurons or cell 
death. The former possibility is particularly unlikely, since orJ cells exhibit delayed 
neurogenesis in vivo, and exposure to Shh, at least at earlier stages, fails to promote 
premature initiation of neurogenesis (Bone-Larson et al., 2000; Robb et al., 1978; 
Rutherford et al., 2004; Sigulinsky et al., 2008). Furthermore, in wild type retinas, 
precocious cell cycle exit is associated with reduced Shh (Wang et al., 2005). A role for 
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Vsx2 in promoting RPC survival is lacking. Although one of the earliest phenotypes 
reported in the orJ retina was the absence of a normal early burst of morphogenetic cell 
death (Theiler et al., 1976), this was later shown to be simply delayed (Robb et al., 1978), 
consistent with the overall delayed development in the orJ retina (Bone-Larson et al., 
2000; Robb et al., 1978; Rutherford et al., 2004; Sigulinsky et al., 2008). Furthermore, at 
P0, orJ retinal cells do not exhibit elevated levels of cell death (Green et al., 2003). 
Despite a lack of propensity towards increased cell death in vivo, preliminary data 
suggest that orJ cells, as a population, are more susceptible to apoptotic cell death in 
dissociated cell cultures. Cell death is not an unexpected finding in dissociated retinal cell 
cultures. In the absence of target-derived trophic factors, ganglion cells survive poorly in 
culture, even in retinal explants, with significant reductions observed within the first 24 
hours (Jensen and Wallace, 1997; Wang et al., 2002). Thus, it is not clear whether the 
elevated levels of apoptotic cell death in orJ cultures is indicative of reductions in the 
RPC population. Further analysis of the apoptotic population with cell type- and 
progenitor-specific markers will be required to assess this possibility.  
The relative contribution of cell death to diminished Hh responsiveness could be 
assessed through experimental manipulations that promote RPC survival. Extrinsic 
signals may act as trophic factors at nonmitogenic concentrations (Reh et al., 1996). In 
the present study, nonmitogenic concentrations of FGF-2 were added in the recovery 
experiments to promote survival, but resulted in little to no effect on the restoration of Hh 
responsiveness in dissociated orJ retinal cells. However, cell death was not assayed in 
these cultures to confirm whether survival was indeed enhanced. Alternatively, the 
effects of blocking apoptosis on restoration of Hh responsiveness in dissociated orJ 
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retinal cells could be tested. Genetic deletion of p53 in mice blocks normal 
developmental apoptotic neuronal loss in the hippocampus (Murase et al., 2011) and 
protects against apoptotic neuronal loss triggered by kainic acid-induced epileptic 
seizures, allowing recovery from damage that normally promotes death (Kinoshita et al., 
2012).  
In an effort to directly assess the RPC population, we examined expression of the 
RPC markers Vsx2 and Smo. Neither is a known target of Hh signaling, and their 
expression was not significantly different between SHH-N treated and control cultures 
(Figure 3.2B). Differences in Vsx2 and Smo expression were not detected between wild 
type and orJ retinas (Sigulinsky et al., 2008), suggesting that they are also not targets of 
Vsx2 transcriptional regulation. Thus, changes in Vsx2 and Smo levels reflect changes in 
the relative contribution of RPCs to the total cell population. Although Vsx2 exhibited 
reduced expression in control wild type and both control and SHH-N treated orJ cultures, 
Smo expression declined similarly in both genotypes and across all treatment conditions. 
Furthermore, the elevated cell death observed in dissociated orJ retinal cells at 24 hours 
was independent of purmorphamine concentration or the presence of DMSO. Thus, it 
appears that neither Vsx2 nor Hh signaling promoted changes in the proportions of the 
RPC population, consistent with previous findings that SHH-N and Vsx2 and do not 
promote cell survival or death, respectively (Green et al., 2003; Levine et al., 1997). 
These findings also argue against the possibility that specific changes in the RPC 
population account for the observed differences in Hh responsiveness. In the absence of 
altered proportions of responsive cells, a global loss of orJ cells in culture, relative to 
wild type, could also mimic loss of responsiveness. However, such a loss was not 
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obvious upon visual inspection of the cultures, and similar numbers of total cells (DAPI-
positive) were counted per field of view in wild type and orJ cultures at 24 hours when 
random field analysis was used to quantify proliferation (data not shown). Given the 
progenitor proportions, as indicated by Vsx2 and Smo expression, a significant progenitor 
population is present, even at the end of the culture period. Together, these findings argue 
that despite elevated apoptosis in orJ cultures, changes in the RPC population are 
unlikely to fully account for the diminished Hh responsiveness observed for dissociated 
orJ retinal cells.  
Assuming the diminished responsiveness of dissociated orJ cells reflects a 
specific role for Vsx2 in the regulation of Hh pathway activity, where does this regulation 
intersect with the Hh pathway? Using pharmacological agents to manipulate Hh signaling 
at different levels in the pathway, we have narrowed the localization of this disruption to 
an intracellular region of the Hh pathway. Although some findings are preliminary and 
will require further confirmation, we believe that the primary disruption occurs at or 
between the levels of Smo activity and PKA regulation. It is important to note, however, 
that because purmorphamine activates Smo in the absence of Hh ligand and 
independently of the Hh receptor Ptch1 (Sinha and Chen, 2006; Wu et al., 2004), we are 
currently unable to rule out any additional deficits in Hh ligand reception. Additionally, 
our observation that the diminished responsiveness manifests upon perturbation of the 
extracellular environment suggests misregulation of an environmentally-sensitive 
component of the Hh pathway. Based on these observations, the most likely candidates 
within the implicated region of the Hh pathway are PKA and Smo.  
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PKA is a critical and dominant negative regulator of the Hh pathway. Increased 
activation is sufficient to block the effects of Hh pathway activation when the activation 
is ligand or Smo based (Fan et al., 1995; Jensen and Wallace, 1997; Wu et al., 2004). 
Additionally, activity of PKA is both positively and negatively influenced by extrinsic 
signals. PKA activity is negatively regulated by PI3K through Akt, and activation of the 
PI3K/Akt pathway by growth factor signaling sensitizes cells to Hh pathway stimulation 
(Riobo et al., 2006b). Conversely, PKA activity is potentiated by increased cyclic AMP 
(cAMP) levels in response to increased production by adenylyl cyclase. Adenylyl cyclase 
is a common target of G-protein coupled receptor signaling activated by intercellular 
signals, such as hormones.  
Is PKA overactive in dissociated orJ retinal cells? Consistent with this possibility, 
inhibition of PKA activity in dissociated orJ cells greatly enhanced their transcriptional 
response to Smo activation. Our preliminary findings that PKA inhibition alone had little 
to no effect on Hh signaling activity contradicts observations in zebrafish where a 
dominant negative form of PKA rescued Hh loss of function phenotypes in Smo mutants 
(Barresi et al., 2000), suggesting that perhaps PKA is not overactive in dissociated orJ 
retinal cells, as PKA inhibition alone was not sufficient to promote Hh target gene 
upregulation in dissociated orJ cells. However, it is unclear whether Hh pathway 
activation is truly absent in zebrafish Smo mutants. Although cloning and functional 
analyses suggest that the mutations in zebrafish Smo mutants are null mutations, maternal 
Smo contribution or duplication of the Smo gene (similar to the Shh gene duplication in 
zebrafish) has not been ruled out and may mediate the observed effects of PKA inhibition 
in Smo mutants and account for the milder phenotypes of these mutants compared to Shh 
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null mutations in mouse (Varga et al., 2001). In LIGHT cells, inhibition of PKA activity 
through IGF-1 activation of the PI3K/Akt pathway was not sufficient to promote Gli 
reporter activity (Riobo et al., 2006b), suggesting that derepression alone is insufficient to 
activate Hh signaling-dependent transcription and that pathway stimulation is required, at 
least in this cell line. H89 inhibits PKA kinase activity by competing with ATP for the 
ATP binding pocket (Engh et al., 1996), suggesting that the effects of H89 should be dose 
dependent; therefore, it is also possible only minimal inhibition was achieved in our 
cultures. Thus, future analyses should seek to confirm whether PKA is indeed overactive 
in dissociated orJ retinal cells. This could be assessed by comparing the dose-dependency 
of Hh target gene expression to H89 at constant purmorphamine or SHH-N concentration 
between dissociated wild type and orJ retinal cells and between dissociated and explant 
cultures of orJ retinal cells. Alternatively, PKA activity from tissue lysates could be 
measured directly (Goueli et al., 2001; Goueli et al., 1995) and several commercially 
available kits are available. 
Smo also remains an attractive candidate for the site of pathway disruption in 
dissociated orJ cells. Reduced Smo activity, as a result of reduced levels or impaired 
function, would impair responsiveness of cells to Hh pathway activation. Reduced Smo 
levels resulting from altered transcriptional regulation is unlikely to mediate the 
disruption in dissociated orJ cells. Our previous analyses did not reveal any significant 
differences in either Smo expression or the relative proportions of Smo-expressing (RPC) 
and non-expressing (neuron) cell populations between wild type and orJ retinas (Green et 
al., 2003; Sigulinsky et al., 2008) suggesting that Smo transcription is unaffected by loss 
of Vsx2. Our current analyses also argue against transcriptional regulation, as changes in 
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Smo expression largely correlate with changes in the RPC population (as indicated by 
Vsx2 expression) during culture across genotypes and treatment groups. Because Smo is a 
transmembrane protein, it is possible that incubation with the trypsin protease during the 
dissociation procedure limited the levels of functional Smo. However, Smo is present on 
the plasma membrane of both stimulated and unstimulated cells and then trafficked via 
lateral transport to the primary cilium (Milenkovic et al., 2009), making it unlikely that 
Smo would be differentially exposed to trypsin between orJ and wild type cells. 
Furthermore, dissociated wild type cells respond robustly to SHH-N, which requires the 
Hh receptor Ptch1, also a transmembrane protein, in addition to functional Smo, 
suggesting that it is unlikely trypsin treatment has a significant impact on the function of 
transmembrane proteins and the resulting responsiveness of cells to Hh stimulation. This 
could be confirmed by using gentler proteases during dissociation. For example, papain 
was found to be less damaging than trypsin and several other proteases for the 
dissociation of retinal cells from turtles (Lam, 1972). Alternatively, Smo protein integrity 
could be analyzed by ESI-MS to determine if the protein sequence is different than 
expected due to truncation or degradation by the protease. ESI-MS is particularly 
amenable to detailed profiling of transmembrane proteins (Souda et al., 2011). 
A more likely scenario is reduced Smo function resulting from misregulation of 
Smo activation. Activation of Smo is tightly regulated and still poorly understood, but 
potentially sensitive to environmental perturbations. Inhibition of Smo activity by the Hh 
receptor Ptch1and its release by ligand binding to Ptch1 is not well defined but may 
involve local regulation of the concentrations of small molecules through Ptch1 acting as 
a pump (Rohatgi and Scott, 2007), but this has yet to be confirmed. Furthermore, 
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activation of Smo involves a conformational change induced via phosphorylation of its 
C-terminal tail by CK1α and GRK2 (Chen et al., 2011), which may also be targets of 
extrinsic signals, much like PKA. This phosphorylation also promotes localization of 
activated Smo to the primary cilium. Although the precise mechanism is still poorly 
defined, it involves lateral transport and dependence on β-arrestin and the kinesin motor 
Kif3b (Chen et al., 2011; Milenkovic et al., 2009). Because Smo activity correlates with 
its level of phosphorylation (Chen et al., 2011) and subcellular localization, these could 
be used to evaluate activation of endogenous Smo in dissociated retinal cells. Using an 
anti-Smo antibody (anti-SmoC, gift of M.P. Scott) that allows visualization of 
endogenous Smo in cultured mouse fibroblasts (Rohatgi et al., 2007), we have 
successfully observed endogenous Smo accumulation in acetylated α-tubulin-positive 
cilia of wild type retinas (data not shown). Using this antibody, activation of endogenous 
Smo could be evaluated based on localization in dissociated cell cultures. However, 
ciliary trafficking of Smo in response to purmorphamine has not been reported and we 
have not ruled out a deficit in Hh reception in dissociated retinal cells. Thus, it may be 
necessary to use an alternative Smo agonist that is known to promote both 
phosphorylation and ciliary localization of Smo, such as SAG (Chen et al., 2011) if 
ciliary localization is not observed in purmorphamine treated cultures of dissociated wild 
type cells. Endogenous Smo activation, could also be assessed by comparing the level of 
Smo phosphorylation in dissociated wild type and orJ retinal cells using Phos-tag PAGE 
(Chen et al., 2011) or ESI-MS (Souda et al., 2011). 
If activation of endogenous Smo is insufficient to overcome the resting levels of 
PKA inhibition due to reduced levels or misregulation in dissociated orJ retinal cells, 
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then transfection with a constitutively active form of Smo should stimulate Hh signaling 
and Hh target gene expression. Because PKA regulation can be dominant, it will be 
important to first determine whether PKA is overactive in dissociated orJ cells, or include 
PKA inhibitors in these cultures. Smo-M2 is an oncogenic form that exhibits the active 
conformation, cilia localization, and activating phosphorylation in a Shh-independent 
fashion (Chen et al., 2011). Although Smo-M2 activity does not require Shh, it does 
require CK1α and GRK2 phosphorylation (Chen et al., 2011). Thus, if Smo-M2 
transfection fails to stimulate Hh signaling in dissociated orJ retinal cells, this may 
indicate a deficit in the phosphorylation activity of CK1α and GRK2, and the 
phosphorylation state of Smo should be assessed. If purmorphamine stimulates the active 
Smo conformation in dissociated orJ retinal cells, but phosphorylation is deficient, then 
co-transfection of CK1α and GRK2 should restore Hh signaling (Chen et al., 2011).  
Establishing the nature of the disruption occurring in dissociated orJ cells will 
provide significant direction for future efforts aimed at identifying the mechanism of 
Vsx2-mediated regulation of Hh responsiveness. Evaluation of PKA activity levels and 
the ability of constitutively active Smo to restore Hh responsiveness in orJ cells will be 
important first steps in evaluating potential targets of this regulation. However, a critical 
unanswered question remains:  Why does this disruption only manifest upon 
dissociation? The contrasting responsiveness of orJ retinal cells to Hh pathway 
stimulation in dissociated versus explant cultures suggests that loss of responsiveness in 
dissociated orJ cells is linked to the disruption of intercellular interactions. Currently, an 
attractive model to account for this observation is that extrinsic signals mediating 
intercellular interactions important for Shh-induced retinal proliferation become limiting 
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upon dissociation and orJ cells are more sensitive as a result of Vsx2-dependent changes 
in the production of or responsiveness to these signals. In retinal explants, dilution of 
extrinsic signals is minimal and a limited impairment of Hh responsiveness in orJ cells 
may be masked by dominating sensitization of orJ cells to Hh stimulation that results 
from prolonged exposure to reduced ligand availability. Feedback inhibition is a 
prominent feature of the Hh signaling pathway and several negative regulators of Hh 
signaling that are also Hh target genes, exhibit reduced expression in the orJ retina 
(Sigulinsky et al., 2008), which may underlie this sensitization. Proliferation in retinal 
cells is particularly sensitive to perturbations of the extracellular environment, setting 
precedence for such a model mechanism. Retinal cells cultured as intact explants 
exhibited significantly greater BrdU incorporation than when cultured as low density 
monolayers (Lillien and Cepko, 1992). BrdU incorporation could be increased in these 
monolayer cultures simply by increasing plating density, suggesting that intercellular 
interactions are important for proliferation of retinal cells. Moreover, the proliferative 
response of retinal cells to SHH-N treatment is also sensitive to intercellular interactions. 
SHH-N was a more potent retinal mitogen when dissociated retinal cells were re-
aggregated into pellet cultures rather than cultured as monolayers (Jensen and Wallace, 
1997). Although it is not clear whether these intercellular interactions are required for 
optimal Hh signaling activity in retinal cells or simply to promote proliferation 
downstream of the Hh pathway, comparison of the transcriptional response in orJ retinal 
cells to Hh pathway stimulation in pellet versus low density monolayer culture would 
allow evaluation of the above-mentioned model by providing insight into whether the 
diminished responsiveness of dissociated orJ retinal cells results from disrupted 
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intracellular interactions. Alternatively, the ability of increased plating density to improve 
the transcriptional response of dissociated orJ retinal cells in our low density monolayer 
cultures could also be examined. 
As previously mentioned, both Smo and PKA are regulated by mechanisms that 
are themselves downstream of extrinsic signals, including the PI3K/Akt and adenylyl 
cyclase/cAMP pathways. An important addition to this list is the MEK/ERK (MAPK) 
pathway. Activation of MAPK signaling sensitizes NIH 3T3 cells to Hh pathway 
stimulation, while inhibition renders these cells unresponsive (Riobo et al., 2006a). 
MAPK-mediated regulation of Hh responsiveness in NIH 3T3 cells was initiated 
indirectly by activation of PKCδ or directly through activation of MEK-1, suggesting that 
a number of extrinsic signals would have the potential to exert such regulation through 
their activation of G-protein coupled receptors or receptor tyrosine kinases and 
demonstrated by the ability of FGF2 to stimulate Gli reporter activity in NIH 3T3 cells in 
a MEK-1-dependent fashion (Riobo et al., 2006a). The mechanism by which MAPK 
signaling regulates Hh responsiveness is still unclear, but promotes Gli transcriptional 
activity. Recent evaluation of the relationship between Hh signaling and the MAPK 
pathway in gastric cancer revealed that MAPK signaling promoted Hh signaling without 
affecting the level of Shh expression (Seto et al., 2009). Furthermore, MAPK-induced 
sensitization could be blocked by overexpression of SuFu, but not cyclopamine-mediated 
inhibition of Smo, suggesting that MAPK signaling intersects with the Hh pathway 
between Smo and SuFu. This localization of MAPK activity is consistent with the current 
localization of the disruption observed in dissociated orJ retinal cells. Thus, an intriguing 
possibility is that the diminished responsiveness of dissociated orJ retinal cells occurs as 
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a result of reduced MAPK signaling. Evaluation of readouts for MAPK signaling, such as 
phosphorylation of ERK, by immunocytochemistry or western blotting, could confirm 
reduced MAPK signaling in dissociated orJ retinal cells (Fogarty et al., 2007). The ability 
of activated MAPK signaling to restore Hh responsiveness in dissociated orJ retinal cells 
could be tested using a number of methods, including transfection of activated MEK-1, 
KRAS (constitutively active Ras) or BRAF, activation of PKCδ by phorbol esters, or 
stimulation with growth factors (Riobo et al., 2006a; Seto et al., 2009). Interestingly, in 
granule cell precursors of the cerebellum, FGF2 blocks Hh signaling through activation 
of MAPK signaling (Fogarty et al., 2007). Thus, it will be important to determine 
whether MAPK activation promotes or inhibits Hh signaling in retinal cells and the 
relevant extrinsic signals mediating this activation.  
The data presented here suggests a potential role for Vsx2 in the regulation of 
RPC responsiveness to Hh pathway stimulation. Whether this role is relevant in vivo 
remains to be determined, as reduced responsiveness of orJ cells to Hh pathway 
stimulation is only revealed upon dissociation. Currently, it is unclear why orJ cells are 
more sensitive to the dissociation paradigm, but an intriguing possibility is that it may 
reflect alterations in extrinsic signals required for the proliferative response of retinal 
cells to Shh. Thus, although the principal limiting factor for Hh signaling in vivo may be 
reduced ligand availability, determining the nature of the disruption in dissociated orJ 
cells may still provide insight not only into Vsx2 function, by identifying candidate 
transcriptional targets, but also into factors required for promoting Hh signaling and 














Figure 3.1.  Diminished proliferative response of orJ RPCs to SHH-N in dissociated cell 
cultures. Dissociated P0 retinal cells from wild type (A-D) and orJ (E-H) mice 
(maintained on the Black Swiss background) were cultured in the absence (A,B,E,F) or 
presence (C,D,G,H) of SHH-N for 48 hours with BrdU present during the last 4 hours. 
(A,C,E,G) BrdU immunoreactivity. (B,D,F,H) DAPI counterstain. (I) Quantification of 
the proportion of BrdU-labeled cells. Each bar represents the mean ± standard error of the 
















Figure 3.2. Diminished transcriptional response of orJ RPCs to SHH-N in dissociated cell 
cultures. P0 dissociated retinal cells were cultured in the presence or absence of SHH-N 
for 8 hours. (A) Fold change in Hh target gene expression due to SHH-N treatment. (B) 
Fold change in control gene (progenitor markers) expression following SHH-N treatment. 
Each bar represents the mean ± standard deviation (SD) in (A) and the mean ± SEM in 

















Figure 3.3. Temporal profile of Hh target gene expression in dissociated wild type retinal 
cells. Relative expression levels of Hh target genes in P0 wild type retinal cells under the 
following conditions:  freshly dissected retina (tissue), dissociated retinal cells at the time 
of plating (t = -1 hour), at the time of SHH-N addition (0 hour) and 4, 8, and 12 hours 
after SHH-N addition. Expression levels were normalized to the expression levels in 
freshly dissected retinal tissue, which was set at 100% and served as the reference 
expression level. Each point represents the mean ± SEM. n = 7 (tissue) or 3 (all other data 


















Figure 3.4. Reduced ability of orJ RPCs to maintain Hh target gene expression in 
response to SHH-N in dissociated cell cultures. Comparison of the relative expression 
levels of Hh target genes in P0 wild type and orJ retinal cells 8 hours after SHH-N 
addition in dissociated cell cultures. Expression levels were normalized to the expression 
level in freshly dissected wild type retinal tissue, which was set at 100% and served as 
the reference expression level. Each point represents the mean ± SEM. n = 7 (tissue) or 3 


















Figure 3.5. Minimal effects of SHH-N treatment or genotype on progenitor marker 
expression  in dissociated cell cultures. Comparison of the relative expression levels of 
control genes in P0 wild type and orJ retinal cells 8 hours after SHH-N addition in 
dissociated cell cultures. Expression levels were normalized to the expression level in 
freshly dissected wild type retinal tissue, which was set at 100% and served as the 
reference expression level. Each point represents the mean ± SEM. n = 4 (tissue) or 3 (8 


















Figure 3.6. Purmorphamine stimulates robust expression of Hh target genes in retinal 
explant cultures. Comparison of the relative expression levels of Hh target genes (Gli1 
and Hhip) and control genes (Smo) in P0 wild type and orJ retinal cells 8 hours after 
purmorphamine addition in explant cultures. Expression levels were normalized to the 
expression level in freshly dissected wild type retinal tissue, which was set at 100% and 
served as the reference expression level. Each point represents the mean ± SEM. n = 7 


















Figure 3.7. Diminished proliferative response of orJ RPCs to purmorphamine in 
dissociated cell cultures. P0 dissociated retinal cells were cultured in the presence of 
purmorphamine (0.01, 0.1, 1, or 10 µM and 0.4% DMSO), DMSO alone (0.4%), or the 
absence of both purmorphamine and DMSO (untreated) for 24 hours with BrdU present 
for the last 2 hours. Graph represents quantification of the proportion of BrdU-labeled 
cells. Each bar represents the mean ± SEM. Statistical significance of purmorphamine 
effect on wild type cells determined by ANOVA, followed by Tukey-Kramer HSD post 
























Figure 3.8. Reduced ability of orJ RPCs to maintain Hh target gene expression in 
response to purmorphamine in dissociated cell cultures. Comparison of the relative 
expression levels of Hh target genes (Gli1 and Hhip) and control genes (Smo) in P0 wild 
type and orJ retinal cells 8 hours after purmorphamine addition (1 µM in 0.4% DMSO) 
in dissociated cell cultures. DMSO (0.4%) served as a vehicle control. Expression levels 
were normalized to the expression level in freshly dissected wild type retinal tissue, 
which was set at 100% and served as the reference expression level. Each point 
represents the mean ± SEM. n = 7 (tissue, Hh target genes), 4 (tissue, Smo) or 3 (8 hours). 


















Figure 3.9. Primary cilia are present on dissociated retinal cells. P0 retinal cells were 
dissociated, plated onto coverslips, and allowed to adhere for 1 hour prior to fixation. 
Visualization of the primary cilium in dissociated wild type (A,B) and orJ (C,D,E) retinal 
cells at 0 hours was accomplished using the cilia marker ARL13B and  a marker of the 
basal body, γTUB. Cells were counterstained for DAPI to visualize the nuclei. As seen in 
A-D, primary cilia are associated with basal body markers. Consistent with previous 

















Figure 3.10. H89 enhances the ability of orJ RPCs to maintain Hh target gene expression 
in response to purmorphamine in dissociated cell cultures. (A-C) Comparison of the 
relative expression levels of Hh target genes (Gli1 and Hhip) and control genes (Smo) in 
P0 wild type and orJ retinal cells 8 hours after purmorphamine addition (1 µM in 0.4% 
DMSO), in the presence or absence of H89 (10 µM)  in dissociated cell cultures. DMSO 
(0.4%) served as a vehicle control. (A) Gli1 expression. (B) Hhip expression. (C) Smo 
expression. Expression levels were normalized to the expression level in freshly dissected 
wild type retinal tissue, which was set at 100% and served as the reference expression 
level. Note that purmorphamine and DMSO data are from Figure 3.8. Each point 
represents the mean ± SEM. n = 7 (tissue, Hh target genes), 4 (tissue, Smo)  >3 (8 hours, 
DMSO, purmorphamine), 2 (orJ, purmorphamine + H89). (D) Effects of H89 treatment 
(10 µM) in the presence and absence of purmorphamine (1 µM, 0.4% DMSO) on Hh 
target gene expression in orJ retinal cells at 8 hours in dissociated cell cultures. 
Expression levels were normalized to the expression levels observed in control (DMSO) 
cultures, which was set at 100% and served as the reference expression level. Bars 




















Figure 3.11. Postdissociation recovery fails to restore responsiveness of orJ retinal cells 
to purmorphamine. Comparison of the relative expression levels of Hh target genes (Gli1 
and Hhip) and control genes (Smo) in P0 orJ retinal cells 8 hours after purmorphamine 
addition (32 total hours in culture) in dissociated cell cultures following an initial 24 hour 
postdissociation recovery period. DMSO served as a vehicle control. Expression levels 
were normalized to the expression level in freshly dissected wild type retinal tissue, 
which was set at 100% and served as the reference expression level. Data points for tissue 
represent the mean ± SEM. n = 7 (tissue, Hh target genes) or 4 (tissue, Smo). Data points 


















Figure 3.12. Cell death in dissociated cell cultures. Quantification of the proportion of 
Caspase-3-labeled cells in dissociated cultures of wild type and orJ retinal cells. (A) P0 
dissociated retinal cells were cultured in the presence or absence of purmorphamine for 
24 hours. Each bar represents the mean ± SEM, where appropriate. n = 3 (wild type) or as 
indicated (orJ). (B) P0 dissociated orJ retinal cells were cultured in the presence or 
absence of purmorphamine and H89 for 8 hours. Each bar represents the mean ± SEM, 
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CELL AUTONOMOUS AND CELL NONAUTONOMOUS 
REQUIREMENTS FOR VSX2 IN THE REGULATION OF 






Vertebrate retinal development requires specification and maintenance of retinal 
identity, proliferative expansion of retinal progenitor cells (RPCs) and differentiation of 
mature retinal neurons and glia. The homeobox gene Vsx2 is expressed in RPCs and 
required for proper execution of this retinal program. To further define the requirement 
for Vsx2 in the regulation of RPC properties, we generated chimeric mouse embryos 
comprised of wild type and Vsx2-deficient cells. We found that Vsx2 maintains retinal 
identity in part through the cell autonomous repression of the RPE determinant Mitf and 
that Lhx2 is required cell autonomously for the ectopic Mitf expression in Vsx2-deficient 
retinas. We also found significant cell nonautonomous contributions to Vsx2-mediated 
regulation of RPC proliferation, indicating that Vsx2 has an important role(s) in 
establishing mitogen signals, or their tissue source, during retinal development. This 
analysis also revealed a previously unappreciated role for regional variation in the 
extrinsic regulation of RPC proliferation. Chimera analysis further demonstrated a cell 
autonomous requirement for Vsx2 in the initiation of neurogenesis, indicating that Vsx2 
is an important regulator of neurogenic competence. Our findings reiterate the importance 
of Vsx2 in retinal development and demonstrate that Vsx2 utilizes both cell autonomous 




The vertebrate retina is one of three ocular tissues that develop from the optic 
vesicle, an evagination of the neuroectoderm at the level of the diencephalon. Extrinsic 
signals pattern the optic vesicle into three distinct domains, thereby specifying the 
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identities of the presumptive retina, RPE, and optic stalk. Growing evidence reveals that 
at least for the RPE and retina, initial specification alone is insufficient for proper 
developmental progression; rather, these identities require active maintenance and 
suppression of aberrant gene expression programs (Horsford et al., 2005; Nguyen and 
Arnheiter, 2000; Rowan et al., 2004; Zou and Levine, 2012). Further development of the 
retina requires coordinated proliferation and differentiation. An initially small population 
of specified retinal progenitor cells (RPCs) undergoes extensive proliferative expansion 
to generate sufficient cell numbers for the formation of a functional retina (Alexiades and 
Cepko, 1996). During this proliferative period, many of these multipotent RPCs initiate 
differentiation to generate retinal neurons and glia (Young, 1985). This occurs according 
to an evolutionarily conserved sequence such that the six classes of retinal neurons and a 
single glial type are each produced during a limited, yet overlapping, interval (Livesey 
and Cepko, 2001). Disruptions in any of these processes impair proper development of 
the retina and visual function. 
The homeobox gene Vsx2 is an essential regulator of retinal development. Vsx2 
expression in the distal optic vesicle initiates around E9.5 (Liu et al., 1994) and is the 
earliest specific marker of specified RPCs. Expression is maintained in RPCs throughout 
retinal development, but terminated in all postmitotic retinal cells, except bipolar cells 
and a subset of Müller glial cells (Liu et al., 1994; Rowan and Cepko, 2004). Human 
patients with mutations in Vsx2 present clinically with microphthalmia, iris colobomas, 
cataracts, and congenital blindness (Bar-Yosef et al., 2004; Ferda Percin et al., 2000). 
Two mouse lines carrying spontaneous recessive mutations in the Vsx2 gene, ocular 
retardation (or) and ocular retardation J (orJ), also exhibit microphthalmia, cataractous 
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lenses, and coloboma, as well as failure to form the optic nerve (Bone-Larson et al., 
2000; Burmeister et al., 1996; Robb et al., 1978; Truslove, 1962). Knockdown of the 
zebrafish homolog Alx with antisense oligonucleotides also promotes reduced eye size 
and disrupted eye development (Barabino et al., 1997). Studies in the defined Vsx2-null 
mouse mutant, orJ, reveal that these defects in ocular development arise from disruptions 
in the execution of the retinal program, including compromised retinal identity, severely 
reduced RPC proliferation, delayed neurogenesis, and absence of bipolar cells (Bone-
Larson et al., 2000; Burmeister et al., 1996; Green et al., 2003; Horsford et al., 2005; 
Rowan et al., 2004).   
Although Vsx2 expression is used to identify the presumptive retina and loss of 
this expression is often associated with the failure of retinal development in many studies, 
evidence suggests that Vsx2 is neither necessary nor sufficient to specify the retinal fate. 
First, retinal specification occurs in the absence of Vsx2 function. Expression of Vsx2 
transcript is unaffected in orJ retinas (Rutherford et al., 2004; Sigulinsky et al., 2008) and 
orJ retinal cells express several additional neural retina-specific markers and generate 
mature retinal cell types (Bone-Larson et al., 2000; Burmeister et al., 1996; Green et al., 
2003; Horsford et al., 2005; Rowan et al., 2004; Rutherford et al., 2004), indicating that 
retinal identity is initially specified and execution of the retinal program persists, albeit 
disrupted, in the absence of Vsx2 gene function. Additionally, misexpression of Vsx2 on 
its own in the presumptive RPE appears insufficient to direct these cells towards a retinal 
fate, although one study demonstrated that Vsx2 was sufficient to downregulate several 
RPE genes (Horsford et al., 2005; Rowan et al., 2004). Instead, Vsx2 is required in the 
maintenance of retinal identity, primarily to prevent activation of nonretinal gene 
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expression programs. Several genes with RPE-restricted expression exhibit ectopic or 
expanded expression throughout all or part of the orJ retina, (Horsford et al., 2005; 
Rowan et al., 2004), which likely contributes to the hyperpigmentation observed in orJ 
retinas as ocular development progresses (Green et al., 2003; Horsford et al., 2005; 
Rowan et al., 2004; Truslove, 1962). Manipulations exacerbating this aberrant gene 
expression program further enhance this hyperpigmentation and disruption of retinal 
development, while manipulations alleviating aberrant gene expression improve retinal 
development and reduce ectopic pigmentation (Horsford et al., 2005; Konyukhov and 
Sazhina, 1966; Zou and Levine, 2012). Acquisition and maintenance of retinal identity 
involve both extrinsic and intrinsic regulators. While studies have implicated Vsx2 
downstream of extrinsic signals and upstream of many intrinsic factors involved in retinal 
acquisition or maintenance (Horsford et al., 2005; Nguyen and Arnheiter, 2000; Rowan et 
al., 2004; Zou and Levine, 2012), it is not clear from these studies whether Vsx2 also 
influences extrinsic signals required for maintenance of this identity. 
Ocular tissues of orJ mice develop normally through the initial formation of the 
optic cup. However, as development proceeds, orJ eyes become increasingly smaller than 
wild type littermates and have thin, hypocellular retinas. Decreased retinal volume and 
cell number are detected as early as E11.5 (Bone-Larson et al., 2000; Burmeister et al., 
1996). By P0, orJ retinas exhibit a striking 19-fold reduction in cell number (Green et al., 
2003). The severe hypocellularity of the orJ retina results primarily from defective RPC 
proliferation (Bone-Larson et al., 2000; Burmeister et al., 1996; Dhomen et al., 2006; 
Green et al., 2003; Konyukhov and Sazhina, 1971). The slowed rate of cell cycle 
progression in the orJ retina appears, in large part, due to aberrant accumulation of the 
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cell cycle inhibitor p27/KIP1. Genetic deletion of p27/KIP1 in the orJ retina largely 
restores retinal cell number without influencing neurogenesis or apoptosis. Regulation of 
p27/KIP1 by Vsx2 is indirect and involves posttranscriptional mechanisms largely 
mediated by Ccnd1 (Green et al., 2003). Additionally, genetic removal of the RPE 
determinant, Mitf, in orJ retinas also improves retinal size and RPC proliferation 
(Horsford et al., 2005; Konyukhov and Sazhina, 1966). In melanocytes and melanoma 
cell lines, MITF directly promotes p27/KIP1, as well as a related CIP/KIP family 
member, p21/CIP (Carreira et al., 2005; Lekmine et al., 2007). Recently, Mitf was also 
implicated in transcriptional activation of p27/KIP1 in the chick optic vesicle (Tsukiji et 
al., 2009), suggesting that Vsx2-mediated regulation of p27/KIP1 may also be partially 
Mitf dependent. Mitogens are also key extrinsic regulators of cell cycle progression. 
Mitogen signals are required in early G1 to promote G1 progression through upregulation 
of D-cyclins [reviewed in (Levine and Green, 2004)]. Ccnd1 expression is reduced in orJ 
retinas (Green et al., 2003), but it is not known whether this results from direct 
transcriptional regulation by Vsx2 or indirectly through Vsx2-mediated regulation of 
mitogen signals or their signaling pathways. We previously reported evidence supporting 
a role for Vsx2 in the regulation of mitogen signaling (Sigulinsky et al., 2008). Sonic 
hedgehog (Shh), through activation of the Hedgehog (Hh) signaling pathway, is an 
important retinal mitogen in mouse (Jensen and Wallace, 1997; Levine et al., 1997; 
Moshiri and Reh, 2004; Mu et al., 2004; Wallace and Raff, 1999; Wang et al., 2005; 
Wang et al., 2002). In the orJ retina, Hh signaling activity is reduced during retinal 
development (Sigulinsky et al., 2008). During embryonic stages, delayed activation of Hh 
signaling correlated with delayed RGC production, the cellular source of Shh in the 
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retina. During perinatal stages, reduced Hh signaling activity persisted and correlated 
with reduced Shh expression, despite evidence suggesting overall progenitor:neuron 
ratios and RGC proportions were unaffected at this age (Green et al., 2003; Sigulinsky et 
al., 2008). Furthermore, we demonstrated that the reduced activity of the Hh pathway 
likely contributes to defective RPC proliferation in the orJ retina at these ages 
(Sigulinsky et al., 2008). 
  Vsx2 also regulates multiple aspects of retinal neurogenesis. Early, Vsx2 is 
required for proper temporal regulation of the initiation of neurogenesis. While the 
general principles of neurogenesis appear maintained in the orJ retina, including the 
central to peripheral wave of neuron production and temporal birth order, initiation is 
delayed by approximately two days (Bone-Larson et al., 2000; Robb et al., 1978; 
Rutherford et al., 2004; Sigulinsky et al., 2008). However, it is not clear whether this 
delay reflects an inability to respond to the neurogenic signal(s) or absence of the 
necessary signal(s). Later, Vsx2 also participates in the regulation of cell fate. Bipolar 
cells are not present in orJ retinas (Bone-Larson et al., 2000; Burmeister et al., 1996) and 
their generation is not rescued in orJ, p27/KIP1 double mutants (Green et al., 2003), 
suggesting their absence is due to a specific requirement for Vsx2 in their specification or 
maturation, rather than a secondary effect of insufficient proliferative expansion. This is 
further supported by a number of studies showing that Vsx2 promotes the bipolar fate at 
the expense of rod photoreceptors (Belecky-Adams et al., 1997; Dorval et al., 2006; 
Hatakeyama et al., 2001; Livne-Bar et al., 2006; Rowan and Cepko, 2004; Rutherford et 
al., 2004; Toy et al., 2002).  
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Our understanding of the molecular mechanisms by which Vsx2 regulates these 
developmental processes is lacking and few direct targets have been identified. To further 
investigate the multiple roles of Vsx2 in retinal development, we generated orJ mutant 
chimeras. Genetic chimeras are particularly useful in examining complex gene function, 
enabling analyses of lineage-specific gene function, competition behavior, and autonomy 
of gene function. Aggregation chimeras for or mutants were previously reported 
(Kindiakov and Koniukhov, 1986; Osipov and Vakhrusheva, 1982, 1984). These studies 
revealed improved eye size and retinal structure in mutant chimeras; however, it is not 
clear whether this resulted from rescued orJ cell behavior or compensation by wild type 
cells. In the present study, we focused our analyses on the embryonic regulation of RPC 
properties by Vsx2, including maintenance of retinal identity, RPC proliferation and 




orJ mice on a 129S/Sv background were purchased from The Jackson Laboratory 
(Bar Harbor, ME, USA). Mice carrying a floxed allele of Lhx2 (Lhx2
f
) were kindly 
provided by Edwin Monuki (University of California, Irvine). The α-Cre transgenic mice 
(Marquardt et al., 2001) were kindly provided by Dr. Valerie Wallace (Ottawa Health 
Research Institute, Canada). Genotyping for the orJ and Lhx2
f
 alleles and α-Cre 
transgene was performed by PCR and subsequent restriction digest [orJ allele, as 
previously described (Burmeister et al., 1996)] using embryonic tail samples or adult ear 
clips. Tg(CAG-EYFP)7AC5Nagy mice were produced and maintained by the Transgenic 
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& Gene Targeting Mouse Core at the University of Utah. Briefly, 7AC5/EYFP ES cells 
(ATCC, Manassus, VA, USA) were injected into C57BL/6J blastocysts. The 
7AC5/EYFP ES cells carry the Tg(CAG-EYFP)7AC5Nagy transgene in which EYFP is 
driven by a CMV immediate early enhancer coupled to the chicken β-actin promoter and 
first intron. Chimeric mice were intercrossed to generate homozygotes and the transgene 
was maintained on (129X1/Svj x 129S1/Sv) x C57BL/6 mixed background. Mice were 
bred overnight and noon the day a vaginal plug was observed was considered embryonic 
day 0.5 (E0.5). Animal use and care was conducted in accordance with IACUC 
guidelines. 
 
Generation of aggregation chimeras  
Chimeric mice were generated by the Transgenic & Gene Targeting Mouse Core 
at the University of Utah using morula aggregation techniques (Figure 4.1). Briefly, 
eight-cell embryos were obtained from three independent homozygous crosses of 





, or homozygous Tg(CAG-
EYFP)7AC5Nagy/Tg(CAG-EYFP)7AC5Nagy, referred to hereafter as orJ, wild type, or 
EYFP mice, respectively. Mutant chimeras were generated by aggregating homozygous 
orJ embryos with homozygous EYFP embryos. Control chimeras were generated by 
aggregating homozygous wild type embryos with homozygous EYFP embryos. Most 
chimeras in this study were generated by aggregating two embryos together. However, in 
order to increase the contribution of orJ cells in the resulting mutant chimeras, some 
chimeras were generated by aggregation of three embryos (i.e., two orJ embryos with one 
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EYFP embryo). Successfully aggregated chimeric blastocysts were surgically transferred 
into the uterine horn of E2.5 or oviducts of E0.5 pseudopregnant C57BL/6J x FVB F1 
females and allowed to develop to the desired stage. Embryo development was timed 
according to the pseudopregnancy of the recipient female.  
 
EdU pulse labeling and detection 
Pulse labeling of control and chimeric retinas was performed in retinal explant 
cultures. Retinas were dissected from surrounding tissues in Hank’s buffered saline 
solution (HBSS), leaving the lens and vitreal chamber intact. Retinal explants were 
cultured for 1 hour in in HBSS containing 33.3 µM 5-ethynyl-2’-deoxyuridine (EdU; 
Invitrogen-Molecular Probes, Eugene, OR, USA). Cultures were incubated at 37 °C and 
5% CO2, with nutating. Explants were fixed in 4% paraformaldehyde (PFA) in 
phosphate-buffered saline (PBS, pH 7.5) for 30 minutes at room temperature, 
cryoprotected, and stored at -80 °C until sectioning. Sections (10-12 µm) were cut and 
stored at -20 °C until use. EdU incorporation was specifically detected in cryosections 
using AlexaFluor568 azide and the Click-iT Cell Reaction (Invitrogen-Molecular Probes, 
Eugene, OR, USA).  
 
Immunohistochemistry 
Whole eyes or isolated retinas of control and chimeric mice were dissected in 
HBSS. Whole eyes for use in MITF expression analyses were fixed in 4% PFA in PBS 
for 2 hours at 4 °C. Isolated retinas with lenses intact, with or without EdU labeling, were 
fixed in 4% PFA in PBS for 30 minutes at room temperature. Following fixation, tissue 
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was cryoprotected and stored at -80 °C until sectioning. Sections (10 µm for E12.5 
samples and 12 µm for E15.5 samples) were cut and stored at -20 °C until staining.  
Frozen sections were rehydrated in PBS and pretreated with blocking buffer (2% 
normal goat or donkey serum, 0.15% TritonX-100, and 0.01% sodium azide in PBS) for 
30 minutes. Primary antibodies are listed in Table 4.1. Primary antibodies were diluted in 
the appropriate blocking buffer and incubated overnight at 4 °C. Antigen unmasking with 
1% sodium dodecyl sulfate (SDS) in PBS was performed prior to blocking pretreatment 
for the MITF antibody. Primary antibodies were detected using species-specific 
secondary antibodies conjugated to AlexaFluor568 or 647 (Invitrogen-Molecular Probes, 
Eugene, OR, USA). Endogenous EYFP signal was visualized without antibody staining. 
Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI; Fluka, Switzerland) or 
TOPRO\u00AE-3 iodide (TOPRO-3; Invitrogen-Molecular Probes, Eugene, OR, USA). 
Sections were mounted with VECTASHIELD Mounting Medium (Vector Laboratories, 
Inc., Burlingame, CA, USA) and covered with glass coverslips for fluorescence 
microscopy.  
 
Image capture and processing 
 
All immunofluorescence images were captured on an Olympus Fluoview 1000 
confocal microscope (Olympus America Inc., Center Valley, PA, USA). Images were 
prepared for quantification and publication using Adobe Photoshop CS5 Extended 
(Adobe Systems Inc., San Jose, CA, USA). Olympus Fluoview confocal files were first 
converted using the Bio-Formats Importer Plugin (LOCI, University of Wisconsin-
Madison, Madison, WI, USA) and ImageJ (NIH).  
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Marker quantification and analysis 
Proliferation was assayed by regional quantification of EdU incorporation in 
E12.5 retinas. Single-slice confocal images of retinal sections were divided into six bins 
(central, intermediate, and peripheral in both retinal hemispheres) using ImageJ and 
Adobe Photoshop CS5 extended. In retinal sections containing an optic nerve head, 
retinal hemispheres were divided according to the position of the optic nerve head. Each 
retinal hemisphere was then further subdivided into three bins (central, intermediate, and 
peripheral). This was accomplished by first drawing a line from the center of the optic 
nerve head to the peripheral tip of the retina, which split the retina’s width at the apical-
basal midpoint. This line was then divided into three equal segments and a perpendicular 
extended to both apical and basal edges. In retinal sections lacking an obvious optic nerve 
head, the line drawn at the apical-basal midpoint was drawn from one peripheral tip to the 
other and divided into six equal segments. Cell counts were performed in Photoshop CS5 
Extended. EdU-labeled orJ cells (EYFP-negative, EdU-positive) and total orJ cells 
(EYFP-negative, DAPI-positive) were counted in central and peripheral retinal bins of 
orJ and mutant chimeras. At least three sections per retina and four animals per condition 
were analyzed. Counts were summed within regions across sections from the same 
animal. The proliferating orJ population was calculated as a percentage of the total orJ 
population and compared in corresponding bins of orJ and mutant chimeras. Statistical 
significance was determined using Student’s unpaired t-test or Welch’s two-sample t-test, 
as appropriate (based on results of an F-test for equal variance) using Jmp Pro 9.0 (SAS 
Institute, Inc., Cary, NC, USA).  
176 
 
Neurogenic output of wild type cells in mutant chimeras was assayed by 
quantification of POU4F2-positive and OTX2-positive wild type cells in orJ versus wild 
type patches of E15.5 mutant chimeras. Wild type and orJ patches in single-slice 
confocal images were masked by hand in Adobe Photoshop CS5 Extended. Regions of 
high orJ contribution were classified as orJ patches and defined by extending 
perpendiculars on either side at the outermost contiguous orJ cell. Regions of orJ cells 
were split into separate orJ patches if 3 or more wild type cell widths spanned the retina 
to divide adjacent groups of orJ cells. Wild type patches contained few or no orJ cells 
and were defined by extending perpendiculars on either side at least 3 cell widths from 
the nearest orJ patch. Cell counts were performed in Photoshop CS5 Extended. 
Differentiated wild type cells (marker-positive, EYFP-positive) and total wild type cells 
(EYFP-positive) were counted in all masked patches of mutant chimeras. Differentiation 
of the wild type population was calculated as a percentage of the total wild type cells and 
compared across patch type. Statistical significance was determined using Student’s 
unpaired t-test or Welch’s two-sample t-test, as appropriate (based on results of an F-test 
for equal variance) using Jmp Pro 9.0 (SAS Institute, Inc., Cary, NC, USA).  
 
RESULTS 
Production of chimeras 
 For our analyses of Vsx2 gene function, we generated both control and mutant 
chimeras using morula aggregation techniques. To distinguish between the composite cell 
populations in the resulting chimeric embryos, EYFP embryos were used as the wild type 
component in both control and mutant chimeras. Table 4.2 describes our efforts to 
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generate these chimeras. Of the 14 control chimeras generated, 9 were E12.5, 3 were 
E14.5 and 2 were E15.5. Of the 21 mutant chimeras generated, 15 were E12.5, 3 were 
E14.5, and 3 were E15.5.  
In control chimeras, the degree of contribution and pattern of EYFP-expressing 
cells was largely consistent across tissues within individual pups (Figure 4.2). Similar 
results were observed in mutant chimeras (Figure 4.2); however, the pattern of chimerism 
in retinas of control and mutant chimeras differed slightly (Figure 4.2B-D). This 
difference is unique to the retina, suggesting that it is likely a consequence of loss of 
Vsx2 function in the regulation of retinal progenitor cell properties. Importantly, both 
EYFP-expressing and nonexpressing cells were observed in the retinas of mutant 
chimeras (Figure 4.2D), indicating mosaic contribution of orJ cells to our tissue of 
interest. 
 
Vsx2-mediated regulation of retinal identity involves cell  
autonomous repression of MITF 
To evaluate retinal identity in orJ cells of mutant chimeras, we examined 
expression of the RPE determinant gene, Mitf. Mitf is required for driving and 
maintaining RPE identity in the eye (Bumsted and Barnstable, 2000; Nakayama et al., 
1998; Nguyen and Arnheiter, 2000). Its ectopic expression in Vsx2-deficient retinas 
reveals compromised retinal identity (Bharti et al., 2008; Horsford et al., 2005; Rowan et 
al., 2004). At E12.5, MITF expression in wild type eyes was restricted to the developing 
RPE and the presumptive ciliary margin (Figure 4.3A). However, in orJ animals, MITF 
expression was not restricted to these regions; rather expression extended ectopically 
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throughout the retina (Figure 4.3B). In the retinas of E12.5 mutant chimeras, ectopic 
MITF expression was detected in EYFP-negative orJ cells, but not adjacent EYFP-
positive wild type cells (Figure 4.3D, E). This is in contrast to control chimeras where 
both EYFP-negative and EYFP-positive wild type cells lacked MITF expression in the 
retina (Figure 4.3C). Furthermore, even isolated EYFP-negative orJ retinal cells also 
ectopically expressed MITF (Figure 4.3E). The failure of orJ retinal cells to 
downregulate MITF expression in mutant chimeras demonstrates a cell autonomous 
requirement for Vsx2 in the repression of Mitf. Furthermore, these findings illustrate that 
compromised retinal identity persists in orJ cells of mutant chimeras due to continued 
aberrant expression of an RPE-like gene expression program. 
 
Ectopic MITF expression in the orJ retina is dependent upon  
cell autonomous regulation by Lhx2  
The LIM homeobox gene Lhx2 is required cell autonomously to induce or 
maintain expression of regional identity genes in the optic vesicle, including Vsx2 and 
Mitf (Yun et al., 2009). Strong LHX2 expression was observed in the retina of orJ mice 
at E12.5 (Figure 4.4A, B), suggesting that ectopic expression of MITF in the orJ retina 
may be dependent upon Lhx2. To test this possibility, we conditionally inactivated Lhx2 
in the retina of orJ mice using a floxed allele of Lhx2 and the α-Cre transgene, in which 
Cre is driven by the retina-specific Pax6 regulatory element. Successful inactivation of 
Lhx2 by Cre recombinase is indicated by expression of β-galactosidase (β-gal). At E12.5, 
in regions where Lhx2 was conditionally inactivated in the retina (β-gal-positive), MITF 
expression was absent or downregulated (Figure 4.4C-C”). In contrast, adjacent 
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noninactivated regions (β-gal-negative) retained ectopic MITF expression (Figure 4.4C-
C”), indicating that Lhx2 is required cell autonomously for ectopic expression of MITF in 
orJ retinas. 
 
Vsx2-mediated regulation of RPC proliferation involves  
significant cell nonautonomous regulation 
To examine proliferation of orJ cells in mutant chimeras, we quantified 
incorporation of the thymidine analog, EdU, following a short labeling pulse at E12.5, 
and compared regional proliferative activity to age-matched orJ retinas. In orJ retinas, we 
observed a striking reduction in EdU labeling in the periphery compared to wild type 
retinas (Figure 4.5A, B), consistent with previous reports of severely reduced 
proliferative activity in peripheral regions of Vsx2-deficient retinas (Bone-Larson et al., 
2000; Burmeister et al., 1996). In mutant chimeras, EYFP-negative orJ cells in the 
peripheral region showed a sevenfold increase in EdU labeling compared to peripheral 
orJ cells of the germline mutant retina (Figure 4.5C, E) (mutant chimeras, 28 ± 8%, n = 
922 EYFP-negative orJ cells from 6 eyes; orJ, 4 ± 2%, n = 1781 orJ cells from 4 eyes; p 
< 0.001). Unexpectedly, we observed a 1.5-fold reduction in EdU labeling of EYFP-
negative orJ cells in the central region of mutant chimeras compared to central orJ retinas 
(Figure 4.5D, E) (mutant chimeras, 19 ± 6%, n = 830 EYFP-negative orJ cells from 6 
eyes; orJ, 30 ± 3%, n = 2406 orJ cells from 4 eyes; p = 0.009). This may be a slight 
underrepresentation of orJ proliferation in central regions of mutant chimeras because the 
analysis included orJ cells immediately surrounding the optic nerve head, which show 
significantly reduced proliferative activity. Optic nerves fail to form in orJ retinas, 
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resulting in small or absent optic discs (Bone-Larson et al., 2000; Burmeister et al., 1996; 
Robb et al., 1978; Truslove, 1962). Thus, orJ retinas do not show a similar reduction in 
proliferative activity in central regions. However, inclusion of orJ cells from these areas 
is unlikely to significantly alter our findings because they represented only a small 
fraction of the orJ population analyzed. The observed changes in the proliferative activity 
of orJ cells in the context of the mutant chimera establish cell nonautonomous 
mechanisms as critical contributors to Vsx2-mediated regulation of RPC proliferation.  
 
Vsx2 cell autonomously promotes initiation of neurogenesis 
Retinal neurogenesis in the mouse initiates at approximately E11 in the central 
retina, dorsal to the optic stalk, and continues in a peripherally-spreading wave (Hufnagel 
et al., 2010). By E12.5, neurogenesis is active throughout the central retina of wild type 
mice but has yet to initiate in orJ retinas (Robb et al., 1978; Sigulinsky et al., 2008). This 
provides a critical time point at which to evaluate the ability of a wild type environment 
to restore neurogenesis in orJ cells at a time when orJ cells aberrantly fail to differentiate.  
We first examined the location of orJ cells in chimeric retinas, as apical-basal 
location within the retina reflects a cell’s differentiation status during the neurogenic 
period. Behind the neurogenic wave front, nascent postmitotic cells migrate basally to 
establish a distinct differentiated cell layer, leaving progenitors in an overlying apical 
neuroblast layer (Figure 4.6A). In the preneurogenic peripheral retina of E12.5 mutant 
chimeras, EYFP-negative orJ cells occupied various positions along the apical-basal axis 
(Figure 4.6B). However, within the neurogenic (central) region of mutant chimeras, 
EYFP-positive wild type cells dominated the basal differentiated cell layer, while EYFP-
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negative orJ cells appeared to be restricted apically, within the neuroblast layer (Figure 
4.6B, a). In contrast, EYFP-negative wild type cells in control chimeras readily populated 
the differentiated cell layer, in addition to the neuroblast layer (Figure 4.6C, b). These 
findings suggest that in mutant chimeras, orJ retinal cells have not participated in 
neurogenesis by E12.5 and remain undifferentiated.  
To determine if orJ cells differentiate in mutant chimeras, but fail to localize to 
the differentiated cell layer, we evaluated the differentiation status of orJ cells in 
chimeric retinas. Retinal neurogenesis produces all seven retinal cell types in a specific 
sequence, beginning with retinal ganglion cells (RGCs). By E12.5, RGCs were abundant 
in the central regions of wild type retinas, as indicated by expression of the RGC marker, 
POU4F2 (Figure 4.7A) (Erkman et al., 1996; Gan et al., 1999; Gan et al., 1996; Qiu et al., 
2008; Xiang et al., 1993). However, POU4F2-positive RGCs were absent in orJ retinas at 
this age, clearly revealing the delay in the initiation of neurogenesis (Figure 4.7B). In 
mutant chimeras, many POU4F2-positive RGCs were present in the central retina, but we 
rarely observed EYFP-negative orJ cells contributing to this population (Figure 4.7D, b). 
This is in stark contrast to control chimeras, where the POU4F2-positive RGC population 
was primarily composed of EYFP-negative wild type cells (Figure 4.7C, a).  
To rule out the possibility that orJ cells differentiate in the mutant chimera, but 
skip the RGC fate, we also evaluated the expression of precursor markers for the other 
early-born retinal cell types:  cone photoreceptors (PR), horizontal cells (HC), and 
amacrine cells (AC). In addition to the RGC marker POU4F2, we examined ISL1 (RGC, 
AC) (Elshatory et al., 2007a; Elshatory et al., 2007b), PTF1A (HC, AC), BHLHB5 (AC), 
and OTX2 (Cone PR, migrating RGC and AC) [see references in (Das et al., 2009)]. To 
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limit the possibility of missing differentiated orJ cells due to low mutant cell contribution 
in chimeras, staining for POU4F2, ISL1, PTF1A, and BHLHB5 was performed in 
combination. The OTX2 antibody also recognizes OTX1, which is upregulated in 
progenitors in the orJ retina, but still distinguishable from postmitotic OTX2 expression. 
Thus, OTX2 was stained separately to prevent misinterpretation of OTX1 upregulation in 
orJ cells as evidence of their differentiation in chimeras. Although wild type retinas 
exhibited differentiation of these early-born cell types at E12.5 (Figure 4.8A, E), orJ 
retinas did not (Figure 4.8B, F). Critically, EYFP-negative orJ cells in retinas of E12.5 
mutant chimeras also lacked expression of these retinal cell markers (Figure 4.8D, b, H, 
d). Neuron Class III β-tubulin (TUBB3) is a specific marker of postmitotic neurons 
(Brittis et al., 1995; Lee et al., 1990) that reliably reflects the progression of retinal 
neurogenesis (Das et al., 2009; Hufnagel et al., 2010; Sigulinsky et al., 2008). Consistent 
with the absence of cell type specific marker expression, we also typically failed to detect 
TUBB3 expression in EYFP-negative orJ cells in mutant chimeras, even when located 
within the differentiated cell layer (Figure 4.7H, d). Together, these findings demonstrate 
that orJ retinal cells persist in mutant chimeras as progenitors and fail to participate in 
retinal neurogenesis.  
Because orJ cells eventually differentiate in the germline mutant retina (Bone-
Larson et al., 2000; Burmeister et al., 1996; Green et al., 2003; Rutherford et al., 2004; 
Sigulinsky et al., 2008), we predicted that orJ cells would also differentiate in chimeras, 
but at later developmental stages. In the orJ retina, all of the early-born retinal cell types 
are detected by E15.5 (Figure 4.9A-E).  As predicted, in the retinas of E15.5 mutant 
chimeras, many EYFP-negative orJ cells expressed the neuron-specific marker TUBB3 
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and contributed to the expanding differentiated cell layer (Figure 4.10A). Furthermore, 
similar to wild type cells in control chimeras (Figure 4.11A-E), orJ cells in mutant 
chimeras contributed to all of the early-born retinal cell types at E15.5, as indicated by 
expression of POU4F2 (RGC), OTX2 (Cone PR, migrating RGC and AC), PTF1A (HC, 
AC), and BHLHB5 (AC) in EYFP-negative orJ cells of mutant chimeras (Figure 4.10A-
E).  
Despite active neurogenesis in orJ retinas at E15.5, the extent of differentiation 
was more centrally restricted than in wild type retinas (Figure 4.9, compare A-E to F-J), 
consistent with delayed initiation of the central-to-peripheral wave of neurogenesis 
(Sigulinsky et al., 2008). Thus, peripheral orJ cells remain undifferentiated progenitors in 
the germline mutant. Similarly, in retinas of E15.5 mutant chimeras, peripheral patches of 
EYFP-negative orJ cells coincided with gaps in the neuronal marker TUBB3, revealing 
their delayed differentiation relative to both adjacent EYFP-positive wild type cells 
(Figure 4.12A,B) and central EYFP-negative orJ cells (Figure 4.10A).  Cell type-specific 
markers also showed a similar trend, but it was less obvious due to the sparse nature of 
their patterns at the leading edge and random positioning of orJ patches. To confirm the 
lag in differentiation of peripheral orJ cells relative to adjacent wild type cells in mutant 
chimeras, we examined an earlier age that exhibited a more pronounced difference in the 
peripheral extent of neurogenesis between wild type and orJ cells. In an E14.5 mutant 
chimera, a number of EYFP-negative orJ cells located within the central retina expressed 
POU4F2, indicating differentiation as RGCs (arrows, Figure 4.12a). In contrast, a patch 
of EYFP-negative orJ cells in a mid-retina region lacked expression of both POU4F2 and 
TUBB3, despite expression of both markers in more peripheral EYFP-positive wild type 
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cells (Figure 4.12b), revealing the failure of these orJ cells to participate in the wild type 
progression of retinal neurogenesis. Interestingly, in the central retina, we only detected a 
few EYFP-negative orJ cells expressing POU4F2 in the differentiated cell layer (red 
arrows, Figure 4.12a); most were still localized to the neuroblast layer (white arrows, 
Figure 4.8), consistent with a more recent birthdate. Together, these analyses at E12.5 
and E15.5 reveal a cell autonomous delay in neurogenesis of orJ cells in retinas of mutant 
chimeras that is consistent with the delayed progression of neurogenesis in the orJ retina.  
 
Cell nonautonomous regulation of neurogenic output  
in wild type cells  
Our examination of E15.5 mutant chimeras also revealed an unexpected change in 
the neurogenic output of wild type cells when exposed to an orJ environment. In areas of 
high EYFP-negative orJ contribution, EYFP-positive wild type cells were predominantly 
found in the differentiated cell layer or scattered along the apical edge of the neuroblast 
layer where Otx2-expressing cone precursors are typically localized; very few EYFP-
positive wild type cells were observed in the intervening progenitor zone of mutant 
chimeras (Figure 4.13A, B). Only in areas of low EYFP-negative orJ contribution were 
patches of EYFP-positive wild type cells found to span the entire apical-basal width of 
the retina and populate the progenitor zone (Figure 4.13A, B). Furthermore, in EYFP-
negative orJ environments, most EYFP-positive wild type cells expressed the neuronal 
marker TUBB3 (Figure 4.10A), suggesting that wild type cells are unable to maintain a 
progenitor population in mutant surroundings.  
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A possible explanation for this observation is that the orJ environment promoted 
the death of enclosed wild type progenitors. This is unlikely, because a very low 
frequency of cell death was detected in the retinas of mutant chimeras at E12.5, E14.5, 
and E15.5, using the apoptosis marker activated caspase-3 (CASP3, Figure 4.14D-G, J, 
K). An elevated frequency of apoptosis was observed in the peripheral retina of an E12.5 
mutant chimera with very high EYFP-negative orJ contribution (Figure 4.14F), but a 
similar level of apoptosis was also observed in E12.5 orJ retinas (Figure 4.14 B) and was 
not specific to EYFP-positive wild type cells in mutant chimeras (Figure 4.14F).  
An alternative possibility is that highly orJ environments in mutant chimeras 
promote precocious differentiation of enclosed wild type cells, resulting in the striking 
loss of wild type progenitors by E15.5. To address this, we calculated the percentages of 
EYFP-positive wild type cells that expressed POU4F2 or OTX2 in wild type and orJ 
patches of mutant chimeras (see Methods). In wild type patches with little orJ influence, 
33 ± 4% (n = 10) of EYFP-positive wild type cells were POU4F2-positive RGCs (Figure 
4.13A, C). In contrast, we discovered a significant overrepresentation of POU4F2-
positive wild type RGCs in orJ environments (50% ± 10%, n = 19; p < 0.000001) (Figure 
4.13A, C). Somewhat surprisingly, there was no difference in the mean production of 
OTX2-positive cone PR precursors by EYFP-positive wild type cells between the two 
environments (16% ± 9%, n = 18 in orJ environments, 16% ± 4%, n = 12 in wild type 
environments; p = 0.83) (Figure 4.13B, D). However, we observed greater variation (both 
over- and under-representation) in individual orJ environments. We did not quantify 
Ptf1a-positive and BHLHB-positive wild type cell populations due to the smaller size of 
these populations and reduced probability of finding EYFP-positive wild type cells to 
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evaluate in the progenitor zone where these markers are localized. This striking 
overrepresentation of EYFP-positive wild type RGCs suggests that the orJ environment 
promotes altered neurogenic output of the enclosed EYFP-positive wild type cells in 
mutant chimeras.  
It is interesting to note that the peripheral extent of orJ and wild type 
differentiation in chimeric retinas does not appear to match that of control orJ and wild 
type retinas. Specifically, the mutant neurogenic region in chimeric retinas appeared 
slightly expanded compared to orJ germline retinas, while wild type neurogenic region in 
mutant chimeras with a high orJ contribution appeared more centrally restricted than in 
wild type controls. Unfortunately, confirming this has been difficult, largely due to the 
random positioning of mutant patches within chimeric retinas and low yield of chimeric 
retinas with high mutant cell contribution. 
 
Discussion 
Vsx2 has multiple key roles in retinal development, but the molecular 
mechanisms by which Vsx2 regulates these diverse and often competing processes is still 
poorly understood. Each of these developmental processes is tightly regulated through the 
coordinated activity of multiple signaling pathways and intrinsic factors, resulting in a 
large number of candidate mediators. Chimera analysis provides a powerful, unbiased 
approach to determine the extent of extrinsic influence Vsx2 exerts in its regulation of 
RPC properties. In the present study, we determined the autonomy of Vsx2 function 
during the embryonic stages of retinal development to help place Vsx2 in the context of 
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known regulatory pathways driving maintenance of retinal identity, RPC proliferation, 
and initiation of neurogenesis. 
 
Retinal identity 
A primary role for Vsx2 in the maintenance of retinal identity appears to be 
preventing aberrant expression of an RPE-like gene expression program through 
repression of the RPE determinant Mitf (Horsford et al., 2005; Rowan et al., 2004). 
Genetic removal of Mitf in orJ retinas improves retinal development, while genetically 
increasing Mitf dosage in orJ retinas further exacerbates the pigmentation program, 
suggesting that aberrant Mitf expression is a major contributor to the orJ phenotype 
(Horsford et al., 2005; Konyukhov and Sazhina, 1966). Mitf expression in the eye is also 
regulated by extrinsic signals, including FGF, Wnt-β-catenin and the TGFβ family 
member, activin (Fu et al., 2006; Fuhrmann et al., 2000; Nguyen and Arnheiter, 2000). It 
was therefore possible that Vsx2 influenced extrinsic signals to repress Mitf. In the 
present study, we show that orJ cells fail to downregulate MITF expression in mutant 
chimeras, demonstrating their inability to fully respond to extrinsic signals driving retinal 
specification and maintenance and revealing a critical cell autonomous role for Vsx2 in 
mediating this response. This cell autonomous repression of MITF expression by Vsx2 is 
consistent with reports that MITF is a direct transcriptional target of Vsx2 (Bharti et al., 
2008). 
FGF signaling is a critical regulator of Vsx2 and Mitf expression within the 
developing eye. Surface ectoderm-derived FGF signals are important for promoting Vsx2 
expression in the presumptive retina (Nguyen and Arnheiter, 2000). FGFs are also 
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sufficient to repress Mitf expression and promote an RPE to retina switch in identity 
(Horsford et al., 2005; Nguyen and Arnheiter, 2000). Failure of FGFs to repress Mitf and 
induce an ectopic retina in orJ retinal explants reveals that Vsx2 mediates much of these 
functions (Horsford et al., 2005). This is further supported by FGF loss of function 
studies in which removal of the FGF source or inhibition of FGF signaling results in 
concomitant loss of Vsx2 expression and ectopic Mitf expression (Cai et al., 2010; 
Nguyen and Arnheiter, 2000). In the orJ retina, maintained expression of Vsx2 transcript 
(Rutherford et al., 2004; Sigulinsky et al., 2008) indicates FGF signaling is still active. 
Given the cell autonomous requirement for Vsx2 in the repression of MITF, as 
demonstrated in the present study, absence of Vsx2 protein in orJ cells explains the 
failure to downregulate MITF expression despite active FGF signaling. However, it is not 
clear why MITF expression persists. What underlies the competence of the retina to 
permit such expression? In the present study, we found that Lhx2 is required cell 
autonomously for the ectopic expression of MITF in orJ retinas, as it is in the developing 
RPE. Because Lhx2 is also required cell autonomously for Vsx2 expression in the retina 
(Yun et al., 2009), we propose a model in which Lhx2 is necessary for expression of both 
Vsx2 and Mitf in the retina. FGF signaling from the surface ectoderm promotes Vsx2 in 
the presumptive retina, which in turn, represses Mitf. A reciprocal inhibitory 
regulation/repression does not appear to be present, at least in the context of the retina, as 
Vsx2 transcript expression is maintained in the orJ retina, despite ectopic MITF 
expression. Thus, Lhx2 is an intrinsic factor necessary to allow ectopic MITF expression 
in the absence of Vsx2. 
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Maintained ectopic expression of MITF in orJ retinas is not sufficient to cause a 
switch in fate from retina to RPE. While MITF expression may promote a tendency 
toward pigmentation and reduced proliferative expansion characteristic of the RPE, orJ 
cells still express retinal markers and generate retinal neurons (Bone-Larson et al., 2000; 
Burmeister et al., 1996; Green et al., 2003; Horsford et al., 2005; Rowan et al., 2004; 
Rutherford et al., 2004). Rather, it appears that orJ cells exhibit a mixed identity, 
containing elements of retina, RPE and perhaps ciliary margin identities. Despite this 
mixed identity, orJ cells readily contributed to the developing retina of mutant chimeras. 
While this is consistent with the execution of a retinal program, albeit disrupted, in the 
germline mutant, it is somewhat surprising given the competition afforded by wild type 
cells within chimeras. Competition with wild type cells in chimeras can reveal disrupted 
developmental processes not detected in germline mutants. In the case of PDGFR 
mutants, muscle cell lineages lack overt developmental defects; however, when PDGFR 
mutant cells were placed in competition with wild type cells in mutant chimeras, 
researchers observed a dramatic reduction in the contribution of PDGFR mutant cells to 
muscle cell lineages compared to wild type PDGFR cells in control chimeras (Crosby et 
al., 1998). Although it is possible that orJ cells are impaired in their ability to contribute 
to the developing retina due to this mixed identity, it is difficult to ascertain at the stages 
examined in this study due to changes in RPC proliferation, which also influence orJ cell 
number in mutant chimeras. However, the presence of substantial numbers of EYFP-
negative orJ cells in the retinas of E15.5 mutant chimeras suggests that they retain 
sufficient retinal identity to contribute to the retina and even differentiate into retinal 
neurons. This is in stark contrast to mutants with fundamental defects in ocular tissue 
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identity. In Rx chimeras, Rx-deficient cells fail to contribute to the retina due to early 
exclusion from the presumptive retinal region of the optic vesicle (Medina-Martinez et 
al., 2009). In Pax6 chimeras, very few Pax6-deficient cells are detected in the retina; most 
are excluded from the presumptive retina in ectopic vesicles (Collinson et al., 2000; 
Collinson et al., 2003; Quinn et al., 1996). Those that do contribute to the retina die 
perinatally, leaving only Pax6-deficient microglia, pericytes, astrocytes and vascular 
endothelial cells, which derive from extra-retinal sources and migrate into the developing 
retina (Li et al., 2007). 
Although orJ cells readily contributed to the developing retina in mutant 
chimeras, they tended to cluster with other orJ cells. This became more apparent at 
E15.5, where most orJ cells were present in fairly orJ-dominant patches. In contrast, wild 
type cells of both EYFP-negative and EYFP-positive lineages were highly intermingled 
in control chimeras. One possibility is that the initial failure of orJ cells to participate in 
neurogenesis and subsequent proliferative expansion of these orJ progenitors may have 
been sufficient to promote the formation of such patches in mutant chimeras. Consistent 
with this, wild type cells were often found intermixed, especially within the differentiated 
cell layer. However, we cannot rule out the possibility that some degree of cell sorting 
contributes. Differential adhesion can be a powerful sorting mechanism, highlighted by 
numerous studies in drosophila (see review by (Irvine and Rauskolb, 2001). Pax6 
regulates several cell adhesion molecules (Simpson and Price, 2002) and differential cell 
adhesion has been proposed to underlie the strict segregation of mutant and wild type 
cells in Pax6 chimeras and physical exclusion of these mutant cells from the presumptive 
retina into ectopic vesicles (Collinson et al., 2000; Collinson et al., 2003; Li et al., 2007; 
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Quinn et al., 1996). The segregation of orJ and wild type cells in mutant chimeras was 
not as strict as seen in Pax6 chimeras and lacked evidence of physical exclusion. 
Culturing chick retinal tissue with antibodies against neural specific cell adhesion 
molecule, NCAM, can significantly disrupt retinal lamination (Buskirk et al., 1980). 
Furthermore, mutations in cell polarity genes (Fu et al., 2006; Georgiadis et al., 2010; 
Sottocornola et al., 2010; Wei et al., 2004) or genes regulating the establishment of cell 
polarity, such as Notch pathway components (Jadhav et al., 2006; Riesenberg et al., 2009; 
Tomita et al., 1996), exhibit severely disrupted lamination and retinal rosettes. Retinal 
lamination is clearly disrupted in the orJ retina, but rescued by significant restoration of 
cell number (Green et al., 2003). Furthermore, in mutant chimeras, we did not detect 
disruptions in lamination or the presence of retinal rosettes, suggesting that cellular 
adhesion and polarity was largely intact. The segregation of orJ cells in mutant chimeras 
could still be driven by homophilic affinity preferences. Such affinity differences are 
likely intimately related to the compromised identity in orJ cells. Numerous cell adhesion 
molecules are expressed in the eye and many exhibit differential expression between 
ocular tissues (Daniele et al., 2007; Faulkner-Jones et al., 1999; Honjo et al., 2000; Neill 
and Barnstable, 1990; Strunnikova et al., 2010; Wohrn et al., 1998; Xu et al., 2002). 
Tissue-specific genes that establish or maintain tissue identity, such as Vsx2 and Mitf, are 
ideal candidates for establishing regionalization of cell adhesion molecules. Mitf 
regulates the expression of several cell adhesion molecules in mast cells (Ito et al., 2003; 
Kim et al., 1998; Shahlaee et al., 2007), suggesting that ectopic Mitf expression, and 
perhaps other elements of the mixed identity exhibited by orJ cells, may promote sorting 




In the present study, significant changes in the proliferative activity of orJ cells in 
mutant chimeras reveals a strong reliance of Vsx2-mediated regulation of RPC 
proliferation on cell nonautonomous mechanisms. In the peripheral retina, orJ cells 
exhibited a sevenfold increase in EdU incorporation in retinas of mutant chimeras 
compared to germline mutants, revealing at least a partial rescue of RPC proliferation by 
extrinsic regulation in this region. This finding indicates that either expression of a retinal 
mitogen normally present in the wild type eye is restored in the eyes of mutant chimeras, 
or production of an inhibitory proliferation signal aberrantly present in orJ eyes is 
prevented. In contrast, orJ cells in the central retina exhibited a 1.5-fold reduction in EdU 
incorporation in mutant chimeras compared to germline mutants. This finding suggests 
the presence of an inhibitory signal in the mutant chimeras that is not typically present in 
the orJ eye or the loss of a mitogen signal ectopically present in the orJ eye, neither of 
which have been suggested by previous studies in orJ retinas. 
While a cell nonautonomous contribution to central RPC proliferation was 
predicted, the direction of the proliferation change was surprising. We previously 
reported evidence for reduced Hh signaling activity in the orJ retina, which correlated 
with delayed RGC differentiation, the retinal source of SHH (Sigulinsky et al., 2008). 
Numerous studies in the mouse reveal Shh is an important retinal mitogen (Jensen and 
Wallace, 1997; Levine et al., 1997; Moshiri and Reh, 2004; Mu et al., 2004; Wallace and 
Raff, 1999; Wang et al., 2005; Wang et al., 2002). Furthermore, we demonstrated that the 
absence of Hh pathway activation during this period likely contributed to the proliferative 
defect of the orJ retina (Sigulinsky et al., 2008). Thus, we predicted that restoration of 
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endogenous SHH through RGC production by wild type cells in mutant chimeras would 
produce a cell nonautonomous increase in proliferation of orJ RPCs. However, we 
observed reduced, rather than increased, orJ proliferation in mutant chimeras, suggesting 
that either the endogenous SHH signal is not sufficient to increase RPC proliferation in 
orJ cells, or that this ability is masked.  
Together, these cell nonautonomous effects on RPC proliferation suggest that 
Vsx2 is critical for establishing retinal proliferation signals in the eye. The identity and 
source of these signals could not be determined from the chimera analyses. However, 
candidate sources include retinal neurons or progenitors within the retina, or adjacent 
tissues whose development may have been deregulated in the orJ retina as a result of 
disrupted tissue-tissue interactions, which have been shown to be critical for proper 
development of ocular tissues (Fuhrmann et al., 2000; Nguyen and Arnheiter, 2000). 
Interestingly, our observation that changes in proliferation in the central and peripheral 
regions occur in opposite directions, argues that regional differences in extrinsic 
regulation must exist. Whether these regional differences reflect variation in availability 
of the extrinsic signals or intrinsic variation concerning the response to such signals will 
be interesting to address. 
 
Neurogenesis 
The cell autonomous delay in neurogenesis exhibited by orJ cells in mutant 
chimeras was consistent with the delayed neurogenic program observed in the germline 
mutant retina. The failure of orJ cells to differentiate, despite active neurogenesis in 
neighboring wild type cells, demonstrates the inherent, although temporary, inability of 
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orJ cells to respond to neurogenic signal(s). Thus, the observed delay in the onset of 
neurogenesis in orJ retinas results from impaired neurogenic competence, as opposed to 
altered environmental signals. The intrinsic mechanism underlying Vsx2-mediated 
competence is not known, but may involve MITF repression.  
Intriguingly, orJ cells in mutant chimeras maintained the central to peripheral 
wave of neurogenesis, despite its delayed onset. Peripheral orJ cells failed to differentiate 
despite active neurogenesis in adjacent wild type cells and more centrally located orJ 
cells in mutant chimeras. Thus, two independent waves of neurogenesis were seen in the 
mutant chimeras:  first, the normal central to peripheral wave of neurogenesis in wild 
type cells, followed by a second central to peripheral wave of neurogenesis in orJ cells. 
According to the sequential induction model, the central to peripheral wave of 
neurogenesis results from signaling by nascent retinal neurons that induces neighboring 
RPCs to differentiate. Consistent with this, both Hh and FGF signals can induce 
premature retinal neurogenesis and influence progression of the neurogenic wave 
(Martinez-Morales et al., 2005; McCabe et al., 1999; Neumann and Nuesslein-Volhard, 
2000). Growing evidence has begun to challenge this model. Peripheral RPCs 
differentiate despite early physical separation from the central retina in chick (McCabe et 
al., 1999) and RGC differentiation could occur even when naïve RPCs were transplanted 
into nonretinal regions of the zebrafish embryo (Kay et al., 2005). In the present study, 
we found that orJ cells at different central to peripheral retinal positions within mutant 
chimeras do not gain competence all at once, as would be expected for the sequential 
induction model involving a signal that had already progressed throughout the retina. 
Furthermore, the ability of more peripheral wild type cells to differentiate beyond an 
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undifferentiated patch of mutant cells suggests that RPCs do not require direct contact 
with nascent neurons to initiate neurogenesis. This has also been shown in mouse retinas 
with mosaic conditional inactivation of Shp2, an important FGF signaling pathway 
component (Cai et al., 2010), although the range of this neurogenic signal could be far 
enough to allow transference of this signal across mutant patches without interruption. 
An alternative model argues for cell autonomous control of neurogenesis, suggesting that 
RPCs differentiate based on a preprogrammed, intrinsic timer. The underlying source of 
this cell autonomous “clock” has remained elusive. The proliferative defect in the orJ 
retina could support a model where this clock was tied to cell divisions; however, we 
found significant improvement in the proliferation of peripheral orJ cells in mutant 
chimeras, yet these cells still remained delayed with respect to neurogenesis. The 
presence of a second central to peripheral wave of neurogenesis in orJ cells of chimeric 
retinas suggests that there is a strong cell autonomous component driving this gradient of 
neurogenesis across the retina. The source of this cell autonomous control may largely be 
based on positional identity. This is consistent with studies in which transplanted 
zebrafish RPCs expressed ath5 (RGC determinant) according to their original retinal 
position, independent of the location into which they are transplanted (Kay et al., 2005). 
Our investigation of neurogenesis in the present study revealed an unexpected cell 
nonautonomous effect on neurogenic output of wild type cells in mutant chimeras. In 
regions with high orJ contribution, wild type cells exhibited an impaired ability to 
maintain a progenitor population and precocious differentiation of RGCs. We failed to 
detect significant levels of apoptosis in mutant chimeras at several ages, suggesting that 
the absence of wild type progenitors is not due to their death. Furthermore, if cell death 
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contributed to the loss of wild type cells in mutant chimeras, we would not predict such a 
significant population of differentiated wild type cells to remain. Unfortunately, we are 
unable to watch neurogenesis occur in mutant chimeras; therefore, we do not know for 
certain the starting location of differentiated wild type cells observed in orJ patches. 
Thus, we cannot rule out the formal possibility that differentiated ganglion cells 
originating in adjacent wild type patches slide in under orJ patches to fill in the ganglion 
cell layer via tangential migration. Reese and colleagues (Reese et al., 1999) elegantly 
demonstrated that virtually every ganglion cell participates in tangential migration. 
Migration distances were variable, but extended up to 144 µm. While tangential 
migration of RGCs was observed as early as E15.5 (Reese et al., 1999), it is not clear to 
what extent it has occurred by this age. However, previous chimera studies indicate that 
clone size at this age (Reese et al., 1999) is smaller than the observed orJ patches in our 
mutant chimeras (also supported by control chimeras in the present study), making it 
possible that the differentiated wild type cells derived from wild type progenitors located 
within the orJ patch.  Additionally, many OTX2-positive wild type cells were detected 
within orJ patches, and OTX2-positive cones do not undergo tangential migration until 
their maturation in postnatal ages (Reese et al., 1999). Although it is possible that a lack 
of cone differentiation in orJ patches exhibiting delayed neurogenesis could trigger 
premature tangential migration of adjacent wild type cone precursors, this has not been 
shown. Therefore, it is likely that OTX2-positive wild type cells in orJ patches derived 
from wild type progenitors within that patch. Thus, while tangential migration likely 
contributes, it is unlikely to fully account for our observations. 
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The simplest explanation for our findings is precocious differentiation of wild 
type cells in regions of high mutant cell contribution. Somewhat surprisingly, there was 
no change in the mean production of OTX2-positive cone and amacrine precursors by 
wild type cells in orJ environments. However, RGCs are the earliest born cell type in the 
retina, with cone, horizontal, and amacrine cells born slightly later, but still overlapping 
RGC production. Thus, depletion of wild type progenitors through precocious 
differentiation into the earliest born cell fate (RGCs) may have precluded an 
overrepresentation of these and later born cell types. This is consistent with the 
observation that few PTF1A (AC, HC) and BHLHB5 (AC)-positive wild types cells were 
detected in orJ environments of mutant chimeras. 
What underlies this cell nonautonomous effect on wild type cells? One possibility 
is that precocious differentiation of wild type cells in orJ environments is a secondary 
effect of the cell autonomous delay in neurogenesis of orJ cells. Absence of 
differentiating orJ neurons early in mutant chimeras could result in non-limiting 
neurogenic signal(s) driving continued differentiation of wild type cells because orJ cells 
were incompetent. Alternatively, reduced neuron production early may result in reduced 
negative feedback and precocious differentiation of competent cells. Differentiated cells 
have been shown to produce signals that inhibit neurogenesis in adjacent RPCs, such as 
Shh (Neumann and Nuesslein-Volhard, 2000) and VEGF (Hashimoto et al., 2006). It is 
not clear, however, whether these signals cause exiting cells to undergo a cell fate switch 
or simply promote the progenitor state. An intriguing possibility is that in addition to 
regulating neurogenic competence, Vsx2 may also regulate availability of RPC-derived 
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neurogenic or progenitor signals. Vsx2 also may be required indirectly by ensuring 
proper development of the source tissue. 
The period of retinal neurogenesis significantly overlaps that of proliferative 
expansion in the retina. Inability to maintain a progenitor population for the production of 
late-born retinal cells types would be detrimental to retinal function and vision. 
Therefore, mechanisms must be in place to either actively regulate or intrinsically 
determine the competence of progenitors to differentiate during retinal development. 
Although both intrinsic factors and extrinsic signaling pathways have been implicated, 
how progenitors persist once neurogenesis is initiated is still poorly understood. In the 
present study, the extent of precocious differentiation of wild type cells in mutant 
chimeras appears to substantially deplete the wild type progenitor population in orJ 
environments. This finding argues that progenitor maintenance is under strong cell 
nonautonomous regulation. Thus, many more progenitors are competent to differentiate 
at any given stage than usually observed because of strong extrinsic regulation preventing 
depletion of this progenitor population to ensure later cell type production.   
 
Conclusion 
Retinal development requires coordinated regulation of RPC behavior. Vsx2 is a 
critical component of this regulation, essential during the embryonic stages of retinal 
development for proper maintenance of retinal identity, proliferative expansion of the 
RPC pool, and initiation of neurogenesis. Chimera analysis provides a powerful and 
insightful approach to further define the roles of Vsx2 in these different processes. In the 
present study, determining the autonomy of Vsx2 actions through the use of genetic 
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chimeras has helped to define the primary level of Vsx2 regulation, not readily obvious 
from studies in the orJ retina, which will be valuable for directing future mechanistic 
studies. The analysis of orJ chimeras also provided insight into aspects of retinal 
development not specifically restricted to Vsx2 function. Here, we provide evidence 
suggesting that extrinsic regulation of RPC proliferation is regionalized, with potentially 
different mitogens important at varying degrees in the central versus peripheral retina to 
drive proliferative expansion. We also provide evidence suggesting that retinal 
progenitors are generally competent to participate in neurogenesis, but strong extrinsic 
regulation driving progenitor maintenance normally restricts their participation. Together, 
the use of genetic chimeras has advanced our understanding of both Vsx2 function and 
principles of retinal development. The continued analysis of chimeras in the future will 
likely prove a valuable tool in further defining the mechanisms of Vsx2 function. We 
have focused on the embryonic roles of Vsx2 in retinal development, but Vsx2 is also 
required in the postnatal production of bipolar cells. Analysis of orJ chimeras at later 
stages would help distinguish between a role for Vsx2 in the response to bipolar 






























Antibody Host Dilution Factor Source 
MITF Mouse 400 Exalpha Biologicals (X1405M) 
LHX2 Rabbit 50 Edwin Monuki 
Β-gal Rat 1000 Nadean Brown 
POU4F2 Goat 50 Santa Cruz (sc-6026) 
ISL1 Mouse 100 DSHB (clone 39.4D5) 
OTX2/1 Rabbit 15,000 Chemicon (ab9566) 
PTF1A Guinea Pig 5000 Jane Johnson 
BHLHB5 Goat 1000 Santa Cruz (sc-6045) 
TUBB3 Rabbit 4000 Covance (PRB-435P) 
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All successfully aggregated and partially aggregated (successful aggregation of 2 of the 
3 morulas during 2:1 morula aggregations) embryos were implanted into pseudopregnant 
females.  
b
Chimeras identified by evaluation of EYFP contribution in eye or limb sections.  
c
3 embryos exhibited light or absent eye pigmentation and were excluded from further 
analysis. 
d
5 embryos exhibited light or absent eye pigmentation and were excluded from further 
analysis. 
e
Includes 102 successfully aggregated embryos, 18 partially aggregated embryos, and 11 
nonaggregated embryos implanted as fillers. 
f
1 embryo was grossly underdeveloped and 1 embryo lacked eye pigmentation. Both 
embryos were excluded from further analysis. 
g
Includes 112 successfully aggregated embryos and 16 partially aggregated embryos. 
h






























































Figure 4.2. Comparison of chimerism in control and mutant chimeras across tissues.  
EYFP signal in the retina (B-D), cortical epithelium (F-H), nasal epithelium (J-L), and 
limb tissues (N-P) of control and mutant chimeras. Diagrams illustrating the morphology 
of the developing retina (A), cortical epithelium (E), nasal epithelium (I), and limb (M), 
along with their associated tissues. Control chimera in (B, F, J, N) exhibits low EYFP 
contribution, while control chimera in (C, G, K, O) and the mutant chimera in (D, H, L, 
P) exhibit medium EYFP contribution. Scalebars:  200 µm. Abbreviations:  b, cartilage 
primordium of turbinate bone (nasal capsule) or phalangeal and metacarpal bones (limb); 
ge, ganglionic eminence (striatum); iz, intermediate zone of telencephalon; L, lens; lv, 
anterior horn of lateral ventricle; nc, nasal cavity; np, nasopharynx; npc, neopallial 
cortex; nr, neural retina; ns, cartilage primordium of nasal septum; oep; olfactory 




































Figure 4.3. Cell autonomous regulation of MITF expression by Vsx2. (A-B) Control 
MITF expression in E12.5 eyes of wild type and orJ mice. Nonspecific staining occurs 
along the vitreal edges of the lens and retina, in the developing corneal epithelium and 
extraocular mesenchyme, but not in the RPE or retina. (C-E) EYFP and MITF expression 
in E12.5 retinas of control and mutant chimeras. Scale bars:  100 µm (A, B, C); 40 µm 





































Figure 4.4. Cell autonomous regulation of MITF expression in orJ retinas by Lhx2. (A-B) 
LHX2 expression in wild type and orJ eyes at E12.5. β-gal (C) and MITF (C’) expression 
in E12.5 eyes of orJ mice with conditional inactivation of Lhx2 in the retina by α-Cre. β-
gal expression marks areas of successful Lhx2 inactivation. Dashed lines in C-C” 
demarcate the border of the neural retina. Scale bars:  100 µm (A, B, C); 40 µm (A’, B’). 













































Figure 4.5. Cell nonautonomous regulation of RPC proliferation by Vsx2. (A, B) EdU 
incorporation in E12.5 retinas of wild type and orJ mice. EYFP expression (C, D) and 
EdU incorporation (C’, D’) in retinas of mutant chimeras in peripheral (C) and central 
(D) regions. White arrows indicate EdU-positive, EYFP-negative orJ cells in mutant 
chimeras. Red arrowheads in C demarcate the peripheral region from the adjacent 
intermediate region in this retina. (E) Quantification of EdU-positive orJ cells at E12.5 in 
peripheral and central regions. Bars represent mean ± standard deviation. p–values 
calculated by Student’s unpaired t-test or Welch’s two sample t-test, as appropriate 











































Figure 4.6. orJ cells are rarely located in the differentiated cell layer of mutant chimeras, 
unlike wild type cells in control chimeras. (A) Diagram illustrating the relationship 
between differentiation status and apical-basal position within the retina. Nascent 
postmitotic cells (gray cells at apical surface) migrate basally to establish a distinct 
differentiated cell layer. (B, C) Distribution of EYFP-positive and EYFP-negative cells in 
E12.5 retinas of mutant (B) and control (C) chimeras. Boxed area in (B, C) shown at 
higher magnification to right (a, b). Scale bars: 100 µm. Abbreviations:  DCL, 




























Figure 4.7. orJ cells fail to express differentiation markers at E12.5. Expression of 
POU4F2 (A-D) and TUBB3 (E-H) in retinas of wild type (A, E), orJ (B, F), control 
chimeras (C, G), and mutant chimeras (D, H) at E12.5. Boxed areas in (C, D, G, H) 
shown at higher magnification to right (a, b, c, d). Dashed line in B delineates the retina 
from adjacent lens tissue. Dashed line in E and F delineates the boundary of retinal tissue. 
All images are maximum Z-projections of confocal scans. Scale bars: 100 µm (A, C, E, 












































Figure 4.8. orJ cells fail to express differentiation markers at E12.5. Expression of the 
combination marker stain (Combo; A-D) and OTX2 (E-H) in retinas of wild type (A, E), 
orJ (B, F), control chimeras (C, G), and mutant chimeras (D, H) at E12.5. Boxed areas in 
(C, D, G, H) shown at higher magnification to right (a, b, c, d). Combo stain represents 
simultaneous staining for ISL1, POU4F2, PTF1A, and BHLHB5. All images are 
maximum Z-projections of confocal scans. Scale bars: 100 µm (A, C, E, G, I, H); 40 µm 





























Figure 4.9. Early-born retinal cell types are generated in orJ retinas by E15.5, but the 
extent of differentiation is more centrally restricted than in wild type retinas. Expression 
of TUBB3 (A, F), POU4F2 (B, G), OTX2 (C, H), PTF1A (D, I), and BHLHB5 (E, J) in 
orJ (A-E) and wild type (F-J) retinas at E15.5. White bars in G and J consequence of 
nonoverlapping fields of view during image capture. Scale bars:  100 µm (A, F). Note 































Figure 4.10. At E15.5, orJ cells contribute to all early-born retinal cell types in the retinas 
of mutant chimeras. Expression of TUBB3 (A), POU4F2 (B), OTX2 (C), PTF1A (D) and 



































Figure 4.11. At E15.5, wild type cells contribute to all early-born retinal cell types in the 
retinas of control chimeras. Expression of TUBB3 (A), POU4F2 (B), OTX2 (C), PTF1A 





























Figure 4.12. Delayed differentiation of orJ cells persists in the periphery of mutant 
chimeras. (A-B) EYFP and TUBB3 expression in the peripheral retina of control and 
mutant chimeras at E15.5. DAPI expression reveals the presence of cells in areas lacking 
EYFP and TUBB3 expression (red brackets in B). (C) EYFP (green) and POU4F2 
(magenta) expression in retina of a mutant chimera at E14.5. Expression of EYFP, 
POU4F2 and TUBB3 for boxed regions in D are shown at higher magnification in (a, b). 
Retina in C was co-immunolabeled for POU4F2 and TUBB3 on the same retinal 
expression. Red brackets in b indicate region of orJ cells. Arrows in a indicate 
differentiated orJ cells in the neuroblast (white arrows) or differentiated (red arrows) cell 































Figure 4.13. Precocious differentiation of wild type cells in regions of high orJ 
contribution in mutant chimeras. Expression of POU4F2 (A) and OTX2 (B) in retinas of 
mutant chimeras at E15.5. Quantification of POU4F2-positive (C) and OTX2-positive 
(D) wild type cells as a function of patch type in retinas of mutant chimeras at E15.5. 
Black diamonds represent individual patch values and illustrate the variation within 
patches of the same type. Red squares represent mean ± standard deviation. p-values 
calculated by Student’s unpaired t-test or Welch’s two sample t-test, as appropriate 






























Figure 4.14. Low levels of cell death are detected in control and chimeric retinas. 
Expression of activated caspase-3 (CASP3) in retinas of wild type, orJ, control chimeras, 
and mutant chimeras at E12.5 (A-F), E14.5 (G), and E15.5 (H-K). Insets show retinal 
cells stained for activated caspase-3 at higher magnification. Arrows point to retinal cells 
expressing activated caspase-3. Scale bars:  100 µm. Note size difference in scale bars 
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Summary and interpretation 
 In the present work, we sought to further define the roles of Vsx2 in the regulation 
of retinal histogenesis. The cellular processes involved in the development of the retina 
during this period are tightly regulated by both intrinsic factors and extrinsic signals. 
Vsx2 is an important intrinsic factor in this regulation, but how Vsx2 function integrates 
with other known regulators is only beginning to be unraveled and few direct targets have 
been identified. In particular, an understanding of whetherVsx2-mediated regulation 
integrates with that of extrinsic signals was lacking. Thus, in the present work, we 
addressed this question by examining the relationship between Vsx2 and the extracellular 
signals and signaling pathways regulating retinal progenitor cell (RPC) properties during 
retinal histogenesis, using multiple approaches. Using a candidate approach, we 
examined the known retinal mitogen, sonic hedgehog (Shh), and its signaling pathway in 
orJ retinas to determine whether changes in this pathway contributed to the disrupted 
RPC proliferation. In a more unbiased approach, we evaluated the contribution of Vsx2-
dependent changes in extrinsic signals to the disruption of retinal histogenesis by 
determining the autonomy of Vsx2 gene function in genetic mouse chimeras. Together, 
these approaches have advanced our knowledge of Vsx2-mediated regulation of retinal 
identity maintenance, RPC proliferation, and neurogenesis, and have provided insight 
into how this regulation may integrate with that of extrinsic signals.   
  
Retinal identity 
Despite its use as one of the earliest, most specific markers of the neural retina 
domain, the role of Vsx2 in retinal identity appears to be one of maintenance, rather than 
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specification. In this role, a primary function of Vsx2 is to ensure efficient execution of 
the retinal program by suppressing competing nonretinal gene expression programs. 
Much of this regulation involves repression of the RPE determinant, Mitf (Horsford et al., 
2005; Rowan et al., 2004). Mitf is a key indicator of an aberrant RPE-like gene 
expression program, as many of the genes exhibiting altered expression in orJ retinas are 
involved in the pigmentation pathway, downstream of Mitf (Rowan et al., 2004). In the 
present work, we demonstrate that repression of Mitf by Vsx2 is a cell autonomous 
function of Vsx2. This finding argues that Vsx2 does not utilize regulation of extrinsic 
signals in its repression of Mitf, which is consistent with previous reports that Mitf 
transcription is directly repressed by Vsx2 (Bharti et al., 2008) and recent reports that 
Vsx2 may repress Mitf function through direct protein-protein interaction (Zou and 
Levine, 2012). This finding also argues that any extrinsic signals involved in preventing 
non-retinal gene expression programs, at least with respect to repression of Mitf, are 
mediated by Vsx2, as restoration of extrinsic signals using genetic chimeras failed to 
repress Mitf in the absence of functional Vsx2.  Furthermore, continued ectopic 
expression of Mitf in orJ cells of mutant chimeras illustrates the persistence of 
compromised retinal identity, demonstrating that orJ cells are unable to fully respond to 
extrinsic signals driving retinal specification and maintenance, thereby revealing a critical 
cell autonomous role for Vsx2 in mediating this response. We also demonstrate that the 
ectopic expression of Mitf in the orJ retina is mediated by cell autonomous activity of 
Lhx2, as in its absence, Mitf expression is not maintained in the orJ retina. 
Our observation that orJ cells readily contribute to the developing retina in 
genetic chimeras, both in their integration into the retinal domain and their generation of 
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retinal neurons, reveals that despite aberrant expression of non-retinal elements, orJ cells 
are predominantly retinal in their identity. While this is consistent with the execution of a 
retinal program, albeit disrupted, in orJ retinas, it is somewhat surprising to find in 
chimeras. The eye field transcription factors Rx and Pax6 are both required for early 
steps in the specification of retinal identity. In chimeras, cells deficient for either of these 
genes, and therefore exhibiting fundamental defects in retinal identity, were largely 
absent in the retina, even at early stages. Those that did contribute, failed to persist, 
removed by cell death or physical extrusion (Collinson et al., 2000; Collinson et al., 
2003; Li et al., 2007; Medina-Martinez et al., 2009; Quinn et al., 1996). Because of the 
additional competition afforded by wild type cells within chimeras, even developmental 
defects undetectable in germline mutants are often revealed, as was described for PDGFR 
mutants in muscle cell lineages (Crosby et al., 1998). Currently, we cannot rule out that 
this mixed identity exhibited by orJ cells impairs their ability to contribute to the retinal 
lineage because the resulting effect on orJ cell numbers in the retina of mutant chimeras 
is not separable from the effects of Vsx2 on RPC proliferation, which also influences orJ 
cell numbers. However, the substantial contribution of orJ cells to chimeric retinas and 
their differentiation into retinal neurons suggests that aberrant expression of non-retinal 
gene expression programs has little impact on their apparent identity. Thus, it appears 
that expression of nonretinal gene expression programs primarily interferes with the 
efficient execution of a retinal program, as opposed to actually promoting a switch in 
identity. To what extent other orJ phenotypes are linked to these aberrant gene expression 





Vsx2 is essential for the proliferative expansion of RPCs. In the orJ mouse, eyes 
are microphthalmic and the neural retina is extremely hypocellular, exhibiting a nearly 
20-fold reduction in cell number by birth (Bone-Larson et al., 2000; Burmeister et al., 
1996; Green et al., 2003). Previous studies implicated the misregulation of several 
intrinsic factors to the defective RPC proliferation observed in the orJ retina, namely, 
ectopic expression of the RPE determinant Mitf and downregulation of Cyclin D1 
(Ccnd1), a G1 phase cyclin critical for initiating the regulatory cascade driving G1 
progression. In support of the former, genetic deletion of Mitf in the orJ retina largely 
restored retinal cell number (Horsford et al., 2005; Konyukhov and Sazhina, 1966). 
However, in the present work, we demonstrate that proliferation of orJ RPCs is 
significantly rescued, at least in the peripheral retina of E12.5 genetic chimeras, despite 
the presence of maintained, high levels of Mitf expression. Currently, we cannot rule out 
some level of contribution to regulation of RPC proliferation by ectopic Mitf, as the 
rescue of RPC proliferation in the peripheral retina, qualitatively, does not appear 
complete. However, our findings strongly argue that it is unlikely that ectopic Mitf 
expression alone fully accounts for the severe disruption in RPC proliferation, at least 
during early embryonic stages in the orJ retina. Furthermore, Mitf in several cell types, 
including optic neuroepithelial cells, directly activates transcription of several cell cycle 
inhibitors, including p27/KIP1 (Carreira et al., 2005; Lekmine et al., 2007; Tsukiji et al., 
2009), which inhibit G1 progression downstream of Ccnd1. Thus, ectopic Mitf may not 
account for the reduced levels of Ccnd1 expression in the orJ retina, whose function 
tightly correlated with the observed changes in cell cycle regulation (Green et al., 2003). 
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Ccnd1 is not a reported transcriptional target of Vsx2. Furthermore, the 
downregulation of Ccnd1 expression in the orJ retina observed in the present study and 
reported previously (Green et al., 2003), would suggest that Vsx2 transcriptionally 
activates Ccnd1, but Vsx2 transcriptional activity is primarily repressive (Dorval et al., 
2005). Although Vsx2 exhibits weak transcriptional activator function in some in vitro 
contexts, much of Vsx2-dependent regulation of retinal development is mediated by this 
repressive activity, including prevention of nonretinal gene expression programs through 
repression of Mitf (Bharti et al., 2008), maintaining multipotent progenitors through 
repression of lineage-restricting factors such as ath5 and Vsx1 (Clark et al., 2008; 
Vitorino et al., 2009), and promoting bipolar cell production through repression of yet 
unidentified targets (Livne-Bar et al., 2006). More likely, reduced Ccnd1 expression is an 
indirect effect of the loss of Vsx2 function.  
Ccnd1 is, however, a well-established target of mitogen signaling pathways 
(Giacinti and Giordano, 2006; Levine and Green, 2004; Lundberg and Weinberg, 1999). 
Thus, we hypothesized that the reduced Ccnd1 expression and RPC proliferation 
observed in the orJ retina may be a consequence of reduced mitogen signaling. In support 
of this mechanism, we demonstrate in the present work that there is a large cell non-
autonomous contribution to the regulation of RPC proliferation by Vsx2, as proliferation 
of orJ RPCs was significantly altered in chimeric retinas. Although orJ RPCs exhibited 
differences in their proliferative response to restored environmental signals in central 
versus peripheral regions, these findings are consistent with significant changes in the 
availability of retinal mitogens or anti-proliferative signals in the orJ retina. Further 
support was revealed by our examination of Hh signaling in the orJ retina. Shh is an 
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essential retinal mitogen, with numerous studies demonstrating that Shh and activation of 
the Hh signaling pathway are both necessary and sufficient for the proliferative expansion 
of RPCs [reviewed in (Amato et al., 2004; Wallace, 2008)]. In the present work, we 
report evidence of reduced Hh signaling in the orJ retina. Further examination revealed 
that this was primarily the result of delayed or reduced Shh ligand production during 
early embryonic and neonatal time points, respectively (Figure 5.1). Addition of 
exogenous Shh enhanced Hh signaling and RPC proliferation at both time points, 
suggesting that the limited availability of Shh ligand likely contributed to reduced RPC 
proliferation in orJ retinas. Furthermore, Ccnd1 exhibited Hh signaling-dependent 
changes in the orJ retina, suggesting that reduced Ccnd1 expression in the orJ retina may 
indeed reflect deficits in mitogen signaling. We also discovered that dissociated orJ 
retinal cells responded weakly, if at all, to Hh pathway stimulation, suggesting that Vsx2 
may also regulate the responsiveness of RPCs to Hh pathway stimulation. Because orJ 
retinal cells respond robustly to exogenous Shh in explant culture and actively respond to 
endogenous Shh in vivo, it is not clear whether this regulation is relevant in vivo and will 
require further evaluation. 
Together, these findings reveal a significant contribution of altered extrinsic 
signals to Vsx2-mediated regulation of RPC proliferation, in contrast to a limited 
contribution of ectopic Mitf, at least at early embryonic stages. Importantly, the observed 
defects in Hh signaling occur upstream of, and in addition to, any direct regulation Vsx2 
or ectopic Mitf may exert on the cell cycle, thereby exposing a previously unrecognized 
role for Vsx2 in mitogen signaling. How does one reconcile these findings with the 
observation that deletion of Mitf produces a significant rescue? One possibility is that 
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mitogen signaling, acting through upregulation of Ccnd1 and potentiated by the strong 
feed forward regulation of this pathway, is sufficient to inhibit the activity of cell cycle 
inhibitors, despite their upregulation by Mitf; but, in the context of reduced mitogens (or 
presence of anti-proliferative signals), the upregulation of cell cycle inhibitors by Mitf 
goes unchecked and is sufficient to overcome mitogen-mediated G1 progression, 
resulting in slowed RPC proliferation.  
  
Retinal neurogenesis 
 Vsx2 is also required to ensure proper temporal initiation of neurogenesis. In the 
absence of Vsx2 function, onset of the neurogenic program is delayed by approximately 
two days, but largely intact (Bone-Larson et al., 2000; Robb et al., 1978; Rutherford et 
al., 2004). In the present work, we show that this delayed neurogenic program is retained 
by orJ cells in the context of genetic chimeras, despite normal progression of 
neurogenesis in adjacent wild type cells (Figure 5.2), indicating strong cell autonomous 
regulation of the temporal initiation of neurogenesis by Vsx2. Our observation that orJ 
cells did not regain neurogenic competence all at once, even in the context of the genetic 
chimeras, but rather retained the stereotyped central-to-peripheral progression of the 
wave front, argues that the intrinsic regulation of this progression is largely unaffected in 
by the loss of Vsx2 function. These findings reveal that Vsx2 primarily functions in the 
temporal regulation of neurogenic competence.  
Previous studies show that initiation and subsequent progression of the 
neurogenic wave are genetically separable events, but only in that progression can be 
blocked independent of initiation (Hufnagel et al., 2010). Progression does appear to 
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require initiation, since manipulations blocking initiation also appear to completely 
prevent neuronal differentiation (Martinez-Morales et al., 2005; Masai et al., 2000). Thus, 
it was unclear from the orJ retina whether the lack of peripheral neurogenesis was simply 
a result of delayed initiation in the central retina. Our observation that neurogenesis in 
orJ cells remained delayed with respect to their wild type neighbors, indicates that 
initiation in wild type cells is not sufficient to promote progression in orJ cells. This 
finding argues that progression is under strong intrinsic regulation and that this regulation 
may be intrinsically linked within individual cells to the initiation mechanism to ensure 
that these events occur in a coordinated fashion.  
Previous studies suggested that progression of the neurogenic wave front is based 
on a preprogrammed intrinsic timer (Agathocleous and Harris, 2009). Our observation of 
two independent waves of neurogenesis in orJ chimeras:  the first reflecting the normal 
progression of the neurogenic wave front in wild type cells, followed by a second, 
delayed wave front in orJ cells (Figure 5.2), supports this notion of a cell autonomous 
timer and further implicates positional identity as a critical component in the regulation 
of this clock. Additionally, peripheral orJ cells still maintained their delayed participation 
in neurogenesis relative to adjacent wild type cells in chimeras, despite significant 
improvement in the proliferation of these peripheral orJ cells, arguing against a model in 
which this clock is strictly tied to cell divisions.  
 Our analysis of neurogenesis in Vsx2 chimeras also provided insight into 
additional regulatory aspects of neurogenesis not mediated by Vsx2. Our unexpected 
observation of precocious neurogenesis of wild type cells in mutant chimeras, reveals a 
strong cell non-autonomous effect on the regulation of the progenitor state. This suggests 
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that typically, many more progenitors are competent to participate in neurogenesis at any 
given stage than is usually observed because of strong extrinsic regulation preventing the 
depletion of this progenitor population to ensure production of later cell types.  
In summary, the present work has helped further define Vsx2 gene function in the 
processes of retinal identity maintenance, RPC proliferation, and neurogenesis, by 
examining the relationship between Vsx2-mediated regulation and that of extracellular 
signals and their signaling pathways. Our analysis of autonomy in Vsx2 chimeras has 
helped to define the primary level of Vsx2 regulation in these processes, which was not 
readily obvious from studies in the orJ retina. Specifically, the autonomy analysis 
identified roles for Vsx2 in establishing the competence in RPCs to fully and 
appropriately respond to signals and factors important for the maintenance of retinal 
identity and initiation of neurogenesis (Figure 5.3). Additionally, it also identified a role 
for Vsx2 in ensuring the availability of extrinsic signals necessary for the proper 
regulation of RPC proliferation (Figure 5.3). This provides significant insight into the 
types of potential mechanismsVsx2 may utilize in its regulation of these processes 
(Figure 5.3), which will in turn provide valuable and needed direction for future studies 
aimed at identifying the mechanisms through which Vsx2 exerts its regulation. 
Furthermore, our targeted analysis of Shh signaling as a candidate mediator of Vsx2 
regulation in RPC proliferation revealed that Vsx2 is required to ensure proper 
availability of mitogenic Shh ligand during the proliferative period (Figure 5.3). 
Although determination of the precise mechanism for this regulation will require further 
study, this finding provides a specific example of Vsx2-dependent regulation of extrinsic 
signals, which was proposed for the regulation of RPC proliferation by the autonomy 
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experiments. Although altered Shh signaling likely contributes to the defective RPC 
proliferation observed in the orJ retina, our observations of orJ RPC proliferation in 
mutant chimeras suggests that additional signals are also involved.  
 
Open questions 
Despite considerable effort, our understanding of how Vsx2 integrates into the 
coordinated regulation of retinal histogenesis is poor. The work presented here 
contributes to our understanding of Vsx2 function in this regulation, but also raises new 
questions and refines existing ones.   
The importance of Mitf in RPE development and the complementary relationship 
with Vsx2 in the developing optic cup are well defined. Thus, many studies interpret the 
ectopic expression of Mitf and pigmentation of retinal cells in the orJ retina as evidence 
of an RPE-like identity. However, Mitf, pigmentation, and many of the other genes 
exhibiting upregulation in the orJ retina are characteristic of the optic neuroepithelium at 
the RPE/retina border in the optic cup, which eventually gives rise to components of two 
peripheral fates, the iris and ciliary body. Furthermore, many of these genes are not 
expressed throughout the entire orJ retina, exhibiting instead, only expanded peripheral 
expression, consistent with the expansion of these peripheral fates (Rowan et al., 2004). 
Recent evidence suggests that these peripheral fates may be induced as early as the optic 
vesicle stage (Cho and Cepko, 2006). Furthermore, experimental manipulations 
promoting peripheral fate in the presumptive neural retina were associated with strong 
downregulation of Vsx2 expression (Cho and Cepko, 2006). As a result, it has been 
proposed that peripheral fates are expanded in the orJ retina, and that Vsx2 also prevents 
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peripheral fate identity. However, Vsx2 is weakly expressed in the presumptive ciliary 
body epithelium (Rowan and Cepko, 2004) suggesting that Vsx2 or the combined 
expression of Vsx2 and Mitf may be important for defining peripheral fate. Further 
evaluation with more specific peripheral fate markers will be required to define the role 
of Vsx2 in peripheral fate identity.  
 In the present work, we demonstrate that Vsx2 is critical for the proper 
establishment of retinal proliferation signals in the eye. These could be mitogenic or 
inhibitory proliferation signals, as extrinsic signals exerting negative effects on retinal 
proliferation have been identified, in addition to a large number of positive signals. An 
understanding of Vsx2-mediated regulation of RPC proliferation will require 
identification of these signals and their sources. Although Vsx2 expression is restricted to 
RPCs, the source of the affected signals may not be similarly restricted. Retinal mitogens 
and anti-proliferative signals are produced by RPCs, retinal neurons, the surrounding 
RPE and other ocular tissues (Anchan et al., 1991; Cho and Cepko, 2006; Close et al., 
2005; Das et al., 2000; Hashimoto et al., 2006; Jensen and Wallace, 1997; Levine et al., 
1997; Lillien and Cepko, 1992). Because proper development of ocular tissues involves 
complicated inter-tissue interactions, disrupted development of one tissue can impact 
development of other tissues. For example, expansion of markers consistent with 
characterization of peripheral fates (iris and ciliary body), suggests this region is 
expanded in the absence of Vsx2 function (Rowan et al., 2004), which could alter the 
expression of mitogens or anti-proliferative signals by these tissues. Our analysis of 
proliferation in orJ chimeras suggests that regional differences in the extrinsic regulation 
of RPC proliferation exist. Thus, it is likely that the availability of multiple signals will 
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be regulated by Vsx2. It will be interesting to determine the degree to which Vsx2-
mediated regulation contributes to these regional differences.  
 Our analysis of the role of Vsx2 in the regulation of retinal proliferation signals 
was limited to E12.5 in genetic chimeras. Regulation of RPC proliferation is dynamic, 
owing to temporal and spatial changes in the expression of extrinsic signals (Close et al., 
2005; Wang et al., 2005) and intrinsic changes that impact the responsiveness of RPCs to 
these signals during development (Jensen and Wallace, 1997; Lillien and Cepko, 1992; 
Lillien and Wancio, 1998). Vsx2-dependent regulation of RPC proliferation also changes 
over time, as manipulations of Vsx2 expression in wild type retinal cells at postnatal ages 
does not affect RPC proliferation (Livne-Bar et al., 2006). Thus, it will be important to 
determine how Vsx2-mediated regulation of retinal proliferation signals also changes 
during development. 
In our evaluation of the retinal mitogen Shh and its signaling pathway in orJ 
retinas, we found that activation of Hh signaling was delayed at E12.5, which correlated 
with the delayed generation of retinal ganglion cells, the relevant source of endogenous 
retinal Shh ligand (Figure 5.1). Because addition of exogenous SHH-N activated Hh 
signaling and increased proliferation, we believed it likely that the delayed availability of 
Shh contributed to the low levels of RPC proliferation in the orJ retina. However, in 
genetic chimeras, where Shh is provided by wild type ganglion cells at the appropriate 
time, proliferation was not improved in the central region where ganglion cell 
differentiation had occurred. In fact, proliferation was actually reduced in this region. 
Based on Hh target gene expression, Shh acts as a short-range mitogen in the retina, 
suggesting that the rescue in peripheral RPC proliferation does not reflect restoration of 
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Shh signals. The reason for the lack of improved RPC proliferation in the central retina is 
not clear. It is unlikely that endogenous Shh fails to activate Hh signaling in orJ cells at 
this age for two reasons. First, orJ cells at this age are competent to respond to exogenous 
SHH-N. Second, orJ cells at later ages actively respond to endogenous Shh. However, 
this could be confirmed by determining whether orJ cells in E12.5 chimeras express Gli1, 
a reliable readout of active Hh signaling. We also suggest that the responsiveness of orJ 
cells to Hh pathway stimulation may be impaired, but this requires further evaluation, and 
could also be examined by analysis of Gli1 expression. If orJ cells do indeed respond to 
the endogenous Shh provided by wild type ganglion cells in mutant chimeras, it is 
possible that the effects are masked by the loss of other retinal mitogens, or overcome by 
the presence of anti-proliferative signals. Alternatively, restoration of endogenous levels 
of Shh may not be achieved in chimeras or may only promote small changes in RPC 
proliferation. Consistent with the latter, the mitogenic potency of Shh changes as 
development progresses, and is stronger at later ages (Jensen and Wallace, 1997; 
Sakagami et al., 2009; Wang et al., 2005).  
By birth, Shh is produced in the orJ retina, but levels appear reduced at both the 
transcript and protein levels. This occurs in the absence of detectable changes in the 
proportion of Shh-expressing cells, as significant differences were not detected between 
wild type and orJ retinas in the progenitor-to-neuron ratio (Green et al., 2003), nor in the 
expression of Pou4f2 (this work), a retinal ganglion cell marker important for the 
maturation of this cell type and direct activator of Shh expression (Mu et al., 2004). 
These findings suggest that Shh production is reduced on a cell-by-cell basis. However, 
Vsx2 is not expressed in differentiating ganglion cells during the period of Shh 
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expression. Thus, it is not clear why or how this change in Shh production occurs. Vsx2 
is expressed in the progenitors from which ganglion cells develop, suggesting that 
changes incurred during its time as a progenitor may impact its later activities. Recently, 
conditional inactivation of Dicer, an enzyme required for the production of microRNAs, 
was reported to promote a dramatic increase in ganglion cell number, but Hh target gene 
expression was markedly reduced (Davis et al., 2011; Georgi and Reh, 2010). Expression 
of Shh was not assessed in these studies, so it is possible that reduced Hh target gene 
expression resulted from the loss of microRNAs in RPCs, rather than reduced production 
of Shh by ganglion cells. But, it is an intriguing possibility that perhaps Vsx2 is important 
for the regulation of microRNAs that ultimately influence the ability of ganglion cells to 
produce Shh. Consistent with this possibility, ganglion cells in Dicer conditional 
knockouts fail to fully mature (Georgi and Reh, 2011). 
In the present work, we demonstrate that Vsx2 is an essential component in the 
temporal regulation of the initiation of neurogenesis through its role in promoting 
neurogenic competence. Interestingly, Vsx2 has previously been implicated as a temporal 
regulator of cell fate, but through inhibition of neurogenic competence. Analysis of Vsx2 
function in zebrafish suggests that Vsx2 maintains the multipotency of RPCs through 
repression of lineage-restricting bias factors, such as ath5 and Vsx1 (Clark et al., 2008; 
Vitorino et al., 2009). As a result of temporal differences in the production of Vsx2-
negative RPCs over the course of retinal neurogenesis, the resulting derepression of these 
bias factors allows for temporally relevant cell fate restriction (Vitorino et al., 2009). 
Repression of Vsx1 is a conserved function of Vsx2 in mouse (Clark et al., 2008), 
suggesting that this model may also be conserved in mouse. However, despite 
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derepression of these lineage-restricting bias factors in the orJ retina, neurogenesis 
remains delayed, suggesting that orJ cells lack the necessary competence factors to 
promote transcriptional activation of bias factors. This could be confirmed by evaluating 
expression of these early lineage-restricting bias factors in orJ or chimeric retinas.  
The intrinsic mechanism by which Vsx2 promotes neurogenic competence is 
unknown, but our observation that this is a cell autonomous function of Vsx2 suggests 
that Vsx2 regulates an intrinsic component. Sox2 and Pax6 are strong candidates due to 
their critical roles in conferring neurogenic competence. However, conditional 
inactivation of Sox2 in the mouse blocks neurogenesis (Taranova et al., 2006), and 
conditional inactivation of Pax6 in the mouse restricts retinal cell production to the 
amacrine fate (Marquardt et al., 2001). Because acquisition of neurogenic competence is 
delayed but not completely blocked in the orJ retina and most retinal cell types are 
eventually produced, only moderately reduced expression of these factors would be 
expected in the orJ retina, suggesting thatVsx2 may only modulate the baseline 
expression level of these candidates. Hes1 exhibits intriguing temporal regulation of the 
initiation of neurogenesis in the mouse.  In Hes1 null retinas, precocious neurogenesis 
was observed days before normal initiation in wild type retinas, but the normal 
progression of cell type determinants was largely retained (Lee et al., 2005). Hes1 is 
known target of Delta-Notch signaling and manipulations of this pathway also promote 
temporal changes in neurogenesis (Bao and Cepko, 1997; Riesenberg et al., 2009; Tomita 
et al., 1996; Yaron et al., 2006). Furthermore, much of Sox2 function in regulating 
neurogenic competence is mediated by its role in promoting Notch1 expression 
(Taranova et al., 2006). Thus, autonomous misregulation of Delta-Notch signaling could 
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also mediate the neurogenic delay observed in the absence of Vsx2 function. However, 
for most of these candidate factors, expression in RPCs is required to promote 
competence or initiation of neurogenesis. Although Vsx2 may exhibit activator functions, 
it is more likely that any regulation of these factors by Vsx2 is indirect. Pax2 is a known 
transcriptional repressor of Pax6 in the retina and is downregulated prior to the initiation 
of neurogenesis (Schwarz et al., 2000). Thus, a potential direct target of Vsx2 repression 
in the regulation of neurogenic competence is Pax2, as its ectopic expression could 
mediate the necessary repression, at least of Pax6.  
In mutant chimeras, the neurogenic delay exhibited by orJ cells could not be 
separated from their ectopic expression of Mitf. Thus, delayed initiation of neurogenesis 
in orJ cells may be, in part, Mitf-dependent. In support of this, genetic deletion of Mitf in 
the orJ retina shortens the delay in the onset of neurogenesis (C. Zou, personal 
communication). Because Mitf-dependent regulation is also expected to affect neurogenic 
competence, but separate from Vsx2-mediated regulation, it will be important to 
determine where Mitf intersects with the retinal differentiation program. However, the 
Mitf-mediated rescue is not complete, and neurogenesis remains delayed by at least a day 
in the double mutants (C. Zou, personal communication), suggesting that Mitf regulation 
alone cannot fully account for the delay in orJ retinas. Thus, it will also be important to 
determine the relative contributions of ectopic Mitf-dependent regulation and loss of 
Vsx2-dependent regulation to the neurogenic delay.  
In orJ chimeras, we observed two waves of neurogenesis: the first in wild type 
cells according to normal neurogenic timing, and a second, delayed wave in the orJ cell 
population. What drives this second, delayed wave of neurogenesis in orJ cells? 
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Progression of the neurogenic wave front is largely controlled by intrinsic factors 
according to a preprogrammed intrinsic timer. This would suggest that downstream 
intrinsic regulators, such as Neurog2, would also exhibit cell autonomous delays. Thus, it 
would be informative to determine whether Neurog2 also exhibits separate waves in wild 
type and orJ cells of chimeric retinas. Alternatively, Neurog2 may proceed across the 
chimeric retina, irrespective of genotype. In Neurog2 null retinas, the neurogenic wave 
front initially stalls, but is rescued at later time points, presumably by a subsequent wave 
of Ascl1 that propagates across the retina shortly after Neurog2, although this latter point 
requires further confirmation (Hufnagel et al., 2010). While an attractive model, it is 
unlikely that Ascl1 drives the delayed wave of neurogenesis in orJ cells of genetic 
chimeras. In Neurog2 null retinas, progression of the wave is indistinguishable from that 
in wild type retinas by E13.5 (Hufnagel et al., 2010); however, in orJ chimeras, a delay is 
still evident in peripheral orJ cells relative to their adjacent wild type neighbors at E15.5. 
While it is possible that another factor mediates the second wave of neurogenesis in orJ 
cells of chimeras, the most likely explanation is that Neurog2 exhibits a cell-autonomous 
delay in orJ cells, but this remains to be tested.  
Shh signaling has been proposed to establish the preprogrammed intrinsic timer in 
RPCs. In the absence of Shh or when Hh signaling is blocked, neurogenesis initiates and 
progresses in a central-to-peripheral wave, but on a delayed schedule (Kay et al., 2005), 
not unlike the delayed wave in the orJ retina. Furthermore, this timer appears to be 
established by midline Shh signals during the period of dorsal-ventral patterning in the 
optic vesicle (Kay et al., 2005).  This timing closely coincides with the initiation of Vsx2 
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expression, making it possible that Vsx2 mediates entrainment of the intrinsic clock in 
RPCs. 
Vsx2 is also required for generation of bipolar cells. Previous studies demonstrate 
that their absence in orJ retinas is due to a specific requirement for Vsx2 in their 
specification or maturation, rather than a secondary effect of insufficient proliferative 
expansion of RPCs for the generation of this late-born cell type (Bone-Larson et al., 
2000; Burmeister et al., 1996; Green et al., 2003).  Numerous studies suggest that Vsx2 
may function as a lineage-restricting bias factor for the bipolar cell fate, or at least a 
subpopulation of bipolar cells in. In zebrafish, all retinal cell types, with the exception of 
several bipolar cell types, derive from Vsx2-negative progenitors, while progenitors 
maintaining Vsx2 expression generate only subclasses of bipolar cells (Vitorino et al., 
2009). Furthermore, misexpression studies show that Vsx2 promotes the bipolar fate, 
typically at the expense of rod photoreceptors (Hatakeyama et al., 2001; Livne-Bar et al., 
2006; Vitorino et al., 2009). However, evidence for immature bipolar cells was reported 
in orJ mice with genetic modifiers, suggesting that Vsx2 may be required for the 
maturation, rather than specification of bipolar cells (Bone-Larson et al., 2000). In 
dissociated cell culture of wild type retinal cells, bipolar cell specification occurs, but 
subsequent maturation fails, suggesting that extrinsic factors may be important for bipolar 
cell maturation. While the role of Vsx2 in bipolar cell fate specification versus maturation 
requires further evaluation, the use of orJ chimeras has the potential for providing insight 
into the role of Vsx2 in bipolar cell production, distinguishing between a requirement for 





The phenotypes exhibited by orJ retinal cells are consistent with the disruption of 
key properties associated with the retinal progenitor state; however, they are also 
reminiscent of unspecified optic neuroepithelial cells in the early optic vesicle. In 
particular, both orJ cells and unspecified optic neuroepithelial cells exhibit expression of 
Mitf, a relatively low rate of proliferation, and lack of neurogenic competence. Thus, it 
appears that many of the key features of orJ cells are shared with early optic 
neuroepithelial cells. Furthermore, initiation of Vsx2 expression is often associated with 
temporal changes in these features. For example, prior to initiation of Vsx2 expression, 
Mitf is expressed throughout the optic vesicle (Horsford et al., 2005; Nguyen and 
Arnheiter, 2000). Additionally, the earliest precocious initiation of retinal neurogenesis 
occurs in Hes1 null mutants, around E9.5 (Lee et al., 2005), which coincides with the 
onset of Vsx2 expression. An intriguing possibility, then, is that Vsx2 is important for 
transitioning optic neuroepithelial cells into the highly proliferative, neurogenically 
competent state characteristic of retinal progenitor cells, and in its absence, this transition 
is impaired.  
 Retinal histogenesis is a complex process requiring the coordinated activity of 
many genes and multiple developmental processes. Both extrinsic signals and intrinsic 
factors have important roles in the regulation of these processes and require coordinated 
integration into efficient regulatory networks that ensure appropriate execution in the 
changing environment of the developing embryo. Additionally, these developmental 
processes are not entirely separable, nor are their regulation. A major reason for this is 
that while RPCs actively maintain their identity, the competing processes of proliferation 
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and differentiation also exert their influences on this same cell population.  Consequently, 
perturbations in one process often elicit secondary changes in the others, and vice versa. 
Moreover, many extracellular signals and intrinsic factors are reused during development, 
contributing to the regulation of multiple processes. Thus, an additional level of 
coordination is required within RPCs to ensure the orderly and efficient execution of 
these cellular processes during retinal histogenesis. Because Vsx2 is expressed in 
multipotent proliferating RPCs, it is expressed at the right time and in the right place to 
provide such coordination. Furthermore, maintenance of retinal identity, RPC 
proliferation, and retinal neurogenesis are severely disrupted in the absence of Vsx2, but 
they still occur to some extent, suggesting that Vsx2 promotes their efficient execution 
rather than being strictly required. Thus, Vsx2 also appears to exhibit the regulatory 
ability necessary for such coordination during retinal histogenesis. Establishment of such 
a role for Vsx2 in the coordination of these diverse cellular processes would also provide 
a mechanism through which Vsx2 could act to promote the transition of optic 
neuroepithelial cells into rapidly proliferating and neurogenically competent RPCs. It will 
be interesting to see whether these predictions hold as the mechanisms of Vsx2 function 
are defined.  
In addition to complex regulation within retinal development, the importance of 
inter-tissue interactions and reuse of intrinsic and extrinsic factors at different times, in 
different places, and even in different ways during ocular development, has made the 
study of complex gene function difficult in retinal development. However, genetic 
chimeras have proven powerful and insightful tools in a number of studies, including the 
present, [(Li et al., 2007; Medina-Martinez et al., 2009) and for review, see (Collinson et 
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al., 2004)]. However, most previous studies used chimeras for assessing lineage 
requirements and patterns of tissue growth. Use of chimeras in assessing cellular 
phenotypes has been limited, but as we demonstrate here, can provide valuable insight 
into gene function. Additionally, chimeras also provided insight into aspects of retinal 
development not specifically regulated by Vsx2, including the regionalization of extrinsic 
regulation controlling RPC proliferation and the importance of extrinsic regulation in 
driving progenitor maintenance. The relationships between intrinsic factors and extrinsic 
signals involved in regulating the cellular processes of retinal histogenesis are only 
beginning to be defined. Continued use of genetic chimeras in these endeavors will be 
beneficial, particularly if combined with evaluation of the activity state of signaling 
pathways in the composite cell populations. 
While genetic chimeras are powerful tools, other methods could have been used 
to address the questions of autonomy presented here. For example, although in vitro co-
culture techniques lack the spatial information provided by chimera analyses, they too 
can address questions of autonomy, with the added benefit of determining primary versus 
secondary effects, since the time of interaction between wild type and mutant cell 
populations is defined. Co-cultures are also particularly useful in addressing questions of 
cell behavior, including those regarding cell adhesion, which will be important to address 
in future studies of Vsx2 function. Generation of genetic mosaics through Cre-loxP 
technology can also address questions of autonomy with similar spatial resolution as 
chimeras, but are limited by the expression pattern of the Cre driver. Additionally, 
chimeras tend to provide more random and variable patterns of chimerism, which permit 
a greater range of questions. However, because of the spatial and temporal control 
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afforded by these Cre drivers, genetic mosaics are particularly useful in circumventing 
early cell autonomous requirements for a gene of interest that prevent analyses of gene 
function in chimeras, such as exclusion of mutant cells from tissues in which they may 
exhibit later functions. In the study of Vsx2 gene function, temporal control of Vsx2 
inactivation may help separate the contribution of ectopic Mitf function in the regulation 
of RPC proliferation and neurogenesis, by inactivating Vsx2 after Mitf is downregulated. 
Furthermore, such temporal control will aid assessment of temporal changes in Vsx2-
dependent regulation of retinal histogenesis. These methods, in combination with 




 In the present work, we illustrate the important relationship between the retinal 
homeobox gene Vsx2 and extrinsic signaling pathways in the regulation of retinal 
histogenesis, by demonstrating a requirement for Vsx2 in promoting both the reception 
and availability of extrinsic signals necessary for the regulation of RPC properties. We 
show that the use of genetic chimeras can advance our understanding of both Vsx2 
function and principles of retinal development, and their continued use will undoubtedly 
prove a valuable tool in further defining the mechanisms of Vsx2 function and other 
genes in the regulation of retinal histogenesis. The present work provides direction for 
future studies that will improve our understanding of progenitor regulation and retinal 
development, which will facilitate the development of therapeutic techniques for the 




















Figure 5.1. Model of disrupted Shh availability and its effects on RPC proliferation in the 
orJ retina. During the period of retinal histogenesis analyzed in the present work, retinal 
ganglion cells are the relevant source of Shh ligand in the retina, and their production of 
Shh ligand is both necessary and sufficient to activate Hh signaling in RPCs and enhance 
their proliferation. In the early embryo, ganglion cells initiate their production of Shh 
soon after their differentiation, which promotes proliferation of adjacent RPCs. In the orJ 
retina, differentiation of retinal ganglion cells is delayed. During this delay, the resulting 
absence of mitogenic Shh contributes to a slower rate of RPC proliferation. Once 
ganglion cell differentiation initiates in the orJ retina, Shh production follows. By birth, 
the ganglion cell population in wild type retinas produces high levels of Shh ligand that 
in turn promotes robust proliferation of RPCs. Although the proportion of ganglion cells 
appears unaffected in the orJ retina at birth, production of Shh is reduced. This limited 
availability of Shh ligand at neonatal ages in the orJ retina then contributes to a slower 
rate of RPC proliferation. Abbreviations:  GC, ganglion cell; RPC, retinal progenitor cell; 





























Figure 5.2. Model of the progression of neurogenesis in the retinas of wild type, orJ, and 
mutant chimeras. In wild type retinas, neurogenesis has progressed throughout the central 
retina by E12.5 and continues in a peripherally-spreading wave that reaches the periphery 
by E15.5. In contrast, neurogenesis has yet to initiate at E12.5 in the orJ retina. By E15.5, 
neurogenesis has initiated and progressed throughout the central retina, but has yet to 
reach the periphery. In mutant chimeras, the patterns of neurogenesis observed for wild 
type and orJ cell populations at E12.5 and E15.5 match that observed in the wild type and 
orJ retinas, respectively, indicating that orJ cells retain their delayed neurogenic program 
despite the normal progression of neurogenesis in adjacent wild type cells. Thus, two 
independent peripherally-spreading waves of neurogenesis propagate across the retina in 
mutant chimeras, one in each cell population. Arrows indicate the spatial extent of 
neurogenesis in the different cell populations. Green represents wild type cell populations 
and magenta represents orJ cell populations. Dorsal is up and posterior is to the left. 


































Figure 5.3. Autonomy of Vsx2 functions in the regulation of retinal progenitor properties 
and potential mechanisms of action. Illustrated are the proposed relationships between 
Vsx2 and the intrinsic and extrinsic factors regulating the maintenance of retinal identity, 
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EXPRESSION ANALYSIS OF SHH AND HEDGEHOG 
PATHWAY COMPONENTS IN THE DEVELOPING 
MOUSE EMBRYO:  RELATIONSHIPS BETWEEN 
REGULATORS OF FEEDBACK INHIBITION 




Sonic Hedgehog (Shh) has emerged as a fundamental signaling molecule in 
vertebrate development. Throughout embryogenesis, Shh is utilized repeatedly to mediate 
a diverse array of developmental processes. Shh regulates proliferation, differentiation, 
fate determination, migration, polarity, and survival in multiple cell types, ultimately 
directing the patterning, growth and morphogenesis of numerous tissues and organs. Shh 
also plays important roles in the establishment of left-right asymmetry and axonal 
guidance (Ingham and McMahon, 2001; Varjosalo and Taipale, 2008). Despite such 
diversity, Shh often controls multiple processes within a single tissue, even in a 
temporally overlapping fashion (Amato et al., 2004; Wallace, 2008).  
Shh is a secreted glycoprotein belonging to the Hedgehog (Hh) family of 
intercellular signaling molecules, which in mammals also includes Desert Hedgehog 
(Dhh) and Indian Hedgehog (Ihh). Much of Shh function is mediated by transcriptional 
regulation of Hh target genes through activity of the Hh signaling pathway (Riobo and 
Manning, 2007; Ryan and Chiang, 2012; Varjosalo and Taipale, 2008). Binding of Shh or 
other Hh ligands to the Hh receptor, Patched homolog 1 (Ptch1), relieves Ptch1-mediated 
inhibition of Smoothened (Smo). Activated Smo inhibits proteolytic processing of the Gli 
transcriptional effectors into truncated repressor forms and promotes the nuclear 
localization and activation of full-length Gli proteins. The resulting reduction of Gli 
repressor forms and accumulation of Gli activator forms in the nucleus upon pathway 
activation promotes both the derepression and activation of Hh target genes. 
Transcriptional targets of the Hh pathway not only mediate downstream signaling 
and cellular responses to Hh ligands, but also participate in feedback loops that further 
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regulate Hh signaling. Ptch1, Ptch2, and Hhip participate in negative feedback loops that 
act at the level of Hh reception. The Hh receptor, Ptch1, negatively regulates the Hh 
pathway through inhibition of Smo activity. Ptch1 is upregulated in response to Hh 
signaling (Chiang et al., 1996; Goodrich et al., 1996). Evaluation of phenotypes and Hh 
pathway activity in mice heterozygous for Ptch1 suggests that Hh activity is sensitive to 
Ptch1 gene dosage (Goodrich et al., 1997). In Drosophila, cellular responses to Hh ligand 
were determined by the ratio of bound to unbound Ptc (Casali and Struhl, 2004). 
Furthermore, overexpression of Ptch1 was sufficient to reduce Shh-stimulated 
upregulation of Hh target gene expression and induce phenotypes consistent with reduced 
Shh signaling (Goodrich et al., 1999). In Drosophila, high levels of Ptc sequester Hh 
ligands and limit their spread within the embryo (Chen and Struhl, 1996). Thus, 
upregulation of Ptc/Ptch1 likely serves to increase sequestration of Hh ligands and 
desensitize the cell to Hh signal, thereby limiting the level and possibly the spatial extent 
of Hh signaling. Patched homolog 2 (Ptch2) shares sequence homology with Ptch1 and is 
also upregulated in response to Hh signaling, although this upregulation may be context 
dependent (Carpenter et al., 1998; Motoyama et al., 1998b; Rahnama et al., 2004). Like 
Ptch1, Ptch2 also binds Hh ligands with high affinity (Carpenter et al., 1998) and inhibits 
Shh-induced changes in gene expression (Rahnama et al., 2004). However, unlike Ptch1, 
Ptch2 fails to block changes in gene expression induced by a constitutively active form of 
Smo and is unable to replace Ptch1 function in basal carcinoma cells or Ptch1 null cells 
(Rahnama et al., 2004; Zaphiropoulos et al., 1999). This inability to mediate Shh-
stimulated signaling suggests that Ptch2 negatively regulates Hh signaling by binding and 
sequestering Hh ligands. Hedgehog-interacting protein (Hhip) also participates in 
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feedback inhibition. Hhip expression is upregulated in response to Hh signaling. Hhip 
binds Hh ligands with similar affinity as Ptch1 and is both necessary and sufficient to 
attenuate Hh signaling during embryonic development (Chuang et al., 2003; Chuang and 
McMahon, 1999). Thus, like Ptch1 and Ptch2, Hhip also negatively regulates the level of 
Hh ligands to which the responding cell is exposed. The principal positive feedback loop 
in the Hh pathway involves the transcriptional effector Gli1. Transcription of Gli1 is 
activated in response to Gli2- and Gli3-mediated transduction of Hh signals. Proteolytic 
processing completely degrades Gli1 with no evidence of a repressor form. This, together 
with its potent activator function, suggests Gli1 serves as a strong positive feedback 
mechanism to increase signaling levels within responding cells while retaining 
dependence on active Hh signaling. In the present study, the dependence of Gli1 
expression on active Hh signaling makes Gli1 an excellent indicator of active Hh 
reception.  
A balance of Hh activator and repressor functions is required for proper 
embryonic development. As a result, Hh signaling is tightly regulated, both externally 
through regulation of Hh ligands and pathway components and internally through 
positive and negative feedback mechanisms. Consistent with the latter is the finding that 
manipulations of these positive and negative regulators often fail to cause dramatic 
phenotypes, suggesting that the pathway is largely resistant to subtle changes in 
regulatory components (Bai et al., 2002; Goodrich et al., 1999; Nieuwenhuis et al., 2006). 
This resistance is likely a result of compensation through feedback mechanisms altering 
expression of other regulatory components. The present study details the expression of 
the regulatory feedback components Ptch1, Ptch2, Hhip, and Gli1 with respect to Shh-
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expressing tissues in the developing mouse to evaluate how expression of negative 




Mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). All 
mice used in this study were on a 129/Sv background. Some mice were heterozygous for 
the ocular retardation J (orJ) allele. The orJ allele is a recessive null mutation in the 
Vsx2 gene (Burmeister et al., 1996). Wild type (+) and orJ alleles were determined by 
PCR and restriction digest, as previously described (Burmeister et al., 1996), from 
embryonic tail samples or adult ear clips. Phenotypes of homozygous orJ/orJ mice are 
restricted to the eye. Previous studies ((Rowan et al., 2004; Sigulinsky et al., 2008) and 
our unpublished observations) suggest that development of the eye and other Vsx2-
expressing tissues in heterozygous (orJ/+) mice is phenotypically indistinguishable from 
wild type (+/+) mice. Thus, both heterozygous orJ and homozygous wild type mice were 
considered equivalent and referred to as wild type in the text. Mice were bred overnight 
and noon on the day of vaginal plug was considered embryonic day 0.5 (E0.5). All 
animal use and care was conducted in accordance with protocols approved by the 
University of Utah IACUC.  
 
In situ hybridization 
 Following dissection in Hank’s buffered saline solution (HBSS), embryonic heads 
were fixed overnight at 4 °C in either 4% paraformaldehyde (PFA) in phosphate buffered 
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saline (PBS, pH 7.5) or 4% formaldehyde in PBS/2 mM EGTA. Fixed tissue was 
cryoprotected by sequential immersion in 5%, 10%, and 20% sucrose/PBS, then 
embedded and frozen in OCT and stored at -80 °C. Serial sections (12 µm) were cut, 
placed on separate slides, and stored at -20 °C until use. Adjacent serial sections from the 
same mouse were stained with digoxigenin-labeled anti-sense probes for Shh, Ptch1, 
Ptch2, Gli1, and Hhip. Section in situ hybridization was performed as previously 
described (Green et al., 2003; Schaeren-Wiemers and Gerfin-Moser, 1993). 
 
Image capture and analysis 
 Embryonic head sections were captured as mosaicked tiles of 8-bit, 1388 pixel 
1036 line frames under voltage-regulated tungsten halogen flux with a variation of 1.2 ± 
0.6%/min (mean ± sd). Mosaic image tiles were acquired with automated image capture 
using with a Peltier-cooled QImaging Fast 1394 QICAM (QImaging, Burnaby, BC, 
Canada) and automated Scan 100x100 stage (Märzhäuser Wetzlar GmbH, Wetzlar 
Germany). Mosaic image tiles were autotiled using a Syncroscan montaging system 
(Synoptics Inc, Frederick, MD, USA). Images were acquired at 10X magnification on a 
Leica DMR upright microscope. Hair follicles were reimaged at 20X magnification with 
DIC under brightfield illumination on a Nikon E-600 epifluorescence microscope 
equipped with a Spot-RT slider CCD camera (Diagnostic Instruments Inc., Sterling 
Heights, MI, USA). Due to their small size, hair follicles could not be analyzed for all 
probes on adjacent serial sections. Thus, similar positions within representative stage-
matched follicles were imaged. Images of adjacent serial sections were aligned by hand 
279 
 




 To evaluate the relationship between regulators of feedback inhibition and Hh 
pathway activation, we compared expression of Ptch1, Ptch2, and Hhip with that of Shh 
and Gli1 in the developing molars, hair follicles, palate, eyelids, and eyes of the E15.5 
mouse (Figure A.1). Shh expression identified structures with active sources of Hh 
signaling. Gli1 served as an indicator of Hh-responsive tissues. Expression was examined 
on adjacent serial sections containing all of the structures of interest. This method 
provides two advantages:  1) expression levels of a single transcript can be directly 
compared across multiple structures, and 2) expression patterns of multiple transcripts 
can be compared within a given structure at relatively similar positions. The following 
sections detail the expression of Shh, Gli1, Ptch1, Ptch2, and Hhip in each structure.  
 
Molars 
Odontogenesis of molars involves the budding of thickened oral epithelium and 
subsequent interactions with condensing neural-crest-derived mesenchymal cells 
(ectomesenchyme). By E15.5, the upper and lower molars have reached the late cap stage 
(Figure A.2A,G). The oral epithelium has undergone drastic morphological changes and 
histodifferentiation, giving rise to the internal and external dental epithelium, 
intermediate stratum, and stellate reticulum, which connect to the oral epithelium via the 
pedicle. Condensation of the ectomesenchymal cells is the process of establishing the 
280 
 
dental papilla and dental follicle. Expression of Hh pathway genes has been described 
previously (reviewed in (Cobourne and Sharpe, 2005)) and is consistent with what is 
reported here.  
Shh expression in the late cap stage is restricted to the epithelial components of 
both the upper and lower molars (Figure A.2B,H). Strong expression is observed within 
the internal dental epithelium and adjacent intermediate stratum. Shh expression also 
extends into varying portions of the stellate reticulum. In the upper molars, expression 
into the stellate reticulum is extensive, but in the lower molars is largely restricted to the 
intermediate stratum. Interestingly, expression in these epithelial tissues is more 
extensive on the lingual (tongue) side of both the upper and lower molars. Similar to Shh, 
Ptch2 transcripts are detected throughout the internal and external dental epithelium 
(Figure A.2.C,I). Strongest expression is observed within the internal dental epithelium 
and extends beyond the range of Shh expression, particularly on the buccal (cheek) side. 
In contrast, expression within the external dental epithelium is weak. Weak Ptch2 signal 
is also observed within the intermediate stratum and stellate reticulum. This expression is 
not uniform and extends beyond the range of Shh expression. Contrary to previous 
reports (reviewed in Cobourne and Sharpe, 2005), Ptch2 is also weakly detected within 
the condensing ectomesenchyme of the forming dental papilla and follicle. In the upper 
and lower molars, Ptch1 is expressed throughout both epithelial and mesenchymal 
components (Figure A.2D,J). Strongest expression is observed in the condensing 
ectomesenchyme, including that forming the dental papilla and follicle, and in the most 
peripheral stellate reticulum and pedicle. Robust expression is also found in the internal 
and external dental epithelium, intermediate stratum, and distal stellate reticulum. Strong 
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expression of Hhip transcripts is restricted to a narrow band of peripheral mesenchyme, 
including the dental follicle, which encompasses the developing molars, many cell 
diameters from Shh-expressing cells (Figure A.2E,K). Faint Hhip expression is also 
detected throughout the remaining mesenchymal and epithelial components of the 
developing upper and lower molars. Gli1 expression (Figure A.2F,L) mirrors that of 
Ptch1. Interestingly, Gli1 expression fails to extend into the oral mesenchyme much 
beyond the extent of strongest Hhip expression in the forming dental follicle. Because 
Gli1 provides a reliable readout of active Hh signaling, expression of Gli1 transcripts 
reveals Hh pathway activation throughout the epithelial and mesenchymal tissues of the 
developing molars.  
  
Hair follicles 
Like molars, hair follicles (HF) arise through a series of interactions between the 
epidermis and underlying mesenchyme. The basal layer of the epidermis thickens and 
grows downward toward condensing dermal mesenchyme. By E15.5, most tylotrich 
pelage hair follicles (Hardy, 1969; Mann, 1962) have reached stage 3 of hair follicle 
morphogenesis (based on morphological classification described in (Hardy, 1969, 1992; 
Paus et al., 1999)). At this stage, the follicle, now termed a hair peg, consists of a solid 
column of epidermally-derived epithelial cells with a concave end that partially or wholly 
encompasses the dermal condensate, which will form the future dermal papilla (Figure 
A.2M).  
Expression of Shh within the stage 3 hair follicle is restricted to the distal end of 
the epithelial downgrowth, within the concave basal border cells that contact the dermal 
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condensate (Figure A.2N). Ptch2 transcripts are similarly expressed in the distal 
epithelium of the hair peg (Figure A.2O), overlapping the region of Shh expression. 
However, weaker Ptch2 expression extends beyond the Shh-expressing region, up the 
outer walls of the hair peg. Ptch1 is expressed in both the epithelial and mesenchymal 
components of the developing hair follicle (Figure A.2P). Strongest expression is 
observed in the distal half of the epithelially-derived hair peg, both in the outer layer cells 
and cells of the interior, and uniformly through the dermal condensate. The most 
proximal aspect of the hair peg only weakly expresses Ptch1. Weak Ptch1 expression 
also extends slightly into the surrounding noncondensed dermal mesenchyme directly 
adjacent to the hair peg and dermal condensate. Expression of Hhip is strongest in a 
narrow region of the noncondensing dermal mesenchyme surrounding the dermal 
condensate and hair peg (Figure A.2Q). Weak expression is also observed in the 
peripheral cells of the dermal condensate and inner portions of the hair peg. Gli1 
expression (Figure A.2R) again mimics that of Ptch1 and is largely restricted within the 
border of high Hhip expression. Gli1 expression reveals active Hh reception and 
signaling in both the mesenchymal and epithelial components.  
Expression of Shh and Ptch2 at stage 3 (Figure A.2N,O) is consistent with reports 
of expression patterns reported for other stages (stages 0-2 and stages 4-5; (St-Jacques et 
al., 1998). While the expression of Ptch1 and Gli1 at stage 3 (Figure A.2P,R) is also 
consistent with reports for earlier stages (0-2), the expression observed at stage 3 is much 




Palate development is a complex process involving elevation, midline contact and 
eventual fusing of the palatal shelves above the tongue (Rice et al., 2006). In the murine 
palate at E15.5, fusion of the palatal shelves is mostly complete and the medial edge 
epithelia seam is undetectable (Figure A.3A). At this rather late stage of palate 
development, expression of Hh pathway components in the palatal tissues is largely 
restricted to the developing rugae (Rice et al., 2006). However, some pathway 
components are also expressed in the developing palatine bones in response to known Ihh 
signals in this structure (Levi et al., 2011; Nelson et al., 2011; Rice et al., 2006).  
Expression of Shh transcripts in the palate is restricted to the small, thickened 
regions of palatal oral epithelium known as rugae (Figure A.3B). Unlike the other 
epithelial/mesenchymal organs described here, a clear Ptch2 signal is undetectable in the 
palatal oral epithelium (Figure A.3C), consistent with previous reports (Rice et al., 2006). 
Ptch2 expression was also not observed in the palatal mesenchyme. In previous reports, 
Ptch2 was weakly detected only in anterior palatal mesenchyme (Rice et al., 2006). Ptch1 
is strongly expressed by the thickened palatal oral epithelium in a region that overlaps 
with but extends beyond that of Shh expression (Figure A.3D). Robust Ptch1 expression 
is also observed extending into the palatal mesenchyme immediately adjacent to the 
palatal oral epithelium in a gradient fashion. Hhip is strongly expressed in the palatal 
mesenchyme adjacent to the palatal oral epithelium of the developing rugae (Figure 
A.3E), in a large region that overlaps and extends beyond that of Gli1 and Ptch1 
expression. This mesenchymal expression is also graded in nature, with the strongest 
expression closest to the oral epithelium. Gli1 transcripts are again expressed in a pattern 
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similar to that observed for Ptch1 in rugae of the palatal oral epithelium and adjacent 
mesenchyme, although slightly more restricted in range and less uniform within the 
mesenchymal component (Figure A.3F). Thus, epithelial-derived Shh activates Hh 
signaling in both the palatal epithelium and adjacent mesenchyme. 
 
Eyelid 
During eyelid development, the lid primordia emerge as folds from the epidermis 
and dermis surrounding the eye, which then grow to extend over the corneal surface of 
the eye until they meet and fuse, only to reopen later. By E15.5 in the mouse, the upper 
and lower eyelids have extended over the corneal surface and fused at approximately the 
center of the eye (Figure A.3G). Expression patterns of Shh, Ptch1 and Ptch2 have been 
reported in the eyelid prior to fusion, during the extension phase (Motoyama et al., 
1998a), and appear to be restricted to the basal layer of the eyelid epithelium.  
Following fusion, expression of Shh, Ptch1 and Ptch2 continues in the basal layer 
of the eyelid epithelium originating from both the upper and lower lid primordial (Figure 
A.3H-J). Shh expression is restricted to a small patch of basal layer eyelid epithelium on 
the corneal side (Figure A.3H). Ptch2 expression is similarly restricted to the basal layer 
eyelid epithelium but exhibits a broader expression territory that overlaps and extends 
beyond the region of Shh expression (Figure A.3I). Ptch1 is also strongly expressed 
within a similar range of basal layer eyelid epithelium (Figure A.3J). However, unlike the 
epithelium-restricted expression observed in the extension stage (Motoyama et al., 
1998a), Ptch1 expression clearly extends into the adjacent mesenchyme of the eyelid tip, 
although at weaker levels. Hhip is only faintly detected in the mesenchyme of the eyelid 
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tip (Figure A.3K). Gli1 is expressed in both the basal layer eyelid epithelium and adjacent 
mesenchyme of the eyelid tip (Figure A.3L) in a range comparable to that of Ptch1 and 
reveals active Hh signaling in these tissues.  
 
Ocular tissues 
Eye development involves a series of complicated morphogenic processes in 
which the retina, retinal pigmented epithelium (RPE), and optic stalk derive from the 
neuroectoderm and come to surround the surface ectoderm-derived lens capsule in a cup-
like fashion. By E15.5, the lens vesicle has detached from the overlying surface ectoderm 
and the remaining surface ectodermal cells together with migrating mesenchymal cells 
have condensed to form the layers of the corneal epithelium. In the optic cup, the RPE 
monolayer surrounding the neural retina has become pigmented (Figure A.4A). 
Furthermore, by this stage of retinal development, retinal neurogenesis is incomplete. 
Thus, the E15.5 neural retinal contains two distinct layers:  a basal differentiated cell 
layer containing nascent neurons and an apical neuroblast layer containing progenitors 
(Figure A.4A’).  
Expression of Hh pathway components in the eye at E15.5 is restricted to the 
developing retina, cells of the developing choroid and sclera surrounding the RPE, and 
differentiating stromal cells of the iris and ciliary body (Figure A.4B-F). In the neural 
retina, Shh expression is restricted to the differentiated cell layer (Figure A.4B,B’), 
consistent with its production by differentiated retinal ganglion cells (Wallace, 2008). In 
striking contrast to the previously described structures, Ptch2 is only faintly detectable in 
the Shh-expressing cells of the differentiated cell layer (Figure A.4C,C’). Expression is 
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also faintly detected in the adjacent neuroblast layer at a level indistinguishable from that 
of the differentiated cell layer. Expression of Ptch1 extends throughout both retinal 
layers, with slightly stronger expression observed in the neuroblast layer (Figure 
A.4D,D’). Interestingly, Ptch1 is expressed at relatively low levels in the neural retina, at 
least compared to Ptch1 expression in other organ structures (compare Figure A.4D,D’ to 
Figures A.2D,J,P and A.3D,J). Hhip is detected throughout the neural retina, also with 
slightly stronger expression observed in the neuroblast layer (Figure A.4E,E’). In 
contrast, expression of Gli1 is restricted to the neuroblast layer (Figure A.4F,F’) and 
consistent with the established roles of Shh and Hh signaling in the proliferation and cell 
fate decisions of retinal progenitor cells (Wallace, 2008). 
A narrow band of Ptch1, Gli1 and Hhip expression is also observed outside the 
retina in the scleral condensation of the periocular mesenchyme (Figure A.4D-F). This 
periocular expression is a response to IHH signals produced by endothelial cells of the 
developing choroidal vasculature, a layer of cells situated between the RPE and scleral 
condensation (Dakubo et al., 2008; Dakubo et al., 2003; Wallace and Raff, 1999). 
Analyses of Hh target gene expression in ocular tissues of Ihh null mice and conditional 
Shh mutants reveal that the range of neuron-derived Shh action is restricted to the neural 
retina, while the range of Ihh action is restricted to the RPE and periocular mesenchyme 
(Dakubo et al., 2008; Dakubo et al., 2003). In addition, Gli1 and weak Ptch1 expression 
are also detected in the stroma of the iris and ciliary body (Figure A.4D,F). The lack of 
detectable Shh expression (Figure A.4B) and proximity to the RPE suggests this 





In the present study, we evaluated the relationship between regulators of feedback 
inhibition and Shh-induced activation of Hh signaling by comparing the expression of 
Ptch1, Ptch2, and Hhip with that of Shh and Gli1 in a variety of developing organs, 
including the molars, hair follicles, palatal rugae, eyelids, and neural retina. 
Organogenesis of most of these structures involves epithelial-mesenchymal interactions 
and Hh pathway components are expressed in both compartments. The neural retina is 
unique in that it is of neural epithelial origin and Hh pathway components exhibit 
variable expression within defined regions of this epithelial tissue.  
This expression analysis revealed several common patterns of expression among 
organs and relationships between Hh pathway components. Shh expression was restricted 
to epithelial tissues within the molars, hair follicles, palatal rugae and eyelids, and to the 
differentiated neurons of the retina. Ptch2 expression was similarly restricted to epithelial 
tissues. Although staining was performed on separate sections, Ptch2 expression appears 
to overlap that of Shh in these epithelial tissues, but more broadly, and is consistent with 
earlier reports (Motoyama et al., 1998a; Motoyama et al., 1998b). In contrast, Ptch2 
expression was not detected in the epithelium of the palatal rugae. In the neural ectoderm 
of the retina, Ptch2 expression was extremely faint, but appeared to be uniform across the 
layers of the retina, in both Shh-expressing and nonexpressing layers. Ptch1 and Gli1 
exhibited largely overlapping patterns of expression. Both were expressed throughout 
epithelial and mesenchymal tissues. Interestingly, mesenchymal tissues stained more 
strongly for Ptch1 and Gli1 in the molars and hair follicles, while epithelial staining was 
stronger in the palate and eyelids. In the neural retina, Gli1 expression overlapped with 
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that of Ptch1 in the neuroblast layer, but was absent from the differentiated cell layer, 
despite Ptch1 expression in this layer. Faint Hhip expression was detected throughout 
both epithelial and mesenchymal tissues in most organs. A strong, narrow band of 
expression was observed in the mesenchyme surrounding both molars and hair follicles at 
the outer edge of Ptch1 and Gli1 expression, at a distance from Shh-expressing cells. In 
contrast, the graded Hhip expression within the palate was strongest immediately 
adjacent to the Shh-expressing epithelium. This expression appeared to extend beyond 
Ptch1 and Gli1 territories, but such extensive expression is unlikely since Hhip depends 
on Hh signaling for upregulation. A possible explanation is that Ptch1 and Gli1 are 
expressed, but below the level of detection. However, it is more likely that these 
differences in the extent of expression reflect slightly different positions along the rugae 
in the different sections. Double labeling will be required to resolve this issue. 
 Upregulation of the feedback inhibitors generally correlated with levels of Shh 
expression. Shh expression was weakest in the neural retina and was associated with 
lower expression of Ptch1, Ptch2, and Hhip compared to other organs. This relationship 
is consistent with their roles in feedback inhibition to attenuate or limit the extent of Hh 
signaling. However, how the highest levels of Hhip expression are accomplished at the 
outer extent of pathway activation in molars and hair follicles is unclear. Interestingly, 
Gli1, a positive feedback signal, exhibited similar expression levels across organs, 
irrespective of Shh levels. It is tempting to speculate that the upregulation of feedback 
inhibitors in the presence of high Hh ligand and upregulation of positive feedback 
components when Hh ligand is low is required to achieve a certain threshold of Hh 
signaling activity. However, Hh signals are important morphogens whose graded 
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signaling determines specific cellular outcomes. How such a morphogen gradient is 
established in the context of these positive and negative feedback signals is not clear but 
may suggest a critical role for complementary gradients by an opposing morphogen.  
 The dependence of Gli1 expression on cell autonomous Hh signal transduction 
makes it a reliable indicator of active Hh reception and signaling within cells. This 
feature also provides insight into paracrine versus autocrine signaling in Hh responsive 
cells. Although expression was analyzed on separate sections, expression of Gli1 was 
both broad and uniform throughout the epithelial tissues exhibiting Shh expression, 
suggesting that coexpression is likely. Thus, activation of autocrine signaling may be an 
important aspect of Shh signaling during organogenesis. Interestingly, in the neural 
epithelium of the retina, Gli1 expression is undetectable in the Shh-expressing neurons of 
the differentiated cell layer, suggesting that autocrine signaling does not occur in this 
tissue. However, Shh directs commissural axon guidance in vivo, independent of 
transcription, through activation of Src family kinases (Yam et al., 2009). Shh-expressing 
ganglion cells are the projection neurons of the retina. Thus, it is possible that autocrine 
signaling also occurs in these cells, but in a transcription-independent fashion. Shh also 
activates paracrine signaling in epithelial tissues since Shh expression was often restricted 
to a defined subregion. In contrast, paracrine signaling is responsible for activation of Hh 
signaling in mesenchymal tissues.  
 Interestingly, negative regulators involved in feedback inhibition of the Hh 
pathway differentially associated with these modes of signaling. Strong upregulation of 
Ptch1 and Hhip was principally associated with activation of paracrine signaling in 
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mesenchymal tissues. In contrast, Ptch2 expression was principally associated with 
autocrine signaling within Shh-expressing epithelial cells. 
Active Hh signaling was also observed in the stroma of the developing iris and 
ciliary body. Proximity of these stromal cells to the endothelial cells of the developing 
choroid, a known source of Ihh (Dakubo et al., 2008; Dakubo et al., 2003; Wallace and 
Raff, 1999), suggests this signaling may be in response to Ihh. In a previous analysis of 
wild type and Ihh null mice, Gli1 expression was not reported in the stroma of the iris or 
ciliary body (Dakubo et al., 2008; Dakubo et al., 2003). However, differentiation of 
neural crest and/or mesenchymal cells to generate the stromal cells of the iris and ciliary 
body initiates around the time that Gli1 expression was examined in Ihh null mice (Cvekl 
and Tamm, 2004). Mutations in Shh are associated with iris coloboma (Schimmenti et al., 
2003); however, this may simply reflect the role of Shh in early patterning events 
required for proper morphogenesis of the optic cup and closure of the choroid fissure. 
Consistent with this idea, ablation of Pax2, a downstream target of midline-derived Shh, 
in mice also results in coloboma (Schwarz et al., 2000). Although Shh was undetectable 
near the peripheral optic cup in the present study, weak expression may have been 
masked by pigmentation of the RPE or iris and ciliary body. Dhh has also been detected 
in the developing postnatal RPE and adult iris of the mouse (Levine et al., 1997; 
Takabatake et al., 1997), but its role in eye development has not been examined. Ihh, but 
not Shh, was also detected in the adult iris of mouse and newt, together with Ptch1 and 
Ptch2 (Takabatake et al., 1997). Thus, the identity and source of the Hh ligand 
responsible for Hh pathway activation in the stroma of the iris and ciliary body will 
require future evaluation. Iris and ciliary body formation is principally regulated by 
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BMP/TGFβ and Wnt signaling (Cvekl and Tamm, 2004; Davis-Silberman and Ashery-




Expression analysis of the Hh pathway components examined in this study reveal 
that participation of negative regulators involved in feedback inhibition is a common 
theme of Hh signaling across organs. Although the individual expression patterns of 
Ptch1, Ptch2 and Hhip differed greatly, patterns were often similar across different 
organs, suggesting that the relationships between these negative regulators and activation 
of the Hh pathway may be fairly consistent. Furthermore, activation of both paracrine and 
autocrine signaling by Shh was associated with the expression of these negative 
regulators. Lastly, the significance of active hedgehog signaling in the developing stroma 
of the iris and ciliary body is unknown. Further analysis is required to determine the 
identity and source of the Hh ligand responsible for this activity and its role in the 


















Figure A.1. Expression patterns for Shh and Hh pathway components in developing 
organs of the embryonic murine head. In situ hybridation for Shh (A), Ptch1 (B), Gli1 

















Figure A.2. Comparison of expression patterns for Shh and Hh pathway components in 
the molars and hair follicles. Expression of Shh (B, H, N), Ptch2 (C, I, O), Ptch1 (D, J, 
P), Hhip (E, K, Q), and Gli1 (F, L, R) in the upper molars (B-F), lower molars (H-L), and 
hair follicles (N-R). Diagrams illustrating the morphology of the developing upper (A) 
and lower (G) molars are shown with buccal to the left, lingual to the right. ide, internal 
dental epithelium; ede, external dental epithelium; is, intermediate stratum; sr, stellate 
reticulum; dp, dental papilla; df, dental follicle; p, pedicle; oc, oral cavity; om, oral 
mesenchyme; oep, oral epithelium; t, tongue. Diagram depicting the morphology of stage 
3 hair follicles is shown in (M). ep, epidermis; ep-bl, basal layer of epidermis; hp, hair 















Figure A.3. Comparison of expression patterns for Shh and Hh pathway components in 
the palate and eyelids. Expression of Shh (B, H), Ptch2 (C, I), Ptch1 (D, J), Hhip (E, K), 
and Gli1 (F, L) in the palate (B-F) and eyelids (H-L). Diagram depicting the morphology 
of the developing palate is shown in (A). r, palatal rugae; poep, palatal oral epithelium; 
pm, palatal mesenchyme; oc, oral cavity. Diagram depicting morphology of the 
developing eyelids is shown in (G). uld, upper lid; lld, lower lid; ep-sbl, suprabasal layer 
of epidermis; ep-bl, basal layer of epidermis; der, dermis; jep; junctional epithelium; p, 















Figure A.4. Comparison of expression patterns for Shh and Hh pathway components in 
the eye and surrounding tissues. Expression of Shh (B, B’), Ptch2 (C, C’), Ptch1 (D, D’), 
Hhip (E, E’), and Gli1 (F, F’) in the eye (B-F) and retina (B’-F’). Diagrams depicting the 
morphology of the developing eye (A) and retina (A’) are shown. nr, neural retina; RPE, 
retinal pigmented epithelium; v, vitreous; L, lens; ce, corneal epithelium; pom, periocular 
mesenchyme; is, iris stroma; cbs, ciliary body stroma; NBL, neuroblast layer; DCL, 
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